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Enterohaemorrhagic Escherichia coli (EHEC) strains are associated with gastrointestinal and 
severe systemic disease in humans.  EHEC O157:H7 is the most common serotype causing human 
infections in North America and the UK.  Human infections mainly originate from cattle, through 
either direct contact with infected animals or indirectly through contamination of food or water 
with animal faeces. From the sequencing of EHEC O157 strains, it is clear that the genomes 
contain multiple prophages, many of them cryptic, which define this E. coli pathotype. These 
regions include the locus of enterocyte effacement (LEE) which is a critical horizontally acquired 
pathogenicity island and encodes a type III secretion system (T3SS). The T3SS translocates 
effector proteins into epithelial cells that enable tight attachment to these host cells and also 
modify innate responses and other cellular functions to promote persistence in the animal host. 
The T3SS is essential for the colonisation of cattle by EHEC O157 where it is localised to the 
terminal rectum.  The regulation of T3S is complex with many regulators and environmental 
factors already identified. Previous work has demonstrated marked variation in the levels of T3S 
among EHEC O157 strains.  The aim of this research was to further investigate the regulation of 
T3S towards two objectives: (1) to understand the localisation of EHEC O157 at the terminal 
rectum of cattle; (2) to understand the strain variation in T3S.  (1) In relation to rectal and mucosal 
colonisation, established aerobic/anaerobic regulators were investigated including arcA, fnr, narX, 
narQ. Briefly, arcA, fnr, narX, narQ were deleted in an E. coli O157 strain ZAP198 by lambda 
red recombination. Apart from the fnr mutant which showed lower levels of T3S, the remaining 
mutants displayed similar T3S protein levels compared to the wild type strain. In addition, no 
significant changes in adherence and A/E lesion formation capacity were measured for the mutants 
following interaction with bovine epithelial cells. (2)  Strain secretion variation was approached in 
two ways; the first was to control expression from the LEE1 operon, required for T3S expression, 
in order to both induce expression and examine the importance of downstream regulation.  The 
second was to investigate variation in T3S between different phages types of EHEC O157.  While 
attempts to construct an inducible T3SS were not successful, intermediate strains made in the 
process have been useful to dissect how regulators being studied in the laboratory control T3S. 
The main novel insights from the research have come from examining T3S in different EHEC 
 
 XIX
O157 phage types. We found that the average level of T3S in PT 21/28 strains was lower than in 
PT 32 strains. Interestingly, most (90%) of PT 21/28 strains contained both Stx2 and Stx2c phages. 
In contrast, only 28% of PT 32 strains had both phages. Taken together, this raised the possibility 
that Stx phage integration might have a repressive impact on T3SS regulation in E.coli O157:H7. 
This hypothesis was addressed using a number of different approaches. Deletions of Stx phages 
were constructed and these had  increased levels of T3S when compared to the parental strains. 
This phage regulation of T3SS was confirmed in an E. coli K12 background by examining an 
induced LEE1 reporter in the presence and absence of a transduced Stx2 phage. In addition, it was 
shown that deletion of the CII phage regulator led to increased T3S and may contribute to the Stx 
phage repression reported above. This work demonstrates for the first time that Stx phage 
integration represses T3S expression. It is proposed that this control may limit immune exposure 
of this critical colonisation factor and that the repression actually allows activation by prophage 
encoded regulators, including PchA/B, that co-ordinate T3S and non LEE-encoded effector 


























1.1 Escherichia coli background 
Escherichia coli (E. coli) is a facultative anaerobic Gram-negative bacterium that 
colonises neonates within a short time of birth (Bettelheim et al., 1974). It was named 
after Theodore Escherich who first isolated and described it in 1885 from the faeces of 
healthy individuals in Germany (Wasteson, 2001). Usually, most E. coli strains are 
harmless and co-exist with the host in the gut. These E. coli strains can benefit the host 
by protecting it from infection by pathogenic bacteria (Reid et al., 2001) and synthesizing 
Vitamin K2 in the host intestine (Bentley & Meganathan, 1982).  However, E. coli strains 
can also cause diseases due to reduced immunity of the host or the evolution of more 
pathogenic E. coli strains (Nataro & Kaper, 1998).  
 
1.2  Pathogenic E. coli  
Enteric infection outbreaks caused by bacterial pathogens remain a problem in 
industrialized countries and developing nations (Fang, 2005).  These infections and 
outbreaks have a significant health and economic impact on humans and animals, and are 
especially severe for the young, elderly and immuno-compromised.  Most of the reported 
outbreaks are associated with pathogenic bacteria belonging to the Enterobacteriaceae. 
The Enterobacteriaceae contain many common bacterial pathogens that cause a range of 
intestinal and systemic illness from food- or water-borne outbreaks worldwide.  The key 
genera in the Enterobacteriaceae include: Salmonella, Shigella, Yersinia and Escherichia. 
 
Many pathogenic E. coli are considered as emerging pathogens and are involved in 
human clinical diseases such as acute intestinal disease and haemolytic uremic syndrome 
- HUS (Garmendia et al., 2005; Kaper et al., 2004). Six categories of pathogenic E. coli 
have been well-described: enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli 
(EHEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), diffusely 
adherent E. coli (DAEC) and enteroaggregative E. coli (EAEC) (Nataro & Kaper, 1998). 
Although the six pathovars show differences in their genome and other aspects, they 
share similar pathogenic mechanisms and can cause overlapping clinical outcomes 
(Kaper et al., 2004) (Fig. 1.1). 
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Fig. 1.1 Pathogenic scheme for diarrhoeagenic E. coli. ( originally from Kaper et 
al.,2004) Each type of diarrhoeagenic E. coli has its own unique features in the 
interaction with eukaryotic cells. Interactions with a target cell for these six categories of 
pathogenic E. coli are shown above. These summaries are mainly from the results of in 
vitro work and will not fully represent the host responses in humans. a. Illustration for 
EPEC: EPEC adhere to small bowel enterocytes, destroy the normal microvillar brush 
border, forming the typical attaching and effacing (A/E) lesion. Cytoskeletal derangement 
was accompanied by diarrhoea and inflammatory response. Three features are identified: 
i. Initial adhesion; ii. Protein translocation by a type III secretion system (T3SS); iii. 
Pedestal formation. b. Illustration for EHEC:   Similarly, A/E lesions exist in EHEC, but 
found in the colon. The distinguishing characteristic of EHEC is the production of Shiga 
toxin (Stx). The systemic absorption of Stx induces potentially life-threatening 
complications. c. Illustration for ETEC:  ETEC strains adhere to small bowel enterocytes 
like EPEC and results in watery diarrhoea by the secretion of heat-labile (LT) and/or 
heat-stable (ST) enterotoxins. d. Illustration for EAEC: EAEC attaches to small and large 
bowel epithelia in a thick biofilm. The distinguishing feature of EAEC is the secretion of 
enterotoxins and cytotoxins. e. Illustration for EIEC: EIEC targets the colonic epithelial 
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cell, lyses the phagosome and moves through the cell by nucleating actin microfilaments. 
Following attaching and invading, EIEC might move laterally through the epithelium by 
direct cell-to-cell spread or might stay and then re-enter the baso-lateral plasma 
membrane. f. Illustration for DAEC: DAEC induces a characteristic signal transduction 
effect in small bowel enterocytes.  This effect increases the growth of long finger-like 
cellular projections, which wrap around the bacteria. BFP, bundle-forming pilus; CFA, 
colonization factor antigen; AAF, aggregative adherence fimbriae; EAST1, 
enteroaggregative E. coli ST1; LT, heat-labile enterotoxin; ShET1, Shigella enterotoxin 1; 
ST, heat-stable enterotoxin; DAF, decay-accelerating factor. 
1.3 Enterohaemorrhagic E. coli (EHEC)  
 
EHEC are a subset of Stx-producing strains of Escherichia coli (STEC), which are 
associated with reported incidences of infection and severe disease. As an emerging 
pathogen, EHEC was identified as a distinct type of pathogenic E. coli from two main 
outbreaks. (i) EHEC was first reported by Riley and co-workers when E. coli O157:H7 
was isolated from a food-borne outbreak associated with watery diarrhoea and bloody 
diarrhoea in 1982 (Riley et al., 1983). This disease was associated with haemorrhagic 
colitis (HC), which results from colonization of the intestinal mucosa and subsequent 
toxin release.  ii) The second outbreak was reported by Karmali (Karmali et al., 1983) in 
1983, who observed the sporadic cases of HUS with faecal cytotoxin and cytotoxin-
producing E. coli in stools. HUS is characterized by the triad of acute renal failure, 
thrombocytopenia, and microangiopathic haemolytic anemia; and it is typically preceded 
by a bloody diarrhoeal illness. EHEC strains are characterized by many specific virulence 
determinants such as Shiga-toxin and locus of enterocyte effacement (LEE).  
 
A geographic distribution of EHEC infection was found, being more common in northern 
than southern states of the United States and more common in western than eastern 
Canada (Nataro & Kaper, 1998). The most often implicated EHEC serotype in outbreaks 
and sporadic cases of infection is E. coli O157:H7 (Karmali, 1989; Paton & Paton, 1998; 
Riley et al., 1983). Between 1 January 1992 and 31 December 2002, 44 of the 1645 food 
borne general outbreaks of infectious intestinal disease were caused by Shiga toxin-
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producing E. coli O157 according to the reports to the Health Protection Agency 





Table 1.1. General outbreaks of infectious intestinal disease (IID), foodborne general 
outbreaks of IID, and foodborne general outbreaks of EHEC O157 infection, England and 
Wales, 1992–2002.  
 
Year                 All                   Foodborne (%) STEC O157 (%) 
1992                373                   224 (60)                            3 (1.3) 
1993               454                    225 (50)                            6 (2.7) 
1994               490                    192 (39)                            0 
1995               837                    183 (22)                            5 (2.7) 
1996               733                    165 (23)                            7 (4.2) 
1997               591                    222 (38)                            4 (1.8) 
1998              610                     121 (20)                            4 (3.3) 
1999              515                     92 (18)                              7 (7.6) 
2000             656                      96 (15)                              6 (6.3) 
2001             526                      70 (13)                              1 (1.4) 
2002             1225                    55 (4)                                1 (1.8) 










1.4  E. coli O157:H7 
More than 100 different serotypes of EHEC have been identified as human pathogens 
such as O26:H11, O86:H34, O111:H8, O113:H21, O117:H14 and O157:H7 (Bettelheim 
et al., 2000).  One way to identify E. coli O157:H7 in microbiological procedures is the 
lack of capacity of most isolates to ferment sorbitol (Mead & Griffin, 1998). However, 
several sorbitol-fermenting, Stx-producing O157:H- strains were also isolated from 
patients with HUS in Germany (Gunzer et al., 1992). The recovery rate of E. coli 
O157:H7 on SMAC agar can be improved by prior enrichment in selective broth. GN 
Broth Hajna and trypticase soy broth supplemented with cefixime (50 ng/ml) and 
vancomycin (40 mg/ml) were both used with success (Karch et al., 1996; Sanderson et al., 
1995). Due to the resistance to cefixime and tellurite, SMAC agar containing cefixime 
and tellurite (CT-SMAC agar) is also commonly used to isolate Stx-producing E. coli 
O157:H7 (Zadik et al., 1993). Among outbreaks and sporadic cases (Friedrich et al., 
2007; Garg et al., 2005), E. coli O157:H7 is the most commonly isolated EHEC in the 
USA and UK and accounts for more than 90% of clinical cases.   
 
1.4.1 Serotyping of E. coli  
A serological system, known as the Kauffman scheme (Kauffmann, 1947), was 
introduced for E. coli classification in 1947. E. coli are serotyped on the basis of three 
types of surface antigen including the somatic (O) antigen (O-specific 
lipopolysaccharides on the outer membrane), the flagellar (H) antigen, and capsular (K) 
antigen (Ewing, 1972; Lior et al., 1996). So far, a total number of 170 different types of 
O antigen have been identified, each of which represents a serogroup.  Each “serotype” of 
an isolate is distinguished by a specific combination of O and H antigens such as E. coli 
O157:H7. The K characterization comes from the process described below. If an isolated 
E. coli strain did not agglutinate with O antisera but did so when the culture was heated, 
it was then defined to have a capsular or K antigen. Specific serogroups can be associated 
with certain clinical syndromes (Table 1.2). However, this association doesn’t indicate 
that certain serologic antigens always confer virulence (Gunzer et al., 1992).  
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Table 1.2. Serotypes characteristic of the diarrhoeagenic E. coli categories (Nataro & 
Kaper, 1998) 
 
Category                         Serogroup                                                Associated H antigen(s) 
ETEC                                  O6                                                               H16 
                                            O8                                                                H9 
                                            O11                                                              H27 
                                            O15                                                              H11 
                                            O20                                                              NM 
                                            O25                                                               H42, NM 
                                            O27                                                               H7 
                                            O78                                                               H11, H12 
                                            O128                                                             H7 
                                            O148                                                              H28 
                                            O149                                                              H10 
                                            O159                                                              H20 
                                            O173                                                              NM 
EPEC                                  O55                                                                 H6, NM 
                                            O86                                                                 H34, NM 
                                            O111                                                               H2, H12, NM 
                                            O119                                                               H6, NM 
                                            O125                                                               H21 
                                            O126                                                               H27, NM 
                                            O127                                                               H6, NM 
                                            O128                                                               H2, H12 
                                            O142                                                               H6 
EHEC                                 O26                                                                 H11, H32, NM 
                                           O157                                                                H7 
                                           O111                                                                H8, NM 
                                           O113                                                                H21 




Category                         Serogroup                                                Associated H antigen(s) 
EAEC                                  O3                                                                    H2 
                                            O15                                                                   H18 
                                            O44                                                                   H18 
                                            O86                                                                    NM 
                                            O77                                                                    H18 
                                            O111                                                                  H21 
                                            O127                                                                   H2 
                                            O?                                                                       H10 
EIEC                                   O28                                                                     NM 
                                            O29                                                                     NM 
                                            O112                                                                   NM 
                                            O124                                                                   H30, NM 
                                            O136                                                                    NM 
                                            O143                                                                   NM 
                                           O144                                                                    NM 
                                           O152                                                                    NM 
                                           O159                                                                    H2, NM 
                                           O164                                                                    NM 
                                           O167                                                                    H4, H5, NM 
NM: strains of E. coli O157:H7 that have lost the flagella H antigen become non-motile 









1.4.2 Phage-typing of E. coli O157:H7 
E. coli O157:H7 or O157:NM (non-motile) are well recognized pathogen serotypes and 
cause diarrhoeal diseases and other syndromes such as haemorrhagic colitis (HC) and 
haemolytic uremic syndrome (HUS). Although serotyping is an important tool to initially 
characterize isolates, more discriminatory methods are needed to relate strains in an 
outbreak and to determine if particular subtypes are more likely to be associated with 
disease.  Phage-typing schemes are used to trace the source of epidemics and classify 
pathogenic E. coli strains. In fact, the phage-typing scheme for Stx-producing E. coli 
O157:H7 has been successfully developed and applied in the investigation of the 
epidemiology of E. coli O157:H7 infections (Khakhriaa & Liora, 1990). Phage typing is 
usually carried out by the plaque assay technique. Briefly, a lawn of tested bacteria is 
cultured on an agar plate. The plate is divided into several distinct quadrants and labelled. 
Each quadrant is then inoculated with respective phage and incubated. Identification of 
lytic activity is then recorded by formation of plaques, which are the clear zones resulted 
from the lysis of the bacterial cells. 62 phage types were reported according to the 
geographical distribution in Canada. In contrast, 66 types were identified by using these 
16 phages in Britain (Smith & Scotland, 1993). A Wellcome Foundation International 
Partnership Research Award in Veterinary Epidemiology (IPRAVE) study revealed that 
phage type (PT) 21/28 is the main phage type found from 952 farms (Table 1.3). 
Consistent with this, PT 21/28 has been the main O157 phage type isolated from human 










Table 1.3.  Comparison of the proportion of phage types between cases of culture positive 
indigenous human E. coli O157 cases reported to HPS and cattle isolates during the same 
periods of the Scottish Executive Environment and Rural Affairs Department (SEERAD) 























1.4.3 Clinical impact of Shiga-toxigenic E. coli infections   
STEC can cause a wide range of clinical symptoms that include asymptomatic infection, 
mild-non bloody diarrhoea, HC (bloody diarrhoea), HUS, thrombocytopenic purpura and 
death (Boyce et al., 1995). The first Pennington report is about a serious E. coli O157:H7 
outbreak in 1996. The outbreak, which killed 21 people and infected 400 people, was 
traced to a butcher’s shop in Wishaw, Lanarkshire. The second Pennington report about E. 
coli O157:H7 referred to an outbreak in South Wales in 2005. This large outbreak 
infected 150 people and one child died (Agency, 2005). E. coli O157:H7 accounts for a 
small proportion of all food-borne cases (1996 [USA] 3 per 100,000); however, it is an 
important threat to public health with the potential for large-scale outbreaks and the 
serious complications associated with infections, including rare fatalities. The most lethal 
STEC outbreak occurred recently (May 2011) in northern Germany caused by an 
O104:H4 serotype.  In this case over 823 HUS cases have come from over 3,688 EHEC 
infection cases with 42 fatalities in Germany (as of 22nd June 2011). Other European 
countries have reported a total of 31 HUS cases (1 fatal) and 73 EHEC cases (none fatal) 
(Table 1.4).  The suspected source of this outbreak is locally produced bean sprouts. The 
sequence of the outbreak strain was cracked rapidly in China by high-technology 
methods. This strain belongs to an EAEC strain carrying Stx phages from EHEC, which 
then means the infection can cause HC and HUS.  In this case the high number of HUS 
cases may result from higher levels of Shiga toxin release due to enhanced adherence or 












Table1.4. HUS and EHEC infection in the Europe and North America as of 22nd June 
 
Country HUS EHEC Comments 
Cases Deaths Cases Deaths  
Austria 1 0 3 0  
Canada 0 0 1 0  
Czech 
Republic 
0 0 1 0 A tourist from the United 
States who had travelled in 
Germany 
Denmark 9 0 13 0  
France 0 0 2 0  
Germany 823 29 2865 13  
Greece 0 0 1 0 A German tourist 
Luxembourg 1 0 1 0  
Netherlands 4 0 5 0  
Norway 0 0 1 0 Contact with a German in 
Norway 
Poland 2 0 1 0  
Spain 1 0 1 0  
Sweden 17 1 33 0  
Switzerland 0 0 5 0  
United 
Kingdom 
3 0 3 0  
USA 3 0 2 0 3 HUS cases (all confirmed) 
and 2 EHEC cases (one 
confirmed and one 
suspected) 
Total 864 30 2938 13  
 
Note. There are 3802 HUS and EHEC cases in total, including 43 fatalities. 
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The main clinical impact comes from the production of Shiga toxins (Stx) or Verotoxins.  
Please see section 1.8.1 for a detailed introduction to the bacteriophages that encode the 
genes for these toxins. Stx produced by the bacteria is initially present in the intestine but 
then enters the general circulation. In polarized intestinal epithelial cells in vitro, Stx 
moves across the epithelial cell monolayer without obvious cellular disruption in an 
energy-requiring and saturable manner (Acheson, 1992). In addition, damage of the 
intestinal epithelium cells by Stx, bacterial lipopolysaccharide (LPS), or other 
inflammatory mediators could also assist translocation of the toxin into the bloodstream. 
This theory is supported by the observation that patients with bloody diarrheoa due to E. 
coli O157:H7 are more likely to develop HUS than those with non-bloody diarrheoa 
(Griffin, 1995). Once Stx is in the general circulation, potentially trafficked by 
granulocytes (Te Loo et al., 2000), it binds to Gb3 expressing endothelial cells lining 
blood vessels in renal glomeruli and other capillaries in the body, including the brain.  
The activity of the toxin is described in section 1.8.1 but leads to endothelial cell death.  
Platelets try and repair this damage but fibrin fibres and clots can block the capillaries 
leading to ‘shredding’ of red blood cells; this and immune complex deposition can block 
the capillaries leading to a restriction in oxygen transfer to the local tissues and tissue 
death. In the kidney this accounts for HUS and kidney failure. HC is caused by E. coli 
O157:H7 colonization of the intestinal mucosa and subsequent toxin release in the 










1.4.4 Epidemiology of E. coli O157:H7   
1.4.4.1  Sources of E. coli O157:H7 infection 
Ruminants, especially cattle and sheep, are considered to be the main common source of 
human infection with E. coli O157:H7 (Hancock et al., 1994; Orskov et al., 1987). It is 
carried asymptomatically in the intestine of ruminants and shed in their faeces. In cattle, 
E. coli O157:H7 colonises at the terminal rectum and does not cause any obvious disease 
(Naylor et al., 2005).  Prevalence studies in Scotland revealed that 23% of herds and 
7.9% of cattle shed E. coli O157:H7 in their faeces indicating a considerable 
environmental risk to humans, particularly by animals shedding high levels of the 
bacterium (Strachan et al., 2006).  In these cattle, some of them were defined as ‘super-
shedders’ with ≥104 colony forming units per g (CFU.g-1) and low-shedders with <102 
CFU.g-1. Preventing colonisation of E. coli O157:H7 in cattle or reducing shedding levels 
excreted by cattle are approaches being investigated to limit the threat to public health.  
 
1.4.4.2  Transmission of E. coli O157:H7 
E. coli O157:H7 can be transmitted through (i) food and water, (ii) animal-to-human 
contact, and (iii) person-to-person contact (Fig. 1.2). Among them, food-borne 
transmission is probably responsible for most infections. 
 
(i) Ingestion of raw or undercooked contaminated foods, particularly of bovine origin 
such as ground beef (hamburgers) and unpasteurized milk, is the most common route of 
transmission of E. coli O157:H7. Contamination either directly from faeces or indirectly, 
through rinsing or preparation procedures, can happen. For example, an outbreak traced 
back to packed spinach occurred in United States in 2006 causing the infection of 200 
people in which 31 (16%) developed HUS.  
 
(ii) Infections through direct animal contact during farm visits have been reported with E. 
coli O157:H7 (Renwick et al., 1993; Shukla et al., 1995). In the United Kingdom, animal 
contacts are also associated with infections as there are a large number of educational 
farm visits annually, particularly by school children (Smith, 1998). Infections can be 
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caused by direct contact with farm animals and their faeces. An outbreak was caused by 
visiting a ‘petting’ farm in 2009 leading to 93 people contracting EHEC O157 
(Committee, 2010). Kidney complications occurred in many of the children.  
 
(iii) Another transmission route is person-to-person spread, which can easily happen in 
settings of poor hygiene or in families where children may have diarrhoea. Transmission 





Fig. 1.2 Transmission diagram of E. coli O157:H7 ( originally from Lim et al., 2010).  
This diagram shows that healthy cattle are the main reservoir of E. coli O157:H7. 
Contaminated food and water linked with cattle are major sources for human infections. 






1.4.5  Infection models of E. coli O157:H7 
Many infection models of E. coli O157:H7 have been developed to study its pathogenesis, 
covering in vitro cell culture, small animal and large animal systems. Most of the in vitro 
methods were used to investigate the adherence of the EHEC strains to epithelial cells or 
Stx effects on cells. Small animals such as mice (Eaton et al., 2008; Karpman et al., 1997; 
Kurioka et al., 1998; Mohawk et al., ; Shimizu et al., 2003), rats (Zotta et al., 2008), and 
rabbits (Garcia et al., 2006), were mainly used for the study of E. coli O157:H7 infection 
and disease. Larger animals including cows (Dean-Nystrom et al., 2008), chickens 
(Beery et al., 1985; Sueyoshi & Nakazawa, 1994), pigs (Tzipori et al., 1986), baboons 
(Taylor et al., 1999), macaques (Kang et al., 2001), and dogs (O’Brien, 1998) have also 
been reported as infection models for EHEC. A/E lesions in the gastrointestinal tract have 
been detected in infected animals such as rabbits, chickens, gnotobiotic piglets, infant 
calves, and macaques (O’Brien, 1998). In addition, HUS-like disease has occurred 
naturally in dogs and rabbits (Cowan et al., 1997; Garcia et al., 2002; O’Brien, 1998). 
 
1.4.6  Evolution of E. coli O157:H7 
1.4.6.1  Evolution of E. coli O157:H7 
The published evolution of E. coli O157:H7 is accompanied by stepwise acquisition or 
loss of virulence and phenotypic traits (Feng et al., 1998). Early evolution involved 
genetic exchange, competition, and selection. An evolutionary model demonstrated the 
evolution pathway of E. coli O157:H7 strains (Fig. 1.3) (Feng et al., 2007). This model is 
based on the molecular tying (PCRs, PFGE eg) and genetic studies. O55:H7 that ferments 
sorbitol (SOR) and is β-glucuronidase positive (GUD+) is considered to be an ancestor 
strain of E. coli O157:H7. As time goes on, this O55:H7 acquired Stx2 phage producing a 
closer ancestor of E. coli O157:H7. By analyzing a sequenced O55:H7 Stx2+ strain, it 
was thought that E. coli O157:H7 derived from its ancestor strains (O55:H7 Stx2+) 
around 400 years ago by using a new clock rate (Zhou et al., 2010 ) Some strains, such as 
EOR-37 and LSU61, were left as the uncertain due to the contradictory molecular typing 
results (Feng et al., 2007). LSU61 is an O157 strain that is SOR+ and have many traits 
proposed for the A3 intermediate. If it is A3 intermediate, it would be related to A2, A4 
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and A5. However, only 60% similarity to A2, A4 and A5 clonal complexes by PFGE 














Fig. 1.3 Evolution model for E. coli O157:H7 (originally from Feng et al., 2007). 
Strains are named in evoluional order. It shows the evolution pathway of O157:H7 from 
O55:H7 by acquriring Stx2 and Stx1 phage with SOR and GUD changes.  For some 
strains, the position on the model still remains to be determined and they are shown with 
dashed lines. 
 
It was apparent from genome analysis that E. coli O157:H7 contains more prophages and 
virulence determinants than the non-pathogenic laboratory strain E. coli K12. For 
example, E. coli O157:H7 (EDL933) and K12 (MG1655) share 4.1 Mb of ‘backbone’ 
sequence. 1,387 additional genes were detected in the EDL933 strain. These include 
genes encoding candidate virulence factors, prophages, and alternative metabolic 
functions (Perna et al., 2001). In total, 1.34 Mb of designated ‘O-island’ DNA, comprised 
of 177 O-islands were specific to EDL933. Similarly, 1.4 Mb of O157 Sakai-specific 
sequence (S-loops) was identified in the Sakai strain (Hayashi et al., 2001). There were 
1,600 genes found in this specific sequence, including 18 prophages (Sp1-18), 6 
prophage-like elements (SpLE1-6) and other potentially horizontally-acquired regions. 
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Significantly, most virulence determinants are present in these regions which include the 
Stx 1 phage and Stx2 prophages (Ogura et al., 2006).  
 
Based on the 29 E. coli genome sequences, it was concluded that the genomes of all 
EHEC strains are much larger than those of the non-EHEC strains (Ogura et al., 2009). 
These EHEC strains (O157, O26, O111, and O103) contain virulence genes for Shiga 
toxins and many other factors. Moreover, it was found that the genes associated with 
T3SS were grouped into three different types: integrative elements (IE) (the locus of 
enterocyte effacement), which encodes the T3SS; SpLE3-like IEs and lambdoid phages, 
which carry numerous T3SS effector genes and other T3SS-related genes.  
 
1.4.6.2  The evolution of phage 
Phage and bacteria have co-evolved and interactions between them continue to drive their 
evolution and the emergence of new pathogens, as is evident from the recent STEC 
O104:H4 outbreak in Germany. Some phages have been separate from bacterial genomes 
for millions of years. Then, some phages stayed independently in the environment. 
Alternatively, some of them were integrated with host bacteria again. Some other phage 
might be generated recently. Horizontal gene transfer (HGT) by transduction is the main 
mechanism involved in phage integration with a bacterial genome. The additional genetic 
elements encoded by these prophages can provide various novel capacities for the 
bacterium, such as niche adaptation and virulence (Filee et al., 2003; Canchaya et al., 
2003). Genetic defects, such as deletions or disruptions, are detected in the prophages. 
Therefore, these prophages can become ‘cryptic and potentially are not functional as 
mobile genetic elements. However, it was recently revealed that many of these defective 
prophages, including the Stx1 phage, are inducible through the activity of other 
prophages (Asadulghani et al., 2009).  This was confirmed by the release of many 
different prophage sequences from the E. coli O157:H7 genome. Furthermore, some of 
these sequences could be transferred to other E. coli strains producing novel pathogenic E. 
coli strains. Interestingly, it was found new Stx1 phages are produced by recombination 




 Little research was done on this phage evolution. DNA sequencing and sequence 
comparison, as the only tool to study the early phage status, was used. Till now, 200 
phage genomes have been sequenced with a total number of 1031 defined phages. No 
consensus model of phage is reported. Although vertical and horizontal evolution models 
and combination of the two have been introduced, the base of these models is limited by 
the number of sequenced phages used in model construction (Canchaya et al., 2003). 
 
1.5 A/E lesions 
In 1987, Knutton and his co-workers demonstrated the accumulation of electron dense 
material under attached bacteria when carrying out infection assays on human intestinal 
biopsy material (Knutton et al., 1987)(Fig. 1.4). Knutton also reported that fluorescein-
labelled phalloidin could be used to visualise the electron-dense material under attached 
EPEC and EHEC bacteria on mucosal surfaces and this staining corresponded in size and 
position with each adherent bacterium (Knutton et al., 1989). Therefore, this specific 
phalloidin staining could be applied to screen for genes that were responsible for these 













Fig. 1.4 A/E lesion caused by E. coli in rabbit intestinal epithelial cells (originally from 
Goosney et al., 1999), bacteria is shown by circle in red, microvilli is suggested by arrow 
in blue, effacement of microvilli is indicated by arrow in red. The brush border in the 




EHEC colonizes the intestinal mucosa and causes A/E lesions following bacterial 
attachment to the host intestinal epithelium. These are characterized by effacement of the 
brush border and actin polymerization underneath the bacteria. After infection, EHEC 
can subvert host cell signal transduction pathways and utilize host cytoskeletal/membrane 
components for localization (Frankel et al., 1998). The adherent bacteria assemble on 
formed pedestals at the surface of one pole of the bacterium by polymerization of the 
eukaryotic cytoskeletal protein actin (Knutton et al., 1987). The forming of A/E lesions 
depends on T3SS (Jarvis et al., 1995), the outer membrane adhesive protein intimin 
(Jerse et al., 1990) and the translocated intimin receptor (Tir), which is translocated into 
the host cell (Kenny et al., 1997). All these elements are encoded in a pathogenicity 
island termed the ‘locus of enterocyte effacement’ – LEE (McDaniel et al., 1995).  
 
1.6 The LEE and Type III secretion 
1.6.1  LEE 
Besides a core genome structure shared between commensal and pathogenic strains, 
pathogenic strains also acquire other genes on pathogenicity islands (PAI) that allow 
niche adaptation and enhance virulence. The locus of enterocyte effacement or LEE is 
one critical PAI encoding a T3SS, various translocators and effectors, the outer-
membrane protein intimin (Hacker & Kaper, 2000; Jerse et al., 1990) and its receptor, 
termed the translocated intimin receptor (Tir). EHEC and EPEC, along with many other 
pathogenic Gram negative bacteria, utilize a T3SS to secrete and inject bacterial effector 
proteins into the cytosol of host cells. A/E lesion formation results from this process 



















Fig. 1.5 Genetic organization of LEE (originally from Deng et al., 2004) 
The whole LEE contains 5 main operons (LEE1-5). There are 54 open reading frames in 
these five operons. ler is the first gene of LEE1 operons. Each open reading frames are 
represnted by arrow with different color indicating different function.  
 
 
The LEE is around 43kb in size and is composed of 54 open reading frames (ORFs) that 
form five main operons (LEE1-5) (Elliott et al., 1998). LEE1-3 encode components of 
the basal apparatus of the T3SS including EscC, J, R, S, T, U, V (Bustamante et al., 2001; 
Garmendia et al., 2005; Sperandio et al., 2003) (Fig. 1.5). LEE4 encodes EspA, B, D, F 
(Crane et al., 2001; Daniell et al., 2001; Delahay et al., 1999; Hartland et al., 2000; 
Knutton et al., 1998; Kresse et al., 1999; Neves et al., 1998; Wachter et al., 1999), SepL 
(Kresse et al., 2000) and EscF (Wilson et al., 2001). LEE5 encodes an outer membrane 
adhesin called intimin, its translocated receptor Tir, and a Tir chaperone known as CesT 
(Sanchez-SanMartin et al., 2001). Tir is located at the host cell plasma membrane and 
forms a hairpin-like structure which binds with intimin (Kenny et al., 1997). Following 
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the assembly of the type III basal apparatus and EspA needle complex, EspB and Tir are 
translocated to the host epithelial cell where Tir is integrated into the plasma membrane. 
The binding of Tir with intimin on the bacterial surface is responsible for the 
rearrangement of the host cell cytoskeleton and subsequent formation of A/E lesions 
during infection with E. coli O157:H7 (Roe et al., 2003b; Sperandio et al., 2002).  SepL 
is required for the formation of intact translocation apparatus and the secretion of Esp 
proteins (Kresse et al., 2000). SepD is the only protein that was revealed to interact with 
SepL by yeast two-hybrid sytem and is considered to have an associated function with 
SepL  (Creasey et al., 2003). 
 
1.6.2 T3SS 
1.6.2.1 Introduction to T3SS 
The Gram negative pathogenic bacteria: Yersinia spp., Salmonella spp., Shigella spp., 
EPEC and EHEC all can express specific but related T3SSs. Pathogenic bacteria utilize 
this system to translocate proteins and effectors into the host cell. Yersinia and Shigella 
possess a short needle complex to inject T3 effectors into host cells. However, EHEC and 
EPEC use a different T3SS in which a filament structure extends to its needle. It is not 
clear why this additional structure is required. But it may act as an initial adhesin (Ebel et 
al., 1998) and may allow the secretion system to penetrate through mucus or past 










































apparatus is composed of EscR, EscS, EscT, EscU and EscV proteins. EscF contains the 
needle structure connecting the bacteria and host cells. EspA is considered as the filament. 
EspB and EspD assemble the pore at the end of the filament.  
 
1.6.2.2 Basal apparatus of the T3SS 
The basal apparatus of the T3S system in EHEC O157 is mainly encoded by LEE1-3 
operons. EscD (Pas), EscQ, EscR, EscS, EscT, EscU and EscV are the main contents for 
the inner membrane (Gauthier et al., 2003; Kresse et al., 1998; Ogino et al., 2006). 
Moreover, EscC and EscV are considered to be the main components of the outer and 
inner membrane ring structures, respectively. These two proteins form a large annular 
complex. The effectors and molecules are transported through this structure across the 
membrane (Hueck, 1998)(Fig. 1.6). By nuclear magnetic resonance, it was revealed that 
EscJ is composed of two structured domains connected by a linker forming a bridge 
across the periplasm. This needle complex connects the outer and inner membrane 
(Crepin et al., 2005). EscN, as the cytoplasm located ATPase, energizes the translocation 
of T3SS by interacting with membrane-bound components of the type III apparatus 
(Gauthier et al., 2003). EscN is requried in EscC insertion. Therefore, it was believed that 
energy might be needed for EscC localization. EscC is one of the family of proteins 
(secretins) which are associated with translocating large molecules across the outer 
membrane (Hueck, 1998). However, the secretion and function of EscC require not only 
the general secretion pathway but also other components of the type III apparatus 
(Gauthier et al., 2003). It was revealed that EscJ is a large 24-subunit ‘ring’ 
superstructure that might bridge the membrane-associated rings of the T3S system 
(Crepin et al., 2005). In addition, T3S system and flagella share high levels of homology 
in the proteins of the basal apparatus (Pallen et al., 2005a). Following assembly of basal 
apparatus, the needle complex can be switched to assemble. EscF encoded by LEE4 
operon is considered to be the main component of needle structure in EHEC and EPEC 
Fig. 1.6 Schematic representation of the EPEC/EHEC type III secretion apparatus. 
(originally from Garmendia et al., 2005). See text for details. 
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(Fig. 1.6). EspA assembly is essential for T3SS. One end of the EspA filament connects 
with the EscF needle (Larzabal et al., 2010).  Previous research revealed that YscU 
(EHEC EscU homologue) regulates the forming of needle complex in Yersinia. It’s also 
found that translocation and secretion by T3SS were blocked in EscU mutation (Tree et 
al., 2009b). This evidence indicated that EscU is likely involved in the switch to 
formation of the later needle complex. 
1.6.2.3 Translocon of T3SS 
With the needle structure in position, the translocon begins to assemble. The translocon is 
encoded on LEE4 operon. EspA composes the main filament extension. It was confirmed 
by the stainning with antibodies on the surface of the bacterium (Fig. 1.7). EspB and 
EspD are considered to make up the pore at the end of the EspA filament.  EspB&D are 
similar in size and are the main T3 secreted proteins that can be detected in EHEC 
supernatants under T3S conditions (Fig. 1.8). It was observed that EspD may have 
multiple activities: to influence the length of the EspA filament; to promote adhesion 
during early stages of infection; and to generate the translocation pore into host cells once 
contact has been established (Daniell et al., 2001). 
 
In addition, the deletion of SepL and SepD caused the failure of the export of the EspA 
translocon (O'Connell et al., 2004; Wang et al., 2008). This indicated that SepL and 













Fig. 1.7 EspA stain of ZAP198 (originally from Naylor et al., 2005), EspA staining is 
indicated by circle in red. It shows some of the bacteria are stained with EspA antibody 
with fluorescence (highlighted). Unstained bacteria keeps dark. 
 
1.6.2.4 Secreted translocon and effectors encoded by LEE  
LEE4 is responsible for effector proteins including EspA, B, D, F, SepL and EscF. The 
regulation of LEE4 was investigated by Androw Roe and his co-workers (Roe et al., 
2003b). The report demonstrated that the expression of EspA filament was heterogeneous 
in all of the tested EHEC O157 strains isolated from bovine and human disease. The 
proportion of the bacterial population expressing EspA filaments was consistent with the 
secreted EspD levels. High EspD-secreting strains had a higher proportion of bacteria 
expressing EspA filaments than low EspD-secreting trains. The regulation of individual 
bacterium to express EspA filaments was not controlled at the level of LEE1-4 operon 
transcription.  LEE4 translocon expression is regulated by a posttranscriptional 
mechanism, which controls the translation of LEE4-espADB mRNA. A classic T3 
secreted protein profile is shown in Fig. 1.8. EspA, B, D secretion level is demonstrated 

















Fig. 1.8 SDS PAGE gel of T3 secreted protein profile 
1-2: Supernatant protein samples (prepared as described in Materials and Methods, 
section 2.10), 3: Wide range molecular weight marker (Sigma), number idicates beside is 
in KD. Precise sizes of secreted proteins are shown on the right. The gel was prepared, 
run, and stained as described in Materials and Methods section 2.11.  
 
 
Other LEE-encoded effectors, which are involved in modulating the host cytoskeleton in 
EHEC, have also been identified including the mitochondrion-associated protein (Map), 
SepZ, EspH, EspF, EspO and EspZ. Each of them is briefly discussed below. 
 
Map was named for its localization to mitochondria via a N-terminal targeting sequence 
(Kenny & Jepson, 2000). Map has three distinct and independent functions: firstly, in the 
initial stages of EHEC infection, Map plays an important role in the transient formation 
of filopodium-like structures at the sites of bacterial infection; secondly, it assists the 
cellular ability of E. coli O157:H7 by triggering the formation of misshapen mitochondria, 
mitochondrial swelling, and damage (Kenny & Jepson, 2000); finally, Map is responsible 
for the disruption or alteration of tight junctions and intestinal barrier function that is 
independent of mitochondrial targeting (Dean & Kenny, 2004). Two new members of 
Map protein family were discovered, which were named as EspM1 and EspM2 (Ando et 
al., 2007). 
 
EspH is found on the host cell membrane and affects the structure of the host actin 
cytoskeleton, which in turn affects filopodia and pedestal formation (Tu et al., 2003). 
SepZ is the most recently observed LEE-encoded effector. However, no evidence has 




EspF is a proline-rich effector protein since it contains four proline-rich repeats in EHEC 
(Viswanathan et al., 2004). It has been reported that EspF can disrupt the intestinal 
barrier function, increase membrane permeability and induce the release of the toxic 
protein cytochrome c (McNamara et al., 2001; Nagai et al., 2005; Nougayrede & 
Donnenberg, 2004). Map and EspF have similar functions in disruption of intestinal 
barrier in the presence of intimin (Dean & Kenny, 2004).  
 
It was recently revealed that EspO can strengthen the adherence of host cells to the 
basement membrane by interacting with integrin-linked kinase (Kim et al., 2009). It also 
plays a role in inhibiting the turnover of focal adhesion in cell motility by blocking the 
phosphorylation of focal adhesion kinase and paxillin.  
EspZ has a similar function as EspO in preventing host cell detachment by interacting 
with host protein CD98 and enhancing phosphorylation of focal adhesion kinase (FAK) 
and 3-kinase (Akt), which reinforces the stability of focal adhesins during infection 
(Shames et al., 2010). 
 
Despite the secreted effectors encoded by local LEE operons, many non-LEE-encoded 
effectors (Nles) were recently reported by using homology searches to identify 
homologous proteins (Pallen et al., 2005b; Pallen et al., 2005c). A large number of Nles 
are identified in EHEC O157 by comparing with other T3S organisms such as plant 
pathogen Pseudomonas syringae. Twenty eight of these predicted effectors were 
confirmed by experiments as detailed below.   
 
1.6.2.5 Non-LEE-encoded effectors secreted by T3SS 
NleG family: NleG proteins have many homologues secreted by T3S system in EHEC 
O157:H7 strain. These effectors belong to a U-Box E3 ubiquitin ligase family. NleG 
binding and autoubiquitination activity was decreased by the alanine substitutions of 
UBE2D2 residues Arg5 and Lys63 (Wu et al., 2010). The NleG effectors are likely 
related to the turnover of host cell proteins and/or other type III effectors by the cell 




NleA-F: Secreted by T3SS, NLeA is translocated into the host cells, localizes in the host 
Golgi apparatus and is required for EHEC virulence (Gruenheid et al., 2004). In contrast, 
NleB and NleE prevent the activation of NF-κB by inhibiting IκB degradation and p65 
nuclear translocation (Nadler et al., 2010; Newton et al., 2010; Vossenkamper et al., 
2010). In addition, NF-κB involves the regulation of cytokine gene expression; however, 
NleC can block the function of NF-κB which increases the secretion of effectors (Pearson 
et al., 2011). Finally, NleB homologs and NleE-F encoded within prophages are 
translocated into eukaryotic cells by T3S system (Tobe et al., 2006).  
 
 
Other effectors: Besides the effectors described above, one effector secreted by E. coli, 
protein J (EspJ), is located in the CP-933U phage and has an effect on TTSS and 
virulence in EHEC (Dahan et al., 2005). Although EspJ is not essential for A/E lesion 
activity in vivo and vitro, EspJ has an effect on the dynamics of clearance of the pathogen 
from the host’s intestinal tract. This suggests its role in host survival and pathogen 
transmission (Dahan et al., 2005). Other effectors include NleD, EspW and EspV. EspV 
is a short protein having a similar function as avirulence (Avr) A effector (Napoli & 
Staskawicz, 1987).   
 
In conclusion, T3SS comprises a basal apparatus with its protein components present in 
both inner and outer bactetial membrane, and a needle complex known as the translocon, 





















1.7 The regulation of Type III secretion  
1.7.1 Regulation inputs into the LEE 
LEE gene expression is regulated in a complex way and it responds to many regulators 
and environmental factors such as pH value, glucose, iron and temperature (Laaberki et 
al., 2006).  The expression of the secretion system is a multi-step process controlled by 
the genes and signals illustrated in Fig. 1.9.    
 
1.7.1.1 The regulators encoded on LEE 
The LEE encoded regulator (ler) is located within the LEE itself and its transcription has 
been shown to be regulated both positively and negatively by two other regulatory 
proteins expressed from the LEE; the global regulator of LEE activator (GrlA) (LEE-
encoded Orf10) and global regulator of LEE repressor (GrlR) (LEE-encoded Orf11) 
(Deng et al., 2004). As shown in Fig. 1.9, besides these regulators, the response to 
environmental factors, which are, in part, mediated through perC-homologous (pch) 
A,B,C in E. coli O157:H7, can also induce up-regulation of the T3S  (Spears et al., 2006). 
Through PchA, B, C, the LEE activator (Ler and GrlA) and repressor (GrlR) proteins are 
stimulated and therefore T3S expression level is affected.  
 
Ler is a 15 kDa protein encoded by the first gene of LEE1 and it directly regulates genes 
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within the LEE and elsewhere in the genome. Ler is considered as an anti-repressor 
protein by displacing the histone-like protein (H-NS) which acts as an inhibitor on 
LEE2/LEE3 promoters (Bustamante et al., 2001). In addition, ler also plays an essential 
role in up-regulating the LEE4 promoter (Elliott et al., 2000). Since most of the genes 
that are important for A/E lesions are regulated by ler, the ler regulator is crucial for 




















Fig. 1.9 Summary of the regulation of the LEE genes in E. coli O157:H7 (originally from 
Spears et al., 2006) 
Thi diagram shows that T3SS is regulated at multiple levels by many facotors. Positive 
regulators are shown in red square. Negative regulators are shown in blue square. The 
effect on ler can be transferred to the later operons. Regulators are represented in green. 
Basal apparatus chaperone and unkown genes are indicated in red. Secreted effectors are 
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GrlA is a positive regulator of LEE expression encoded by orf11, whereas GrlR acts as a 
negative regulator on LEE expression encoded by orf10 (Fig. 1.5). They both have an 
effect on the upstream ler and lead to regulation of LEE expression through ler. GrlR is 
considered to achieve the effect on LEE gene expression by interacting with GrlA (Deng 
et al., 2004). 
 
1.7.1.2 The regulation of aerobic/anaerobic respiration and impact on T3S 
E. coli possesses a large number of sensing/ regulation systems for the rapid response to 
the availability of oxygen and presence of other electron acceptors (Guest JR, 1996; 
Gunsalus, 1992; Park & Gunsalus, 1995; Unden et al., 1995). The adaptive responses are 
co-ordinated by a group of global regulators including a one component fumarate, nitrate 
reduction (Fnr) protein, and the two-component aerobic respiration control (Arc) system 
(Gunsalus, 1992; Lin & Iuchi, 1991; Lynch & Lin, 1996). The Arc system is a two-
component regulatory system including ArcA, the cytosolic response regulator, and ArcB, 
the transmembrane histidine kinase sensor. Fnr is mainly active during anaerobic growth.  
It activates and represses target genes in response to anaerobiosis. Moreover, the response 
to nitrate and nitrite is regulated by the nitrate reductase (Nar) two-component regulatory 
systems (Bearson et al. 2002),. NarX and NarQ sense then respond to nitrate and/or 
nitrite by auto-phosphorylating the conserved histidyl residue in the transmitter module. 
Phosphoryl transfer to the conserved aspartyl residue in the receiver domain of the 
response regulators NarL and NarP results in activation or repression of target operon 
transcription. In the absence of nitrate and nitrite, NarX sensor acts as a phospho-NarL 
phosphatase. A similar relationship between the NarQ sensor and phospho-NarP is 
presumed.  
 
According to Ando and coworkers report (Ando et al., 2007), the activation of the 
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anaerobic respiratory system accelerates the maturation of a functional TTS apparatus. 
Previous research in ZAP lab identified the terminal rectum (TR) as the principal site of 
E. coli O157:H7 colonisation in the bovine gut (Naylor et al., 2003).  Colonisation of this 
site is associated with high-level shedding individuals (super-shedders) and these animals 
are responsible for maintenance of E. coli O157:H7 in the host population (Matthews et 
al., 2006). An overall aim within the Edinburgh research group is to investigate the 
molecular basis of this tropism. E. coli O157:H7 requires the locus of enterocyte 
effacement (LEE) pathogenicity island for colonisation of the bovine TR (Naylor et al., 
2005).  If this system is deleted, EHEC O157 does not colonise cattle.  A hypothesis that 
I wanted to test with this research is whether the tropism is driven by when the secretion 
system is expressed in the animal.  This would be a relatively simple question to address 
if the T3SS regulation was well understood and therefore easy to manipulate.  
 
1.7.2 Timing of secretion 
After the assembly of the translocon, the secretion of effector proteins starts. It has been 
reported that there are extensive ordered synergistic and antagonistic relationships in the 
secretion of T3S effectors and that the order of secreted effectors matters (Cain et al., 2008). 
In EPEC, the translocation of effectors was shown to follow the order: 
Tir>EspZ>EspF>EspH> EspG > Map, based on the translocation efficiency (Mills et al., 
2008). It is considered that the T3S effectors function co-ordinately within the host cell and 
this different translocation efficiency leads to a hierarchy in effector translocation (Ghosh, 
2004); (Tu et al., 2003) and therefore activity in the cell. 
 
Secretion of effectors seems to be in an ordered process that is dictated by intracellular 
concentration of each effector and affinity for cytoplasmic chaperones. The function of 
many T3 secreted proteins requires a chaperone protein which binds to the secreted effector 
protein. For example, Tir translocated into host cells mediates the A/E effect in which a 
chaperone protein, CesT, is involved in the maximizing the efficiency of Tir delivery to the 
T3SS (Abe et al., 1999; Elliott et al., 1999). Another protein, SepD is also essential for the 
secretion of T3S effectors and A/E formation by binding with SepL. The deletion of SepD 




1.7.3 The non LEE encoded regulators  
PerC family: Seven homologues of PerC are encoded within O-islands (Ois) in EHEC 
including PchA-E, PchX and PchY. The pch genes include three different classes based 
on sequence similarity. The pchA, pchB and pchC belong to one class sharing a high 
similarity in sequence.  These three prophage-encoded genes are all positive regulators of 
LEE1 and in turn of other LEE encoded genes (Iyoda & Watanabe, 2004). It was also 
revealed PchA-C facilitates the activation of the genes encoded on OIs (Porter et al., 
2005). PchA is repressed by the RcsBCD phospho-relay system. However, RcsB serves 
as a positive regulator of LEE transcription through the activation of another OI encoded 
regulator, GrvA, an EHEC-specific activator of ler (Tobe et al., 2005). In addition, the 
different expression of pchA, pchB and pchC is also controlled by the stringent response. 
This regulation is responsible for the up-regulation of T3S level under different 
physiological conditions, such as the growth-regulated expression of LEE in batch culture 
(Nakanishi et al., 2006). The other two classes of pch genes are pchD and pchE. The 
function of these two genes is not clear, it was demonstrated that pchD and pchE cannot 
activate LEE1 expression in a K12 background and these are both smaller variant 
proteins than PchA/B (Porter et al., 2005). Recent studies have shown that PchA and/or 
Ler bind to and activate transcription of many genes encoding effectors outside the LEE 
and horizontally-acquired genes coding for virulence factors by transcriptional profiling 
and chromatin immuno-precipitation (Abe et al., 2008).The key issue is that pch genes 
are usually encoded on prophage regions that also encode non LEE-encoded effector 
proteins.  The Pch family induce the expression of these effectors at the same time 
ensuring the T3SS is also produced, thereby enabling their export and impact of that 
integrated region.  These regions also encode phage secretion regulators (Psr) that appear 
to repress the main LEE-encoded effecotors to allow the Nles to compete for 
translocation (Tree et al., 2011). 
 
pch adjacent genomic region: As described above, pch genes are involved in the co-
ordination of  LEE expression. Interestingly, it was recently observed that in contrast 
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with the highly conserved pch genes, a pch adjacent genomic region (pch AGR) showed 
extensive variation by genomic study (Yang et al., 2009). The pattern of this variation is 
largely correlated with phylogenic marker distribution on the chromosome. In addition, 
by quantitative analysis of transcriptional LEE1 promoter, the variation of pch AGR was 
proved to be pivotal in absolute levels and patterns of LEE1 transcription. pch AGR 
variation is responsible for the diversity of LEE expression patterns. Other OI encoded 
regulators were also found in David Gally laboratory such as Ecs1581 (not published).  
 
QseA regulator: T3S is also regulated by the host hormones epinephrine and 
norepinephrine (Epi/Ne) via the quorum-sensing regulator QseA, which controls the 
transcription level of ler and grlA. Furthermore, QseA is in turn regulated by the signals 
from Epi/Ne and inducer-3 (AI-3) through the two-component system consisting of qseC 
and qseB (Sperandio et al., 2003).  
 
1.8 Shiga- like toxin (Stx) and Stx phage 
1.8.1 Introduction 
Phages play an important role in the evolution and virulence of many pathogens such as 
E. coli, C. botulinum, S. aureus P. aeruginosa, etc (Brussow et al., 2004). Genome 
sequencing has really clarified just to what extent the evolution of particular bacteria is 
inter-related with that of bacteriophages. Many bacteriophages carry additional ‘cargo’ 
genes (also termed morons or lysogenic conversion genes). These genes are not 
necessarily required for the phage life cycle, so why are they present in the 
bacteriophages?  In fact, many of the cargo genes encode potential or proven virulence 
factors.  They are considered to contribute to a change of phenotype or fitness of the 
lysogenized bacterium. Consequently, these resultant strains are more competitive in the 
host or other environments; this may also mean more pathogenic in humans. 
 
Stx-producing EHEC are responsible for human HC and HUS associated with Stx 
activity (Besser et al., 1999). Mortality and morbidity are linked to the activity of this 
potent toxin in patients infected with E. coli O157:H7 as described in section 1.4.3. There 
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are two major immunologically non-cross-reactive groups in the Stx toxin family, Stx1 
and Stx2 (Mainil et al., 1987). Stx2 contains multiple subtypes such as Stx2c and Stx2e. 
A single EHEC strain may produce Stx1, Stx2 or both, and sometimes even multiple 
forms of Stx2.  
 
Although Stx1 and Stx2 are similar in mode of action, structure and general 
characteristics, there are no cross neutralization effects between them. The prototypical 
Stx1 and Stx2 toxins share 57% homology in amino acid sequence in the A subunit and 
60% in the B subunit (Jackson et al., 1987).  Stx1 from different origins has more than 
99% homology in nucleotide sequence, whereas Stx2 shows more variations and is sub-










Fig. 1.10 Alignment of predicted amino acid sequences of the A subunit of Stx2 variants 
with the published sequences of Stx2dact of STEC strain B2F1 (Stx2d2) (GenBank 
accession no. AF479829) and Stx2 (GenBank accession no. AB035143) (Zheng, 2008). 
Dots indicate residues identical to those in Stx2dact. Residues Ser313 and Glu319 in the 
A subunit and residues Asn35 and Asp43 in the B subunit, which distinguish Stx2d from 









Stx1 from EHEC is identical to Shiga toxin from Shigella dysenteriae type 1. The basic 
A-B subunit structure in all members of the Shiga toxin family is retained. Stx1 is 
comprised of an A subunit of ~32 kDa and five B subunits of ~7.5 kDa each. 
Furthermore, the single 32 kDa A subunit consists of a 28 kDa peptide (A1) and a 4 kDa 
peptide (A2), and the A1 and A2 combine through a disulfide bond. The A1 peptide 
contains the enzymatic activity, while the A2 peptide is responsible for linking the A 
subunit to a pentamer of 7.5 kDa B subunit. The B subunits recognize a specific 
glycolipid receptor, globotriaosylceramide (Gb3), on the surface of eukaryotic cells. The 
Gb3 receptor is the main binding target for Stx; while the Stx2e variant uses Gb4 as its 
receptor. These receptors can be found on the surface of cultured human renal epithelial 
cells, human platelets, erythrocytes and some other cell types. Once the toxin is bound to 
the cell membrane, the holotoxin is internalized by endocytosis through coated pits and 
delivered to the trans-Golgi network apparatus. The toxin is then transported to the 
endoplasmic reticulum and finally to the cytosol (Sandvig & van Deurs, 1994). In the 
cytoplasm, the A subunit cleaves the 28S rRNA of the eukaryotic ribosome, and this 
leads to the inhibition of protein synthesis (Law, 2000). The consequent prevention of 
protein synthesis results in the death of cells that possess the Gb3 (or Gb4 for Stx2e) 
receptor, such as renal intestinal epithelial cells, endothelial cells, Vero and HeLa cells.  
 
Epidemiological data demonstrated that Stx2 has a more important role than Stx1 in the 
development of HUS (Griffin, 1995). It was revealed that E. coli O157:H7 strains that 
carry Stx2 alone are more likely to be associated with HUS than strains producing Stx1 
alone or both (Pickering et al., 1994).  It has been also reported for both cultured renal 
endothelial cells (Louise & Obrig, 1995) and mice (Wadolkowski et al., 1990) that Stx2 
is critical for renal damage, but not Stx1. As mentioned above, although Stx1 and Stx2 
share commonality in structure and general biochemical characteristics, significant 
differences in amino acid sequence within the A subunit can lead to differences in toxin 





1.8.2 The lytic and lysogenic decision of bacteria phage lambda (λ) 
In the evolution of EHEC strains, there are many phages obtained by integrating with the 
host genome. When the phages enter the bacteria, a decision between lysis or lysogeny is 
made. Two key features are characterized in the lytic and lysogenic development 
pathway. Firstly, following the infection by the phage, a decision between lysis or 
lysogeny is made depending on environmental signals and the number of infecting 
phages per cell (Oppenheim et al., 2005). Secondly, the lysogenic state is very stable and 
only responds to SOS induction.  
 
 If the bacteria follow the lytic pathway, phage can reproduce as package virons; then the 
replicated phages are released by lysis. Alternatively, if the lysogeny pathway is activated, 
phage DNA is integrated into the host genome, which is accompanied by the switch-off 
of the lytic pathway. Moreover, the prophage DNA is replicated with the host 
chromosome in the later cell division and also contributes immunity to the host cell 
against other phage infections. Normally, the lysogenic state is very stable. However, 
DNA damage can arise in some extreme conditions. When the SOS response is induced 
as a result of DNA damage, the switch from lysogeny to lysis state is turned on as a result 
of CI autocleavage mediated by activated RecA. This is confirmed by the low 
spontaneous prophage induction in a recA mutant (Morelli et al., 2009). Host cell lysis is 
followed after the replication of phage. At the same time, few of these induced host cells 
can enter an abortive lytic cycle in which the prophage DNA is lost and host cells are 
cured of the phage (curing) (Fig. 1.11). 
 
CI and Cro regulation proteins control the lytic or lysogenic development with a bistable 
genetic switch system. The CI regulator sustains the lysogenic state by controlling the 
expression of three promoters PL, PR and PRM; while the Cro protein regulates lytic 














Fig. 1.11 Schematic diagram of lysis and lysogeny in λ phage (originally from 
Oppenheim et al., 2005). It shows the lytic and lysogenic pathway of phage. In the lytic 
process, phage is released due to bacteria lysis by producing package virons. In lysogenic 
pathway, phage is integrated to bacteria chromosome. The integrated phage genes are 




An immunity system is usually used by lambda like phage to prevent the multiple 
infections of lysogens. The CI protein is essential in this immunity system. CI keeps a 
certain level of expression which represses other phage genes involved in the integration 
into the host genome and lytic replication cycle. Consequently, the integrase from 
incoming lambda like phage is inhibited resulting in a single lysogen in the host bacteria 
(Ptashne, M. 2004). However, multiple lysogens were found in Stx phage Ф 24B and 
confirmed by the transcription expression of anti-repressor ant using RT-PCR (Fogg et 
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al., 2007). This superinfection leads to an increase of intracellular recombination of Stx 
prophages and in turn enhanced virulence (Fogg et al., 2010). Fogg and his co-workers 
also demonstrated that additional lambda phages were detected following formation of a 
lambda lysogen. This result was confirmed by Southern hybridization and quantitative 
PCR. In addition, phage immunity mutation was excluded by analysis of the complete 
immunity region in the integrated lysogens.  
 
Lambda phages including Stx coding phages share a similar genomic structure. The 
centre region of regulatory circuitry termed immunity region. This immunity region 
usually locates between N to O gene on lambda and contains two genes encoding specific 
DNA binding proteins, CI and Cro, and six operator sites to which CI and Cro bind 
(Degnan et al., 2007). By comparing eight lambdoid phages including three Stx 
producing phage, high similarity was observed in the immunity region. These immunity 
region sequences are usually well conserved (Fattah et al., 2000). However, it was 
proposed that the difference in the immunity region might account for the different phage 
lysis patterns leading to the different phage types.  
 
1.8.3 The regulation of Stx phage  
In the sequenced genome of E. coli O157:H7 strain EDL933, Stx1 and Stx2 are encoded 
by two different prophages: CP-933V & BP-933W (Karch et al., 1999; Unkmeir & 
Schmidt, 2000). The sequences of these prophages show a high degree of homology to 
that of phage lambda (Karch et al., 1999). So, Stx1 and Stx2 phage all belong to the λ  
phage family. The Phages in the λ family have a similar genome structure and are 
regulated by the same mechanisms (Fig. 1.12).   
 
Stx genes are usually found immediately downstream of the Q gene. So Stx will be 
produced at the end of the lytic process when naive bacteriophages are produced. Stx 
expression is usually repressed in lysogenic bacteria. However, once the phage lytic 
program is induced, transcription initiates at early promoters PL and PR and this results in 
Stx expression or release through terminating and anti-terminating transcription (Fig. 
1.12) (Fogg et al., 2010).  Transcription elongation begins with the λ-encoded anti-
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termination protein N. In the beginning, the N protein binds at the RNA site ‘N 
utilization’ (NUT) and activates transcription that initiates at PR. As a result of the switch 
of this transcription, terminators were overridden and antiterminator protein Q was 
activated. According to sequence and structure analysis, there are three parts in the NUT 
site, including BOXA, which is considered to interact with NusB and ribosomal protein 
S10 (NusE), a spacer region, and a stem-loop structure, BOXB, which interacts with N 
and NusA (Chattopadhyay et al., 1995; Mogridge et al., 1995). When the NUT RNA is 
synthesized, the various proteins associated with the NUT sequences combine together 
with the RNA polymerase (RNAP), forming a complex that overrides downstream 
transcription termination signals.  
 
 
Fig. 1.12 Lambda immunity region. Closed boxes represents transcription terminator 
regions. Open circles indicates OL and OR operator binding regions. Transcription is 
indicated by black arrows raised above the genetic map.  represents transcripts that 
extend beyond the border;  indicates transcript termination. (Fogg et al., 2010) 
 
When PR promoter is activated, the anti-terminator protein Q is produced. Q recognizes a 
DNA sequence, the qut site, partly within PR΄ (Guo & Roberts, 2004), which allows 
transcription to proceed. Stx expression is turned on as a result of Q protein binding at 
PR΄ which promote the read through (Neely & Friedman, 1998).  Because Q production 
requires transcription from the early PR promoter that is in turn stimulated by N protein, 










1.8.4 The role of CII  
The switch to the lysogenic process needs a set of conditions, including integration of 
DNA, repression of the early promoters, and inhibition of lytic gene expression 
(Oppenheim et al., 2005). CII is essential in this process. Int and CI are activated by CII, 
which turns on pI and pRE promoters. Antiterminator Q is repressed by CII through paQ 
promoter. CII recognizes these promoters by binding to a direct repeat TTGC-N6-TTGC 
sequence on the promoter. The N6 region location in these promoters corresponds to the -
35 postion. The mechanism of the activation of the three promoters by CII remains 
unclear.   
 
The structure of CII protein has been revealed recently (Datta et al., 2005a; Datta et al., 
2005b; Jain et al., 2005). The quaternary structured CII is composed of two nearly 
equivalent dimers. Each monomer has a helix-turn-helix DNA binding motif. However, it 
was proved that only two of the four monomers are involved in the binding with direct 
repeat sequence. The pI, pRE, and paQ promoters belong to Xis, CII, and Q protein 
coding sequence, respectively. When CII is induced, it activates the pI promoter. This 
promoter is responsible for the activation of Int and repression of Xis. Xis is a DNA-
binding protein that binds as a trimer to its DNA binding site and interacts cooperatively 
with Int for excision. Int is required for both the integrative and excisive reactions. The 
integration host factor (IHF) is also required for efficient integration. Therefore, 
following the activation of pI promoter, CII promotes the lysogenic integration by 
switching on the synthesis of Int, which helps the integration and represssing Xis protein.   
 
CII is essential in the decision of lysis or lysogeny. The regulation of CII is in response to 
many factors (Herman et al., 1993) (Hoyt et al., 1982) (Kihara et al., 1997; Rattray et al., 
1984; Shotland et al., 1997). CII is controlled at multi-levels as detailed below (Fig. 1.13); 
(i) The transcription level of cII is repressed by CRO and CI through binding to oR. At 
the same time, cII transcription is activated by antitermination N factor that acts at NUTR. 
High expression of CII is only detected shortly before the repression of CRO and CI. (ii) 
The translation of CII is stimulated by IHF (Hoyt et al., 1982). Although the mechanism 
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is not clear, IHF is considered to activate the translation by binding to the upstream of CII 
(Mahajna et al., 1986; Peacock & Weissbach, 1985). (iii) CII mRNA is degraded by OOP 
RNA which is a 77-nucleotide major transcript synthesized from bacteriophage lambda. 
OOP RNA is an antisense complementary to the 3’ end of cII mRNA. Therefore, it binds 
to cII mRNA. A double-stranded RNA is formed as a result of binding. This double-
stranded RNA is recognized and cleaved by RNase III (Krinke & Wulff, 1990; Krinke et 
al., 1991). cII mRNA is reduced rapidly by RNase III. (iv) CII protein is also degraded 
rapidly by ATP-dependent protease FtsH (Shotland et al., 1997; Kihara et al., 1997; 
Greenblatt et al., 1998). It was reported that ftsH mutations resulted in an increased 
stabilization of CII and in turn lysogenic frequency was increased as well (Banuett et al., 
1986). FtsH acts at the C-terminal of CII leading to the rapid proteolysis of CII (Datta et 
al., 2005b; Kobiler et al., 2002). (v) Cro is inhibited by CI RNA which acts as antisense 
to cro. This was confirmed in ftsH host mutant, in which the repression of Cro and high 
concentration of CII were found. (vi) CIII, a 54-residue long peptide, functions as an 
activator of CII by repressing the FtsH protease (Herman et al., 1997; Kobiler et al., 2002; 































The CII repressors are indicated in red. The cII gene, promoter and CII activator are 
depicted in blue. The direction of CII is labeled in blue with a red arrow for OOP. CII is 
inhibited by CI and Cro at transcription level. tR1, the promoter of cII, is repressed by Rho 
factor which leads to the reduction of cII transcription. The antiterminator N is required for 
the transcription initiation of cII by acting on NUTR site. The OOP RNA, as an antisense 
RNA, decreases CII mRNA stability via RNase III cleavage function. FtsH is essential in 




1.9 Research background and aims of this project 
Previous research in the Zoonotic and Animal Pathogens Laboratory (ZAP Lab) has 
shown that EHEC O157:H7 strains vary significantly in their capacity to secrete LEE 
T3SS proteins (Roe et al., 2003b). For example, secretion of T3S proteins is much higher 
in TUV93-0 (Stx negative derivative of EDL933) compared to EDL933 (contains both 
Stx1 and Stx2 phages). This leads to the possibility that Stx phages may have an effect on 
T3S expression.  The basis to this variation is unclear.   
 
It is also evident that particular strains are more likely to be associated with human 
infections than others. As the main reservoir, cattle play a key role in human infection via 
food contamination or direct exposure.  From a large survey of 430 farms, some cattle 
were defined as super-shedders with ≥104 colony forming units per g-1 (CFU.g-1) and 
some as low-shedders with <102 CFU.g-1 (Chase-Topping et al., 2007a). Interestingly, PT 
21/28 was found to be more common in the supper-shedders and PT 32 was more often 
detected in the low-shedders. The basic hypothesis is that higher shedding levels from 
cattle may make it more likely to be the strains which will end up infecting humans.  As 
T3S is essential for cattle colonisation, it is proposed that: 
 
1. Oxygen sensing regulation of T3S may account for the tropism of EHECO157:H7 for 
the terminal rectum of cattle. Oxygen level might vary in the different parts of 
gastrointestinal tract. This could lead to the colonization tropism of terminal rectum in the 
cattle due to the variation in T3SS expression in the intestine.  
 
2. Variation in the regulation of T3S is associated with variation in excretion level of 









This PhD was focused on addressing these two areas: (1) to understand the localisation of 
EHEC O157 at the terminal rectum of cattle; (2) to understand the strain variation in T3S.  
 (1) In relation to rectal and mucosal colonisation, established aerobic/anaerobic 
regulators were investigated including arcA, fnr, narX, narQ. Then the T3S levels, 
adherence efficiency and A/E lesion formation were measured in these four mutants. 
 (2)  Strain secretion variation was approached in two ways; the first was to control 
expression from the LEE1 operon, required for T3S expression, in order to both induce 
expression and examine the importance of downstream regulation.  The second was to 














































2.1 Bacterial strains, media & plasmids 
Details of the strains and plasmids in this work are shown in Table 2.1 and 2.2. Bacteria 
were cultured either in Luria-Bertani (LB) broth or Minimal Essential Medium with 25 
mM Hepes modification (MEM-Hepes) (Sigma-Aldrich). Glucose was added to MEM-
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Hepes to give a final concentration of 0.2%. Antibiotics were included when required at 
the following concentrations: chloramphenicol (CAM) 20 μg ml-1, kanamycin (KAN) 50 
μg ml-1, Ampicillin (AMP) 100 μg ml-1. Other chemicals added to media were bromo-
chloro-indolyl-galactopyranoside (X-gal) 20 μg ml-1 (dissolved in dimethylformamide) 
and Isopropyl β-D-1-thiogalactopyranoside (IPTG ) 2μg ml-1. 
 
Table 2.1. Bacterial strains associated with this work 
 
Strain Details Source 
ZAP198 E. coli O157 :H7 Nalidixic acid resistant, 
Shiga toxin-negative 
(Naylor et al., 
2003) 
ZAPΔarcA   arcA replaced with CAM cassette in ZAP198 This study 
ZAPΔfnr fnr eplaced with CAM cassette in ZAP198 This study 
ZAPΔnarX   narX replaced with CAM cassette in ZAP198 This study 
ZAPΔnarP   narP replaced with CAM cassette in ZAP198 This study 
ZAP1212 lacYZ replaced with sacBkan cassette in 
ZAP198 
This study 
ZAP1213 lacYZ replaced with PN25&tetR in ZAP198 This study 
ZAP1238        E. coli O26 Stx2+ (Mellmann et 
al., 2008) 
ZAP1239 E. coli O26 Stx2- (Mellmann et 
al., 2008) 
EDL933 E. coli O157:H7 EDL933,Stx1+ Stx2+    Lab stock 
TUV93-0  EDL933 with excised Stx1 and Stx2 phages (Campellone et 
al., 2007) 
 
Strain Details Source 
ZAP1321 EDL933 z1449(cIIstx2)<>sacBkan.  Constructed 
by allelic exchange using pXLS13 (Table 2.2) 
This study 
ZAP1322 EDL933ΔBP-933W (Stx2 phage) by allelic This study  
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exchange of ZAP1321 using pXLS15 (Table 
2.2) 
ZAP1323 ZAP1321∆z1449 This study 
ZAP1324 ZAP1323 z3357<>sacBkan This study 
ZAP1325 ZAP1324 ∆z3357-delete This study 
ZAP1326 ZAP1322 CP-933V<>sacBkan This study 
Sakai stx2A::kan 
 
Sequenced E. coli O157:H7 Sakai strain with a 
kanamycin cassette replacing the stx2A toxin 
gene (Sp5 stx2::KmR) 
(Dahan et al., 
2004) 
TUV+Stx2 TUV93-0 containing a marked Stx2 phage 
conjugated from Sakai stx2A::kan via JC5029 
as described in Material and Methods 
This study 
AAEC185 Laboratory K-12 strain for plasmid cloning (Blomfield et 
al., 1991) 
E. coli K12 MG1655 
(NalR) 






E. coli K12 MG1655 
(Sp5 stx2::KmR) 
Generated by transduction from the Sakai 
stx2A::kan strain 
This study 
JC5029 Hfr strain Coli Genetic 
stock centre 
(CGSC ) 
E. coli O157:H7 
PT21/28 and PT32 
bovine isolates 
18 strains isolated as part of an international 
partnership in veterinary epidemiology 
(IPRAVE) project 2001-2006. Further 
information is provided in Table 5.1. 
(Chase-Topping 
et al., 2007b) 
E. coli O157:H7 
PT21/28 and PT32 
human isolates 
20 strains provided by Dr. Lesley Allison from 
the E. coli reference laboratory, Edinburgh. 
Further information is provided in Table 5.1. 
(Chase-Topping 




Table 2.2. Plasmids used in the study 
 
Plasmid Details Source 
pIB307 pMAK705-based vector for allelic exchange; 
temperature-sensitive replicon  
(Blomfield et 
al., 1991) 
pAJR27   Andrew J.Roe provided, lacIA flanking regions 
from E. coli O157 (ZAP1) cloned into pIB307   
(Roe et al., 
2003b) 
pAJR33 Andrew J.Roe provided, lacIA flanking regions 
cloned into pIB307 with sacBkan cassette   
(Roe et al., 
2003b) 
PZS4Int-laci/tetR   Commercial vector  Expressys 
pKC26 pACYC184 with GFP fusion  (Holden et al., 
2007) 
pTP883 The cat gene cloned into pTP809 originally from 
pBR322   










pXLS01 ler with 567 bp of the promoter region was 
amplified with primer pair Ct-ler-SalI and Nt-ler-
PstI, cloned into pWSK29 with Sal I and Pst I 
This study  
pXLS02 PN25&tetR amplified from PZS4Int-laci/tetR 
inserted into pAJR27 at BamH I site 
This study 
pXLS03   tet promoter inserted into Xba I site in pKC26 This study 
pXLS04   LEE1 promoter flanking regions for first 
construction amplified from EDL933 and cloned 
into pIB307  
This study 
pXLS05   LEE1 promoter flanking regions for second 
construction amplified from EDL933 and cloned 
into pIB307 
This study 
Plasmid Details Source 
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pXLS06   sacBkan cassette was cloned into pXLS04 at  
BamH I site 
This study 
pXLS07   tet promoter was cloned into pXLS04 at BamH I  This study 
pAJR32 Source of sacBkan cassette  (Porter et al., 
2004) 
pBAD/His A Expression vector designed for regulated, dose-
dependent recombinant protein expression and 
purification in E. coli 
Invitrogen 
pBAD-N Amplified with primers JTstx2.N.F.NcoI and 
JTstx2.N.R.Hind III from EDL933 and cloned via 
NcoI and Hind III sites in pBAD/His A. 
This study 
pBAD-CRO Amplified with primers JTstx2.CRO.F.NcoI and 
JTstx2.CRO.R.Hind III from EDL933 and cloned 
via NcoI and Hind III sites in pBAD/His A. 
This study 
pBAD-CI Amplified with primers JTstx2.CI.F.NcoI and 
JTstx2.CI.R.Hind III from EDL933 and cloned via 
NcoI and Hind III sites in pBAD/His A. 
This study 
pBAD-CII Amplified with primers JTstx2.CII.F.NcoI and 
JTstx2.CII.R.HindIII from EDL933 and cloned via 
NcoI and Hind III sites in pBAD/His A. 
This study 
pBAD-Q Amplified with primers JTstx2.cI.Q.NcoI and 
JTstx2.Q.R.Hind III from EDL933 and cloned via 
NcoI and Hind III sites in pBAD/His A. 
This study 
pAJR70  pACYC184 containing egfp (Blomfield et 
al., 1991) 
pAJR71      LEE1 promoter fusion  (Blomfield et 
al., 1991) 
 
Plasmid Details Source 
pXLS10 z3357( cIIstx1) flanking regions amplified from This study 
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EDL933 and cloned into pIB307 as described in 
Material and Methods (used to make ZAP1325) 
pXLS11 z1449( cIIstx2) flanking regions from EDL933 
cloned into pIB307 as described in Material and 
Methods (used to make ZAP1323 & pXLS13)  
This study 
pXLS12 Stx1 phage (CP-933V) flanking regions from 
EDL933 cloned into pIB307 as described in 
Material and Methods (used to make pXLS16) 
This study 
pXLS13 z1449 flanking regions from EDL933 cloned into 
pIB307 with sacBkan cassette (used to make 
ZAP1321)  
This study 
pXLS14 z3357 flanking regions from EDL933 cloned into 
pIB307 with sacBkan cassette (used to make 
ZAP1324) 
This study 
pXLS15 Stx2 phage (BP-933W) flanking regions from 
EDL933 cloned into pIB307 as described above in 
Material and Methods  (used to make ZAP1322) 
This study 
pXLS16 Stx1 phage (CP-933V) flanking regions from 
EDL933 cloned into pIB307 with sacBkan cassette 












Table 2. 3. Oligonucleotide primers used in this study. Standard letters represents the 
original target sequence, capital letters represents the additional sequence and underlined 
capital letter represents introduced enzyme restriction site. 
 

























5-ArcA cagaccccgcacattcttatc This study
3-ArcA cttccagatcaccgcagaagc This study
5-up-ArcA cgggtcctgagggaaagtaccc This study
3-down-ArcA gctggtggtggcgctggccggc This study 
3-Fnr ggcaacgttacgcgtatgacc This study
5-up-Fnr cggaattctctgctgttaaggtttg This study
3-down-Fnr gtcctggttaggatcgataac This study
Primer Detail Source 
5-NarX cgttgtctctctccgctcacc This study
3-NarX gggtatctccttggacgtctg This study
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5-up-NarX ccgggtatgggtatacttcag This study
3-down-NarX gttcatgccgggcatattgag This study
5-NarP cctgaagcaacgccttttcag This study
3-NarP gcgcagtagattgcgaatatg This study
5-up-NarP gatgccaaagcgaacgacaa This study
3-down-NarP cctttgagcagcagcgatttg This study
5-lacI ggccgattcattaatgcagctg This study
3-lacA caacttctgatggatgcgagtg This study
5-lacZ gcattttaaatctcacttcggc This study
3-lacY gccctggaaaccgatgctttc This study
5-PN25-BamHI AAAAAGGATCCtcgagggaaatcataaaaaatttatttgc This study











5-GFP ggccaacacttgtcactactttgac This study
3-GFP gtttgtgtccgagaatgtttccatc This study
5-LEE1 up FR 
XmaI 
AACCCGGGgcagcatctaaaactaaagatgc This study
3-LEE1 UP FR 
BamHI 
CCGGATCCcccaggagcttacataagtaag This study
5-LEE1 down FR 
1st BamHI 
CCGGATCCtaatagcttaaaatattaaag This study
5-LEE1 down FR 
2nd BamHI 
CCGGATCCcttaaaatattaaagcatgcg This study
Primer Detail Source 
3-LEE1 down FR 
XbaI 
CCTCTAGAgactcagtgtctctattag This study
5-LEE1 test   cttatgtaagctcctgggga This study
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5-PIB test gtcataagtgcggcgacgatag This study
3-PIB test cagtagtaggttgaggccgttg This study
stx2 up 5' aaaaaGGATCCgacatgttgaaacgatggcac This study
stx2 up 3' gggggAAGCTTcgagcaatagacagttcttcc This study
stx2 down 5'  aaaaaGGATCCcaatatgtccgtacatggaataa This study
stx2 down 3' aaaaaGAGCTCgatggctttttgacgagcttaa This study
stx1 up 5' aaaaaGGATCCcacgcgcgtaacgtgacag This study
stx1 up 3' gggggAAGCTTcgcacgggtattggcaatag This study
stx1 down 5' aaaaaGGATCCcgagatcaaacgctggatcg This study
stx1 down 3' aaaaaGTCGACgttcgattttcaccgcacca This study
z1449 up 5' aaaaaGAGCTCcaaacaacatcaacgtttagaa  This study
z1449 up 3' aaaaaGGATCCttcttaagatttccaatag tgaa  This study
z1449 down 5' aaaaaGGATCCgggaattactggatcaatcc  This study
z1449 down 3' cccccAAGCTTgaaagatcgttttctggctg  This study
z3357 up 5' aaaaaGTCGACctttcttgttcctaactcgtag   This study
z3357 up 3' aaaaaGGATCCttgttaattttcctatattgatattg This study
Primer Detail Source 
z3357 down 5' aaaaaGGATCCgggaattactggatcaatccac This study
z3357 down 3' gggggAAGCTTgtcgttttctggctggtcaga This study
Stx1 phage (CP933-V) left end  
   yehU cacatctgctgaagcagcagc This study
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  Z3305 gcgatacagatctcaacacgc  This study
Stx1 phage (CP933-V) right end  
   intV atcacgaacagatagaactcc This study
   yehV agcgtctgggcggggtaatcc This study
stx2 phage (BP933-W) left end  
 wrbA cgcccgtctggtcgaggaagg This study
 intW tacaatgtttatggtgcatgg  This study
stx2 phage (BP933-W) right end  
 z1503 ttttttccctcgcccataacc This study
z1504 cggaatagagataacacgagg  This study
 SLT-I-1  cagttaatgtggtggcgaag  (Blomfield 
et al., 
1991) 
 SI-1 cgcctgctattttcactgagc  (Blomfield 
et al., 
1991) 
z1449 5' gctattttcacaatggacattc This study
z1449 3' tcagaattgcatatcaatttgc This study
z1449 external 5' cacgcatacctttcaactagc  This study
z1449 external 3' ctgtggattgatccagtaattc  This study
z3357 5' aaaaaGAATTCtcagaattgcatatcaatttgc This study
z3357 3' aaaaaCCATGGatggcacaagcaagctacag This study
z3357 external 5' gtcataatgaatcctgtggatt This study
Primer Detail Source 
z3357 external 3' ggtgtgccgctataactcaa This study
SacB 5' gcaactcaagcgtttgcgaaag This study
SacB 3' ggcttgtatgggccagttaaag This study





stx2 3' tcccgtcaaccttcactgta (Blomfield 
et al., 
1991) 
stx2c 5' gcggttttatttgcattagt (Blomfield 
et al., 
1991) 
stx2c 3' agtactcttttccggccact (Blomfield 
et al., 
1991) 
Ct-ler-SalI   aaaaaGTCGACtcatgttaaatatttttcagcgg This study
Nt-ler-PstI                 aaaaaCTGCAGgtatcatatagcatcatatagtg  
This study 
JTstx2.N.F.NcoI ggCCATGGcacgcagaactcagtt This study
JTstx2.N.R.HindIII ggAAGCTTtcacctcgccgtcagttgtt This study
JTstx2.CRO.F.NcoI ggCCATGGaaaatcttgatgagcc This study
JTstx2.CRO.R.HindIII      ggAAGCTTttatgcagccagaaggttct This study 
JTstx2.CI.F.NcoI ggCCATGGttcagaatgaaaaagt This study
JTstx2.CI.R.HindIII ggAAGCTTtcacgaacttttcagccact This study
JTstx2.CII.F.NcoI ggCCATGGaacaaacaagttacag This study
JTstx2.CII.R.HindIII ggAAGCTTtcagaattgcatatcaattt This study
JTstx2.Q.F.NcoI ggCCATGGgtgatatccggcaggttc This study
JTstx2.Q.R.HindIII ggAAGCTTttacgatcgtaaactattttttcg This study
 
 
2.3 DNA manipulation 
2.3.1 DNA agarose electrophoresis 
To detect and separate DNA fragments, DNA agarose electrophoresis was carried out as 
described below. The required concentration of agarose (Melford) was added to Tris 
borate EDTA (TBE), the volume was dependent on the the size of gel. 1 litre of TBE 
contains 0.09 M Tris base, 0.09 M boric acid and 0.002 M EDTA disodium salt dissolved 
in dH2O. The agarose solution was heated in a micro-wave for 2-5 min to dissolve the 
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agarose. The solution was cooled down in water and added with 10,000 x Safe view 
(NBS biologicals). DNA samples were loaded in gel wells after mixing with 6 x DNA 
loading buffer (Fermentas),. An appropriate DNA marker: 100 bp or 1Kb ladder 
(Fermentas) was also loaded into an additional well. After running at 100 volts for 40 min 
(depending on the size of expected DNA), the gels were analyzed and photographed with 
ultra violet light using the Flowgen Multi-Image cabinet and Image Capture software. 
Fig. 5.10 and Fig. 5.13 are shown in high constrast.  
 
2.3.2 PCR purification 
In order to purify specific PCR product, a GeneJET™ PCR Purification Kit (Fermentas), 
was used after the PCR process. One volume of the binding buffer was added to one 
volume of PCR product. The mixture was then removed to a GeneJET™ purification 
column in a collection tube and centrifuged at 13,000 rpm (revolutions per minute) for 
30-60 s. The flow-through was discarded. Then 700 μl wash buffer was added to the 
column with centrifugation at 13,000 rpm for 30-60 s. Discarding the flow-through, the 
column was centrifuged at 13,000 rpm for 1 min again to remove any residual wash 
buffer. The spin column was placed in a clean 1.5 ml micro-centrifuge tube and 50 μl of 
elution buffer added to the centre of the column. The column was incubated at room 
temperature for 1 min and centrifuged at 13,000 rpm for 1 min. The elution tube 
contained the purified PCR product was stored at -20 oC.  
 
 
2.3.3 DNA sequencing 
Nucleotide sequencing was performed in The Gene Pool, School of Biological Sciences, 
University of Edinburgh. 1 μl primer (3.2 pmol/μl) was mixed with 5 μl DNA for 
sequencing.  ABI Prism Big Dye terminator cycle sequencing kit version 3.1 (Applied 




2.3.4 DNA sequence analysis 
Sequencing data was obtained using a Chromas Lite 2.01 and copied into Vector NTI 
Suite 8 (Invitrogen). DNA sequence was aligned and compared with expected sequence 
with Vector NTI Suite 8 or blasted with NCBI Nucleotide Blast.  
 
2.3.5 Purification of DNA from gel 
The GeneJET™ Gel Extraction Kit (Fermentas) was used to purify DNA from gels 
following separation by agarose electrophoresis. Briefly, the labelled DNA band was cut 
from the agarose gel by imaging with ultra-violet light and placed in a 1.5 ml sterilized 
Eppendorf tube. The excised gel fragment was weighed. If the band exceeded 400 mg, it 
was divided into two fragments. 1:1 volume of Binding Buffer was added to the gel slice 
(volume:weight, i.e. 100 μl binding buffer for 100 mg of agarose gel). The gel mixture 
was incubated for at 50oC for 10 min or until the gel mixture is completely dissolved. 
When the gel was dissolved completely, the solutions were removed into a GeneJET™ 
purification column with a collection tube. The columns were centrifuged at 13, 000 rpm 
for 30-60 s, during which time the DNA binds to the matrix. Discarding the flow through, 
700 μl wash buffer was added to the column with centrifugation at 13,000 rpm for 30-60 
s. Discarding the flow through, the column was centrifuged at 13,000 rpm for 1 min again 
to remove any residual wash buffer. The spin column was placed in a clean 1.5 ml micro-
centrifuge tube. 50 μl elution buffer was added to the centre of the column. The column 
was incubated at room temperature for 1 min and centrifuged at 13,000 rpm for 1 min. 
The purified DNA was processed as required or stored at -20oC. 
2.3.6 Plasmids DNA extraction and purification  
The Fermentas GeneJET™ Plasmid Miniprep Kit was used to extract plasmid DNA. 
Firstly, a colony was inoculated to 5 ml LB with appropriate antibiotic. After overnight 
culture at 37oC with shaking at 200 rpm, the culture was centrifuged at 4,000 rpm for 5 
min at room temperature. Discarding the supernatant, the pellets were resuspended in 250 
μl Resuspension Solution and transferred to a 1.5 ml Eppendorf tube. A 250 μl aliquot of 
Lysis Solution was added and mixed thoroughly by inverting the tube 4-6 times until the 
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solution became viscous and begins to clear (alkaline lysis). Then 350 μl Neutralization 
Buffer was added and mixed immediately and thoroughly by inverting the tube 4-6 times. 
Centrifugation was carried out at 13,000 rpm for 5 mins at room temperature. The 
supernatant was removed to a GeneJET™ spin column by decanting or pipetting and 
centrifuged at 13,000 rpm for 1 min. Discarding the flow through, the column was 
washed with 500 μl Wash Solution and then centrifuged at 13,000 rpm for 1 min. The 
wash step was repeated and an additional centrifugation was carried out to remove the 
residual wash buffer. The column was then placed in a clean 1.5 ml micro-centrifuge tube 
with 50 μl elution buffer addedto the center of GeneJET™ spin column. After 2 min 
incubation at room temperature, the columns were centrifuged for 2 min to collect the 
plasmid DNA. The columns were discarded and DNA stored at 20oC. 
 
2.3.7 Electro-transformation 
2.3.7.1 Preparation of competent cell 
Bacteria were cultured in LB with appropriate antibiotic to an optical density at 600 nm 
of 0.4-0.6. Cultures were transferred to 50 ml tubes and cooled on ice for 30 min. 
Following centrifugation at 4,000g for 7 min at 4 oC in a pre-chilled centrifuge, the pellets 
were washed in a 0.5 volume of 10% chilled glycerol and re-centrifuged at 4,000 g for 7 
min at 4oC.  The pellets were again washed in a 0.25 X original volume of 10% chilled 
glycerol and centrifuged at 4,000 g for another 7 min at 4 oC. Finally, pellets were 
suspended in a 0.01 X original volume (0.5 ml for a 50 ml culture) of 10% chilled 
glycerol and distributed into 60 μl aliquots and stored at -70 oC.  
 
2.3.7.2 Electro-transformation 
The competent cells were kept on ice for 5-10 min after removal from -70oC storage. 
Plasmid DNA (1-3 μl) was added to each 60 μl competent cell aliquot. The mixed 
reaction was left on ice for 10-15 min. Electro-transformation was carried out at 2500 V 
for 0.005 s. Then 400 μl Super Optimal broth with Catabolite repression (SOC) was 
added to each reaction for recovery. After incubation at 37 oC 110rpm for 1 h (at least two 
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hours for the pIB307-based plasmids as these are cultured at 28-30 oC), 100 μl of cells 
were spread gently per plate containing  appropriate antibiotic(s).  
 
2.3.8 Chemical transformation 
2.3.8.1 Preparation of calcium-chloride competent bacteria 
A 1 ml overnight culture was added to 100 ml LB (a dilution of 1:100) broth. This 100 ml 
LB culture was incubated at the appropriate temperature at 200 rpm to reach 0.4-0.6 at 
OD600 nm, the bacteria were chilled on ice for 30min in 50 ml tubes. The cell culture was 
pelleted at 4000 x rpm for 10 min at 4oC in a chilled centrifuge. For this and each 
subsequent step the bacteria need to be treated gently. The pellets were resuspended in 
0.4 x the volume of ice-cold TFBI, i.e. 40 ml for a 100 ml culture. The bacteria were 
chilled on ice for 10 min and pelleted by centrifugation at 4000 x rpm for 10 min in a 
chilled centrifuge. The bacteria were suspended in 0.04 x volume (4 ml for a 100 ml 
culture) of TFBII. The suspension was kept on ice for at least 30 min before aliquoting 
(200 μl), then stored at –70 oC.  
 
SOC medium 
Bacto-tryptone           20 g 
Bacto-yeast extract    5 g 
NaCl                           20 g 
1M KCl                       2.5ml  
Dissolved in 1000 ml distilled water, adjust pH to 7.0 with 10N NaOH and autoclave to 
sterilize. Add 20 ml sterile 1 M glucose immediately before use. 
 
TFB I Solution (1 litre) 
30mM KoAc       2.94 g 
10mM CaCl2.2H2O  1.47 g 
100mM KCl       7.45 g 
15% Glycerol     150 ml 
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Dissolved in 900 ml distilled water and autoclaved, 100 ml of autoclaved 500 mM MnCl2 
(50 mM final concentration) was then added. 
 
TFB II Solution ( 1 liter) 
75mM CaCl2.2H2O  11.03 g 
10mM KCl        0.745 g 
15% Glycerol      150 ml 
Diluted in 900 ml distilled water and autoclaved, then 100 ml of autoclaved 100 mM Na-
MOPs pH7.0 (2.09 g MOPs with 10 mM NaOH ) was added. 
 
2.3.8.2 Chemical transformation 
Briefly, 10 μl ligation product was added to 200 μl chemical competent cells. Then it was 
kept on ice for 30 minutes, and heat-shocke 
d at 42 oC for 1 minute and then put back on ice for 2 minutes. 1 ml SOC was added to 
each tube and incubated at 37 oC for 1 hour (80 rpm). 100 μl of cells were spread gently 







2.4 Construction of mutants 
2.4.1 The construction of ZAP198 mutants in genes involved in  aerobic and 
anaerobic respiration  
λ-Red recombineering technology has been used extensively in E. coli for PCR product-
mediated generation of deletion mutants. The λ Red recombination system uses Bet (a 
ssDNA annealing protein) and Exo (a 5'-3' dsDNA exonuclease) to promote gene 
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replacement of linear DNA substrates that are electroporated into the required E. coli 
strain (Murphy KC, Campellone KG, 2003.).. Bet and Exo are introduced into the 
required strain background on a plasmid (pKM201, Table 2.2) by transformation. Murphy 
and co-workers (Murphy KC, Campellone KG, 2003) reported that EHEC deletion 
mutants can be easily and precisely achieved by using PCR-generated product consisting 
of antibiotic markers flanked by 40 bp of target DNA.  
 
2.4.1.1 Preparation of electrocompetent hyper-rec EHEC carrying λ-Red functions 
on pKM201 
Plasmid pKM201 was electro-transformed into the strain to be manipulated as described 
in Section 2.7 and cultured at 30 oC on LB-AMP plates. A single fresh colony was placed 
into 5ml LB with AMP and cultured overnight at 30 oC. Then the overnight culture was 
diluted into fresh prewarmed medium at 1:100. When the bacteria have grown to an 
optical density at 600 nm of 0.3, the bacteria were induced with 4mM IPTG for 60 min. 
The culture was then heat-shocked at 42 oC for 15 min and chilled on ice for 10 min. 
Bacteria were centrifuged at 4000 g at 4 oC and suspended in 5 ml cold 20% glycerol. 
The centrifugation step was repeated and the cells were re-suspended in 2 ml cold 20% 
glycerol. The cells were divided into 90 μl aliquots. The competent cells were either used 




2.4.1.2 Electro-transformation of PCR products into EHEC strains containing 
pKM201 
PCR-generated DNA substrates were amplified by using the relevant primer sets detailed 
in Table 2.3. Individually, primer pair 5-ArcA and 3-ArcA were used to amplify DNA 
fragments for the arcA deletion; primer pair 5-Fnr and 3- Fnr were used for construction 
of the fnr deletion;, primer pair 5-NarX and 3- NarX were used for generation of the narX 
deletion, and primer pair 5-NarP and 3- NarP were used to construct a narP mutant. 
Prior to electroporation, cuvettes (VWR) with a l mm gap were cooled in an ice-water 
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bath for at least 10 min prior to use. DNA samples containing either 0.05–1 μg of purified 
DNA fragments were added to 90 μl of competent cells in an electroporation cuvette, and 
incubated on ice for 10 min. The cuvette was quickly dried and the cells shocked at 
2200V for 0.005 sec. Following electroporation, SOC was immediately added to a total 
volume and 1 ml transferred to a culture tube and incubated with shaking at 30 oC for 2 
hour. The bacteria were then plated onto LB plates containing 10–15 μg/ml CAM. 
Following subculture, PCR primers (Table 2.3) were used to screen for deletions.  
 
2.4.2 The creation of LEE1 promoter constructs 
The aim is to construct a LEE1 promoter artificially controlled by adding aTc inducer. 
Briefly, the original LEE1 chromosomal promoter will be replaced by the tet promoter 
using allelic exchange. This promoter is controlled by tetR and the tetR will be placed in 
lacZY location by the same method. Therefore, LEE1 expression would be quantitatively 
expressed by using aTc  and then LEE2-LEE5 expression and other effector expression 
could be investigated with a constant LEE1 expression system. The experimental process 





























Fig. 2.1 Summary diagram of constructs for LEE1 constructions (A-D) 
pAJR33 is used to produce ZAP1212 with lacYZ replaced by sacBkan cassette. pXLS02 
is designed to construct  ZAP1213. pXLS06 is used to produce ZAP1213 with LEE1 
promoter replaced by sacBkan cassette in first construction.  pXLS07 is constructed for 






2.4.2.1 Constructs for allelic exchange 
pAJR 33 was used to replace lacYZ genes with sacBkan cassette. To construct a strain 
with sacBkan cassette in lacYZ loci replaced by TetR gene, a plasmid containing tetR 
gene in pAJR27 was made. PZS4Int-laci/tetR plasmids contain the tetR gene controlled 
by a constitutive promoter (PN25). PN25&tetR was PCR amplified from PZS4Int-
laci/tetR plasmid by using primer pairs 5-PN25-BamHI and 3-PN25-BamHI (Table 2.3), 
then cloned into pAJR27 in the BamH I site creating pXLS02 to allow the exchange for 
sacBkan cassette.  
 
In order to construct plasmids facilitating exchange of LEE1 promoter with tet promoter, 
plasmid with LEE1 promoter flanking regions was obtained. According to LEE1 
promoter and tet promoter structure, two constructs will be made. The first construction 
will keep the original transcriptional start site and -10 region of LEE1 operon promoter, 
while the -35 regions will be replaced by AT rich DNA sequence synthesized artificially. 
For the second construct, only the original transcriptional start site will be kept with -35 
and -10 regions replaced. Briefly, PCR fragments were amplified from TUV93-0 using 
the primer pairs shown in Table 2.3: 5-LEE1 UP FR XmaI and 3-LEE1 UP FR BamHI 
for upstream flanking region, 5-LEE1 down FR 1st and 3-LEE1 down FR for downstream 
flanking region for the first construction and 5-LEE1 down FR 2nd and 3-LEE1 down FR 
for downstream flanking region for the second construction. These PCR fragments were 
digested with proper enzymes and cloned into PIB307. The resultant plasmids containing 
both flanking regions for the first and the second construction were termed as pXLS04 
and pXLS05 respectively. Then a sacBkan cassette cut from pAJR32 was cloned into 
pXLS04 at BamH I site. This plasmid was termed as pXLS06. In addition, tet promoter 
which was PCR synthesized by using primer pairs 5-Tet promoter BamHI 1st 3-Tet 








2.4.2.2 The construction of mutants for LEE1 constructions 
(1) The exchange of lacYZ genes with sacBkan cassette. To replace lacZY, the plasmid 
pAJR33 was used that contains lacIA flanking regions cloned into pIB307 with a 
sacBkan cassette. The method of Hamilton et al (Hamilton et al., 1989) was applied 
for the allelic exchange in this study. Briefly, the plasmid containing the appropriate 
flanking regions was electroporated into the strain to be manipulated and cultured at 
30 oC on LB-CAM plates. Ten transformants were then inoculated into pre-warmed 
LB-KAN at 42 oC and passaged repeatedly in LB-KAN broth at 42 oC to obtain 
cointegrates. The culture was further passaged at 30 oC in LB-KAN broth in which a 
secondary recombination event resulted in the lacYZ being replaced by the sacBkan 
cassette. The correct replacement strain (ZAP1212) was determined by KAN 
resistance and CAM sensitivity further confirmed by PCR with primer pairs in 




(2) The exchange of sacBkan cassette with PN25&tetR in lacYZ location. To generate 
the exchange of the sacBkan cassette with PN25&tetR, plasmid pXLS02 was 
electroporated into ZAP1212 and the above process repeated with the following 
differences: the second of cultures at 30 oC was performed without antibiotic 
selection, and the correct clones were identified by sensitivity to both KAN and 
CAM on replica plates, and confirmed by PCR using primer pair 5-PN25-BamHI 
and 3-PN25-BamHI (Table 2.3) for PN25&tetR, primer pair 5-lacI and 3-lacA 
(Table 2.3) for flanking the region. The strain obtained from this exchange is named 
as ZAP1213.  
 
(3) The exchange of LEE1 promoter with sacBkan cassette. The exchange method was 
used as described in Materials and Methods. Specifically, pXLS06 was electro-
transformed into ZAP1213 and cultured at 30 oC on LB-CAM plates separately. Ten 
transformants were then inoculated into pre-warmed LB-CAM at 42 oC and 
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passaged repeatedly in LB-CAM broth at 42 oC to obtain cointegrates. The culture 
was further passaged at 30 oC in LB-KAN broth in which a selection of LEE1 
promoter replaced by the sacBkan cassette was carried out. The correct replacement 
strain was determined by KAN resistance and CAM sensitivity. Further 
confirmation were carried out by PCR with primer pairs in Table 2.3: 5-LEE1 test 
and 3-LEE1 test for inside of LEE1 promoter, 5-SacB and 3-SacB for inside of 
sacBkan cassette and 5-LEE1 UP FR XmaI and 3-SacB for cross junction of 
sacBkan cassette and chromosome. 
 
(4) The exchange of sacBkan cassette with tet promoter in LEE1 promoter location. 
Once the sacBkan cassette is placed on LEE1 promoter region, plasmids pXLS07 
was transformed into the strain to be manipulated. The same procedure will be 
performed as mentioned in “The exchange of sacBkan cassette with PN25&TetR in 
lacYZ location”. The resultant colonies were screened by PCR with primer pair 5-
SacB and 3-SacB (Table 2.3) for inside of sacBkan cassette, primer pair 5-PN25-
BamHI and 3-PN25-BamHI (Table 2.3) for PN25&tetR (Table 2.3), primer pair 5-
Tet promoter BamHI 1st  and 3-LEE1 down FR XbaI cross junction of tet promoter 
and chromosome. 
 
2.4.2.3 Testing  aTc induction efficiency by TetR using GFP measurement 
In order to test the aTc induction efficiency and allelic exchange for replacing lacYZ with 
TetR, the tet promoter was PCR amplified by using primer pair 5-Tet promoter-XbaI and 
3-Tet promoter-XbaI (Table 2.3), then cloned into pKC26 plasmid in XbaI site creating 
plasmid pXLS03. This plasmid places GFP under control of the tet promoter. pXLS03 
was transformed into ZAP1213 by standard electro-transformation as mentioned above. 
The resultant transformants were grown overnight in LB containing appropriate 
antibiotics. For the total GFP measurement, the overnight was diluted into fresh LB with 
appropriate antibiotics to reach an OD600 value of 0.05. According to the preliminary 
experiment, a concentration of 200ngml-1 was used to induce the maximum induction. 
Normally, 25 ml media with bacteria was cultured in Erlenmeyer flasks with shaking at 
200 rpm at 37°C in dark to protect aTc activity. The optical density of the cultures was 
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measured at OD600 every one hour and analyzed by testing 100 μl aliquots of culture with 
a fluorescent plate eader (Fluorostar Optima; BMG). ZAP198, ZAP1213 and 
promoterless plasmids pKC26 in ZAP1213 were used as a negative control for 
background fluorescence. 
2.4.3 The construction of EDL933 mutants in Stx1&2 phage and cII genes 
2.4.3.1 Constructs for allelic exchange.   
In order to construct plasmids that would facilitate chromosomal exchange, flanking 
regions of the z1449 (cIIstx2) genes and Stx1 and Stx2 phages were PCR amplified and 
cloned into the temperature-sensitive plasmid pIB307 (Table 2.2). Primer pairs as 
described in Table 2.3 z3357 up 5', z3357 up3' and z3357 down 5', z3357 down 3' ; z1449 
up 5', z1449 up3' and z1449 down 5', z1449 down 3'; stx1 up 5', stx1 up3' and stx1 down 
5', stx1 down 3'; stx2 up 5', stx2 up3' and stx2 down 5', stx2 down 3 were used to amplify 
z3357, z1449 Stx1 phage and Stx2 phage flanking regions sequences from E. coli 
O157:H7 EDL933. These products were cleaned with a Invitrogen PCR purification kit, 
digested with BamH I and Hind III or Sac I, or Sal I , re-cleaned, and then ligated with 
digested PIB307(Table 2.2) to obtain pXLS10, pXLS11, pXLS12 and pXLS15 
containing flanking regions of z3357, z1449, stx1 phage, and stx2 genes respectively. To 
produce plasmids for exchange, a sacBkan cassette was cloned into the BamH I sites of 
pXLS11, pXLS10 and pXLS12 creating pXLS13, pXLS14 and pXLS16 that would allow 
the chromosomal replacement of z1449, z3357 and stx1 genes respectively with a 
selectable marker and a counterselection gene.  
 
2.4.3.2 Mutant construction 
The method of Emmerson et al. was used for allelic exchange (Emmerson et al., 2006).  
Plasmids pXLS13 was transformed into EDL933 to obtain the intermediate strain with 
z1449 (cIIstx2) replaced by sacBkan cassette. Briefly, pXLS13 was electroporated into 
EDL933 (Table 2.1) and cultured at 30°C on LB-C plates. Ten transformants were then 
inoculated into pre-warmed LB-C at 42°C and passaged repeatedly in LB-C broth at 
42°C  to obtain co-integrates. The culture was further passaged at 3°C in LB-K broth to 
select for the complete exchange. The kanamycin resistant and chloramphenicol sensitive 
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strain was confirmed by PCR with primer pairs z1449 5’ and z1449 3’ for inside of z1449, 
z1449 external 5’ and z1449 external 3’ for outside of z1449, sacB 5’ and sacB 3’ for 
sacBkan cassette (Primer Table 2.3). The resultant strain was termed as ZAP1321. 
ZAP1321 was then transformed with plasmids pXLS15 and pXLS11 and allelic exchange 
carried out to generate strains with Stx2 phage and z1449 (cIIstx2) clean deletions. These 
allelic exchanges were as above except that the cultures at 30 oC did not contain any 
antibiotic selection.  The required clones were identified by sensitivity to both KAN and 
CAM and confirmed by PCR using primer pairs: wrbA and intW plus z1503 and z1504 
for the junction sites of Stx2; wrbA and Z1504 for a region inside the Stx2 phage; z1449 
5’ and z1449 3’ for inside of z1449 (cIIstx2), z1449 external 5’ and z1449 external 3’ for 
outside of z1449, sacB 5’ and sacB 3’ for sacBkan cassette. The clean stx2 and z1449 
deletion strain were termed ZAP1322 and ZAP1323 respectively (Table 2.1).  In order to 
construct a strain deleted for both Stx1 and Stx2 phages, ZAP1322 was used to create 
strain with stx1 replaced with sacBkan cassette using pXLS16. The required strain by 
exchanger was determined by KAN resistance and CAM sensitivity; further confirmed by 
PCR with primer pairs yehU and z3305 for left end of Stx1 phage, intV and yehV for 
right end of Stx1 phage, SLT-I-1 and SL-1 for inside of Stx1 phage, sacB 5’ and sacB 3’ 
for sacBkan cassette (Primer Table 2.3). The resultant strain was termed ZAP1326 
(EDLStx1&2-). To construct a strain with both z1449 (cIIstx2) and z3357 (cIIstx1) deleted, 
ZAP1323 was used for allelic exchange. pXLS14 was transformed into ZAP 1323 and 
exchange was done as described above to produce strain with z3357 replaced by sacBkan 
cassette using. The strain obtained by exchanger was determined by KAN resistance and 
CAM sensitivity; further confirmed by PCR with primer pairs z3357 5’ and z3357 3’ for 
inside of z3357, sacB 5’ and sacB 3’ for sacBkan cassette (Primer Table 2.3). This 











2.5 Quantification of population fluorescence levels 
Strains were electro-transformed with pAJR70–71 (Table 2.2) under standard conditions. 
The resultant transformants were cultured overnight in LB broth and then diluted 1:100 
into fresh, MEM-HEPES with appropriate antibiotics. Typically, 30 ml was cultured in 
Erlenmeyer flasks shaken at 200 rpm, 37°C. The optical density of the cultures was 
monitored by determination of the OD600. Cultures were sampled every hour for optical 
density and GFP measurement. The total fluorescence produced by the population was 
determined by analyzing 100 ul aliquots of culture with a fluorescent plate reader 
(Fluorostar Optima; BMG). Promoterless plasmid pAJR70 acted as a control for 
background fluorescence. 
 
2.6 Preparation of bacterial and epithelial cell cultures for infection 
assays 
For routine cultures, EHEC strains were grown in LB medium at 37°C. Prior to cell 
challenge, the required strains were cultured to saturation in LB overnight, then diluted 
and cultured in MEM-Hepes starting at an optical density at 600 nm of 0.05. Embryonic 
bovine lung (EBL) cells were cultured in Minimum Essential Medium Eagle (Sigma) 
supplemented with 10% heat inactivated foetal bovine serum (FBS) (Sigma), 100U/ml 
penicillin, 100 µg/ml streptomycin (Gibco) and 2 mM L-glutamine (Gibco). Cells were 










2.7 Bacterial infection assays and immunofluorescence microscopy 
To assess cell binding and actin pedestal formation by E. coli O157 strains, EBL cells 
were used that had been seeded (5 x 104 cells/well) into 8-well chamber slides (BD) the 
day prior to carrying out the assay. One hour before addition of the bacteria, the EBL 
cells were washed and cultured with pre-warmed bacterial culture medium MEM-Hepes 
to remove the antibiotics.  Then EBL cells were infected with a 2 x 106 bacteria in MEM-
Hepes for 3 hrs. Monolayers were washed two times with PBS, fixed for 20 min with 
PBS + 2.5% paraformaldehyde (PFA), permeabilized for 5 min with PBS + 0.1% Triton 
X-100, washed three times with PBS and treated with anti E. coli O157:H7 rabbit 
antibody (MAST ASSURE) diluted in PBS 1:50 for 35 min. Monolayers were then 
washed three times, incubated with Alexa 568-conjugated anti-mouse IgG (Molecular 
Probes) at a dilution of 1:1000 for 30 min. The chamber slides were then washed three 
times and stained with 1 μg ml–1 TRITC–Phalloidin (Sigma) for 30 min, washed two 
times with PBS and mounted with mounting medium (Invitogen). These are left to set for 
at least one night and then examined by fluorescence and light microscopy. The cell-
binding frequencies of EHEC strains were quantified by counting the number of bacteria 
(identified by anti-O157-staining) associated with randomly chosen fields of view. 
Twenty fields of view were examined per strain for cell binding and actin pedestal 
formation assays. Pedestal formation frequencies were quantified by counting the number 
of localized F-actin pedestals (identified by intense phalloidin staining) on randomly 
chosen EBL cells. 
 
2.8 Comparative genomic hybridization (CGH) 
A total of 12 IPRAVE strains (6 for PT21/28 and PT 32) were selected for CGH based on 
T3 profile. Genomic DNA was extracted with Invitrogen ChargeSwitch gDNA Mini 
Bacteria Kit (Invitrogen). Labeling was carried out with Bioprime Plus Array CGH 
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Genomic Labelling System (Invitrogen). Protocol for pre-hybridization, hybridization 
and washing for ultragaps slides was from UBEC project (School of Biosciences, 
University of Birmingham). Briefly, array slides were washed twice in Wash Buffer II 
(0.1% SDS, 0.1x saline-sodium citrate (SSC), each time for 30S. Then slides were 
transferred in pre-hybridization buffer (0.1% BSA, 0.1% SDS, 5x SSC) for 120 min. 
After washing in Wash Buffer II and III (0.1 unit SSC), the denatured hybridization probe 
mixture (30% formamide, 5x SSC, 0.1% SDS, 0.1mg/ml Salmon sperm DNA, 1x 
Denhardt’s Solution (Sigma) and 80 pmoles Cy3 and Cy5 dye (Invitrogen) probe) was 
added to slides and incubated for overnight. Next day, the array slides were washed in 
Wash Buffer I (0.1% SDS, 2x SSC), II and III and scanned in Axon scanner. With the 
help of Jai Tree in the ZAP laboratory, CGH was carried out and data was analyzed.  
 
2.9 PCR to identify Stx2 and Stx2c phage 
Genomic DNA for 62 tested strains was extracted with the Invitrogen Charge Switch 
gDNA Mini Bacteria Kit. The concentration of the genomic DNA was measured by a 
nanodrop. The method of Wang et al. (Wang et al., 2002) was used for PCR to determine 
Stx2 and Stx2c phage. A mount of 100 ng genomic DNA was used for each PCR reaction. 
A size of 115 bp specific DNA fragment was amplified from Stx2 phage, while a 124 bp 
DNA fragment was designed for Stx2c phage according to the specific gene sequence for 
each phage. 
 
2.10 Preparation of secreted proteins and bacterial fractions for protein 
analyses 
Bacteria were cultured in 30 ml of MEM-HEPES at 37°C (200 rpm) to an OD600 of 0.8 
unless specifically stated. The bacterial cells were pelleted by centrifugation at 4000 x g 
for 15 min, and supernatants were passed through filters (0.45 μm). Supernatant proteins 
were precipitated overnight with 10% TCA, and separated by centrifugation at 4000 x g 
for 30 min (4°C); the proteins were suspended in 100 μl of 1.5 M Tris (pH 8.8). The 
bacterial pellet was initially suspended in 50 μl laemmli sample buffer (Sigma) and 50 μl 
molecular water.  Proteins were separated by SDS-PAGE using standard methods and 
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Western blotting performed as described previously (Naylor et al., 2005; Roe et al., 
2003b). Antibodies used specifically recognized EspD (Gift from Prof. T. Chakraborty, 
University of Giessen), EscJ (Gift from Dr Ando and Prof. Abe), RecA (Stressgen/Enzo 
Life Sciences). 
 
2.11 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
Secreted proteins and bacterial fractions were separated on SDS-PAGE gel using Bio-
Rad Mini Protein II gen apparatus (Bio-Rad). Protein Samples were diluted into 2 X 
loading buffer (Sigma) and boiled for 5 mins in water bath. Prepared samples were 
loaded in a 5% stacking gel (5% acrylamide-bisacrylamide, 0.125 Tris-HCL (pH 6.8), 
0.1% SDS, 0.1% ammonium persulfate (APS), 0.001% N, N, N', N'-
tetramethylethylenediamine (TEMED)) and resolved in a 12% resolving gel (12% 
acrylamide-bisacrylamide, 0.375 Tris-HCl (pH 8.8), 0.1% SDS, 0.1% ammonium APS, 
0.001% TEMED) by electrophroesis. Electrophroesis was performed in Tris-glycine 
running buffer (25 mM Tris-HCl (pH 8.3, 192 mM glycine, 0.1% SDS) at 150 B for 1 
hour.  
 
2.12 Colloidal coomasie blue staining of SDS-PAGE gels 
Gels were stained by colloidal coomassie blue stain (Severn Biotech) for overnight. De-
staining was carried out in distilled water. Gels were viewed and imaged by a Flowgen 












2.13 Western blotting 
Firstly, SDS PAGE was carried out as described above. The stacking gel was removed. If 
required for orientation, one corner was removed from the resolving gel. Four sheets of 
gel-sized filter paper and one gel-sized piece of nitrocellulose (Amersham Hybond ECL) 
and two pieces of gel-sized sponge were soaked in transfer buffer. The blot was 
assembled in the order: Black Plate – sponge – 2x filter paper - gel – nitrocellulose – 2x 
filter paper – sponge – Clear Plate. The tank was filled with transfer buffer and blotting 
was carried out at 60 V for 1.5 hours or 10 V for overnight. If running at 60 V a frozen 
water block (stored at -20oC) was included in the running tank to prevent overheating. 
The nitrocellulose was incubated with blocking buffer (8 % (w/w) milk in PBS) for at 
least 1 hour at room temperature or overnight at 4 ºC. The blot was washed 3 times with 
washing buffer (0.05 % (v/v) Tween-20 in PBS) on a “gyro rocker” at room temperature 
for 15 mins. Primary EspD antibody was added (1: 5000 dilution) in testing buffer 
(0.05 % (v/v) Tween-20 in PBS), with incubation for at least 2 hours on a “gyro rocker” 
at room temperature. The wash steps were then repeated. Secondary antibody 
(horseradish peroxidase labeled, 1: 4000) in testing buffer was added with incubation of 1 
hour on a “gyro rocker” at room temperature. Wash as before. Equal volumes of ECL 
Solutions 1&2 were mixed and added to the blot and left for 5 mins at room temperature. 
The ECL signal is short-lived (<1 h.) The blot was sealed in clingfilm and taped inside a 
film exposure cassette, exposed to Amersham Hybond ECL film for the required time 










2.14 Statistical analysis 
2.14.1 Statistical analysis in Chapter 3 
The cell binding data and A/E lesions data was analyzed by F-test and t-test. F-test (two 
sample variance) was performed for each pair of data with tested sample and wild type. 
P<0.05 from F-test indicated an unequal variance and in turn two sample assuming 
unequal variances was applied for t-test. In contrast, if P>0.05 from F-test, two sample 
assuming equal variances was carried out for t-test. P<0.05 (two tail) from t-test was 
considered to indicate statistical significance. 
 
2.14.2 Statistical analysis in Chapter 7  
This work was carried out by Dr. Darren J. Shaw. Differences in the level of fluorescence 
from the PT32 strains compared to PT21/28 strains and strains containing both Stx2 or 
Stx2c prophages compared to strains only containing one were compared by standard 
two-sample t-tests on log10 transformed values. Standard two-sample t-tests were also 
performed to compare relative fluorescence in specific TUV, EDL and K-12 strains. All 
analyses were carried out in R (© R Development Core Team (2009).R version 2.10.1(© 
Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL 






























































Cattle are known as a main source of human infection with E. coli O157:H7 (Hancock et 
al., 1994; Orskov et al., 1987).  E. coli O157:H7 mainly colonizes at the terminal rectum 
in which a T3SS is essential (Naylor et al., 2003). Ando and coworkers reported (Ando et 
al., 2007) that the activation of anaerobic respiratory system accelerates the maturation of 
the functional T3S apparatus under anaerobic growth conditions. The hypothesis to be 
tested is that the tropism is driven by when the secretion system is expressed in the 
animal under changes in anaerobic/aerobic conditions in the gastrointestinal tract.  To 
investigate the effect of the respiration regulatory system on T3SS expression, arcA, fnr, 
narX and narP deletion mutants were constructed by λ Red recombination in the 
background of the E. coli O157:H7 ZAP198 strain. λ Red recombination has been used 
extensively in E. coli for PCR-mediated generation of deletion mutants. Murphy and co-
workers reported that EHEC deletion mutants can be easily and precisely achieved by 
using PCR-generated products containing drug markers flanked by 40 bp of target 
homologous (Murphy & Campellone, 2003). Once the mutants were obtained, the T3S 
profiles and T3S levels of these mutants were examined as well as the capacity of the 
















3.2.1 The deletion of E. coli O157 respiration regulators 
Four mutants were obtained by λ Red recombination including ZAP198 ΔarcA, ZAP198 
Δfnr, ZAP198 ΔnarX and ZAP198 ΔnarP. These mutants were confirmed by PCR.  Each 
deletion construction and confirmation is now described. 
 
3.2.1.1 The construction of an arcA deletion 
By using PCR primer pair 5-ArcA and 3-ArcA (Table 2.3), a DNA fragment containing 
the CAM cassette flanked with 40bp of arcA upstream and downstream was amplified 
(Fig. 3.2A). This PCR product was electroporated into ZAP198 carrying pKM201 that 
encodes the λ Red recombinase. The arcA gene locus and correct recombinants with 
designed primers were shown in Fig. 3.1. The resultant strain was verified by PCR with 
primer pair 5-KO-ArcA and 3-KO-ArcA (Table 2.3) for the CAM cassette (Fig. 3.2B), 5-
ArcA and 3-ArcA (Table 2.3) for detecting arcA (Fig. 3.2C), 5-up-ArcA and 3-down-
ArcA (Table 2.3) for outside of the arcA (Fig. 3.2D). 4 colonies contained the CAM 
cassette, but only one of them had lost the arcA gene (Fig. 3.2B-C). That colony was 
confirmed by PCR using primers outside of arcA indicating the recombinant is 
approximately 200 bp larger than the wild type sequence (Fig. 3.2D). This is the expected 
size difference between the CAM cassette (900 bp) and the arcA gene (717bp). Colony 2 
























Fig. 3.1 A: Structure diagram of arcA locus and primers in ZAP198 
             B: Structure diagram of CAM cassette and primers in arcA mutant 
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M   1   2    3    4    5 
Fig. 3.2 PCR for generation of the deletion cassette with arcA, fnr, narX, narP flanking 
regions and for screening of arcA recombination 
(A) PCR fragments for construction of deletion mutants: Lane M: 1kb ladder, Lane1: arcA, 
Lane 3: fnr Lane 5: narX Lane 7: narP, Lane 2,4,6,8: negative control  
(B-D)  Screening of recombinant colonies for deletion of arcA Lane M: 1kb ladder                  
Lanes 1-4 contain amplified products from tested colonies 1-4 respectively; Lane 5 contains 
products amplified from E. coli O157:H7 ZAP 198 as a control unless otherwise stated. . 
(B) PCR screening of recombination of CAM cassette to replace arcA; the 4 colonies all 
contain the CAM cassette with pTP883 (CAM+) as a positive control. (C) Screening of 
recombinant colonies for deletion of arcA. Colony 2 has no detectable arcA  with ZAP198 
used as a positive control. (D) PCR screening of recombinant colonies across the arcA 
region. Colony 2-4 show the size difference between CAM cassette (900bp) and the arcA 
(717bp). ZAP198 was used as a control.  
1kb 





3.2.1.2 fnr deletion 
The same method was used to generate an fnr deletion. The CAM cassette with flanking 
regions for fnr was amplified by primer pair 5-KO-Fnr and 3-KO-Fnr (Table 2.3) (Fig. 
3.2A). The fnr gene locus and correct recombinants with designed primers were shown in 
Fig. 3.3. To determine the right replacement, primer pair 5-KO-Fnr and 3-KO-Fnr (Table 
2.3) were used to detect the CAM cassette (Fig. 3.4A), primer pair 5-Fnr and 3-Fnr 
(Table 2.3) were used to identify the presence of the fnr gene (Fig. 4B), and primer pair 
5-up-Fnr and 3-down-Fnr (Table 2.3) for amplifying across the fnr region (Fig. 3.4C). As 
shown in Fig. 3.2A, colony 1 contained a CAM cassette with fnr removed. The correct 
recombinant, colony 1 was further confirmed by PCR across the fnr gene region (Fig. 
3.4C) with a 150bp distinction which is consistent with the difference between wild type 








Fig. 3.3 A: Structure diagram of fnr locus and primers in ZAP198 













3-KO-Fnr 3-down-Fnr  






1   2   M 
Fig. 3.4 PCR screening of recombinant colony 1  
Lane M: 1kb ladder; Lane 1: colony 1; Lane 2: control as stated:  
(A)  PCR screening for CAM cassette with pTP883 (CAM+) as a positive 
control, colony 1 contains the CAM cassette. 
(B)  PCR screening for the fnr gene, expected size is 753bp, colony 1 
contains no amplified product for fnr. The control is E. coli O157 
ZAP198. 
(C)  PCR screening across fnr; the PCR product from colony 1 is larger than 
for the wild type control (ZAP 198) as expected for the difference 
between amplifying across the CAM cassette (900bp) vs. fnr (753bp). 
1        2           M 
A B C 































3.2.1.3 narX deletion  
As showed in Fig. 3.1A, the PCR generated DNA substrate was amplified by using 5-
KO-NarX and 3-KO-NarX (Table 2.3). The narX gene locus and correct recombinants 
with designed primers were shown in Fig. 3.5.To identify a gene replacement, primer pair 
5-KO-NarX and 3-KO-NarX (Table 2.3) was used to test the presence of the CAM 
cassette (Fig. 3.6A), primer pair 5-NarX and 3-NarX (Table 2.3) were used to identify the 
presence of narX (Fig. 3.6B), and primer pair 5-up-NarX and 5-down-NarX (Table 2.3) 
were used to amplify across the narX gene (Fig. 3.6C).  Fig. 3.3.A indicates that both 
colonies 1 and 2 contained the CAM cassette (900bp). From further tests, it was 
demonstrated that colony 1 has lost the narX gene (1797bp) (Fig. 3.6B) and colony 1 
amplified a product across the regions that was approximately 900bp smaller than 
expected for the wild type region from E. coli O157 ZAP198, indicating narX has been 








Fig. 3.5 A: Structure diagram of narX locus and primers in ZAP198 
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M       1      2       3 
Fig. 3.6 PCR screening of colonies for replacement of narX with a CAM cassette 
(A-B): Lane M: 1kb ladder; Lane 1: colony 2;  Lane 2: colony 1; Lane 3: positive 
control. (A): Screening for the CAM cassette, two colonies were isolated that 
contained the CAM cassette, the expected size is 900bp. (B): Screening for narX 
deletion, only colony 1(Lane 2) has no amplified product indicating loss of narX 
(1797bp). (C): Screening across the narX region: Lane M: 1kb ladde.  Lane 1 contains 
colony 1; Lane 2 contains colony 2; Lane 3 uses ZAP198 as a template.  The PCR 
product from colony 1 (lane 1) is smaller than from the WT ZAP198 and these sizes 
are consistent with the expected difference between insertion of the CAM cassette 
(900bp) and the wild type narX (1797bp).  






3.2.1.4 narP deletion 
The same procedure was used to delete narP using 5-KO-NarP and 3-KO-NarP (Table 
2.3). The narP gene locus and correct recombinants with designed primers were shown in 
Fig. 3.7.CAM resistant colonies were analysed by PCR tests with primer pair 5-KO-NarP 
and 3-KO-NarP (Table 2.3) for the CAM cassette, 5-NarP and 3-NarP (Table 2.3) for 
narP, and 5-up-NarP and 5-up-NarP (Table 2.3) for a region across narP. The PCR 
results showed that colonies 1-6 all possess the CAM cassette (Fig. 3.8A), but only 
colony 3 does not amplifty a narP product (Fig. 3.8B).  The insertion of the CAM genes 
was verified by PCR across the region indicating a 250bp difference between the isolate 










Fig. 3.7 A: Structure diagram of narP locus and primers in ZAP198 













3-KO-NarP 3-down-NarP  



































1     2    3     4     5    6    M 1     2     3     4     5     6    M M    1   2    3    4    5    6 
Fig. 3.8 Screening of colonies for deletion of narP 
Lane M: 1kb ladder Lanes 1-5; colonies 1-5; Lane 6 contains control template as defined. 
(A) PCR screening for the CAM cassette, the expected size is 900bp, all colonies 
generated an amplified product of the expected size for this CAM screening PCR.  
(B) Screening for narP, only colony 3 did not generate a product of the expected size if  
narP is present; ZAP198 template was used as a positive control. 
(C) Screening of colonies for outside of narP, colony 3 was verified by size difference 





3.2.2 Growth of ZAP198 and mutant strains 
To test the growth defect of the constructed mutants, growth optical density were 
measured for each mutant strain and the parent strain (ZAP198) in triplicate. Time of one 
generation for each strain was determined by half of the time gap between OD 0.15 and 
0.6 at 600nm (Fig. 3.9). The results showed that the time of one generation for ZAP198, 
ZAP198∆arcA, ZAP198∆fnr, ZAP198∆narX, ZAP198∆narP is 1 hour (hr) 15 min, 1 hr 
45 min, 1 hr 7 min, 1 hr 35min and 1 hr 40 min respectively. It demonstrated that the 
deletion of ArcA, NarX and NarP all led to growth defect in MEM-Hepes medium. 
However, no defective effect was found in Fnr mutant. In contrast, the growth rate in fnr 
mutant was increased compared to the wild type. Significant differences (P <0.001) were 
found in the time of two generation in all four mutants by comparing with the wild type 














































Fig. 3.9 One generation time of the four mutants and wild type (ZAP198) 
The LB cultures were incubated overnight and inoculated in MEM-Hepes with a start 
value 0.02 at OD600 . he cultures were measured at different time points  and the time 
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graph plotted. Calculation of mean generation times indicate doubling time of each strain. 
The results indicated an increase in fnr mutant and a decrease in other mutants in growth.  
These differences in the mutants already indicated that there were going to be difficult 
issues dissecting effects based on growth rate changes from any impact the regulation 
may have on T3S. Certainly this variation needed to be taken into consideration with the 
phenotyping assays shown below.   
            
 
 
3.2.3 Cell binding assay of ZAP198 and mutant strains on EBL cells 
To assess the cell binding capacity of ZAP198 and the four regulatory mutants obtained 
as described above, the EHEC strains were cultured overnight in LB broth and diluted in 
MEM-Hepes with glucose and iron additions to reach an optical density at 600nm of 0.5-
0.6. EBL cells were infected with 2 x 106 bacteria and incubated for 3 hours in MEM-
Hepes medium. The EBL cells were fixed and then stained with anti-O157 antibody to 
identify bacteria as described in Materials and Methods (Fig. 3.10A). The number of 
adherent bacteria per mammalian cell was determined by microscopy. The results showed 
that the binding efficiency of arcA, narX and narP mutants was significantly decreased 
compared to ZAP198 (wild type) after 3 hours of infection (Fig. 3.10B). All the mutants 
demonstrated some reduction in adherence level, while arcA and narX mutants showed a 
significant decrease (P < 0.01). The binding ability in narP mutant was decreased 












































Fig. 3.10.  Cell binding of E. coli O157: H7 ZAP198 and isogenic mutants in arcA, fnr, 
narX and narP.  
A-B. EHEC strains were cultured in LB overnight and diluted in MEM-Hepes, and then 
used to infect EBL cells. Infected cells were treated by anti-O157 antibody to identify 
bacteria. Bacteria were indicated in circles. C. Cell binding capacity of ZAP198 and 
defined mutants. All the four mutants exhibit lower binding capacity compared to 
ZAP198, while arcA and narX mutants showed significant decrease (P < 0.01). The 
binding ability in narP mutant also decreased significantly (P < 0.05). Scale bar in A 





3.2.4 A/E lesion formation by ZAP198 and isogenic strains with deletions in 
specific respiration-associated genes 
To investigate whether the ZAP198 respiration regulators affect A/E lesion formation and 
T3SS within cultured EBL cells, fluorescent actin staining was performed as described in 
Materials and Methods after EHEC infection, and the number of condensed actin 
pedestals was quantified microscopically. Consistent with the adherence results, the 
numbers of A/E lesions associated with all four regulatory mutants was decreased 
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 Fig. 3.11 A/E lesion formation by ZAP198 and defined respiration-associated mutants. 
A-C. Infected cells were co-stained using anti-O157 antibody (B) and TRITC-Phalloidin 
(C) to identify bacteria and actin respectively (as described in Materials and Methods). D. 
The number of condensed actin pedestals per cell. All the four mutants display a lower 
capacity to generate A/E lesions by comparison with the WT ZAP198 strains, especially 





3.2.5 T3S level in ZAP198 and the respiration regulation mutants 
ZAP198 and the defined mutants were cultured in LB overnight and inoculated into 
MEM-Hepes to examine the T3S profile and relative secretion levels. The cultures were 
incubated in an anaerobic cabinet and harvested at OD 0.8 after centrifugation at 4000 
rpm for 15 min. A final concentration of 10% trichloroacetic acid and 4 μg ml-1 bovine 
serum albumn were added to supernatant and left at 4 oC for overnight. The proteins were 
recovered by centrifugation at 4000 rpm for 30 min at 4 oC.  SDS-PAGE was performed 
as described in Materials and Methods. A demonstration gel was illustrated in Chapter 1 
Introduction (Fig. 1.9)  The result indicates that an fnr mutant possesses lower T3S levels 
when compared to ZAP198 with no obvious secretion differences indicated for the  other 
mutants (Fig. 3.12). Because no significant difference was found in T3S profile gel in the 
four mutants, Western blotting has been performed to identify smaller changes in the 











































Fig. 3.12 SDS-PAGE analysing supernatant proteins of ZAP198 and isogenic mutants 
deleted for specific respiration-associated genes.  
M-wide range marker ;: ZAP198. lane 2 - arcA mutant ; lane 3 - fnr mutant ; lane 4 - 
narX mutant ; lane 5 - narQ mutant. The precipitation control (BSA) and putative 


























Cattle are the main source of the transmission for EHEC O157:H7 (Gansheroff & 
O'Brien, 2000). EHEC O157:H7 was demonstrated to have a colonization tropism in 
cattle. The organism colonizes the terminal rectum of the animal’s gastrointestinal tract 
with little apparent disease (Naylor et al., 2003; Rice et al., 2003). High colonisation of 
this site is associated with high-level shedding individuals (super-shedders) and these 
animals are considered to be important for maintenance of EHEC O157:H7 in the host 
population (Matthews et al., 2006).  This tropism was supported by long term culture of 
E. coli O157:H7 in the bovine gastrointestinal tract (Lim et al., 2007). It was revealed 
that recto-anal junction mucosa is the main region of the gastrointestinal tract supporting 
the growth of E. coli O157:H7 (Lim et al., 2007). Colonization of the gastrointestinal 
tract is promoted by attachment to epithelial cells. This attachment requires the outer 
membrane adhesin intimin and its translocated receptor Tir. These two factors are both 
expressed from the LEE5 operon. Previous research has demonstrated that the LEE4 
operon is required for terminal rectum colonization as deletion of LEE4 negates 
colonization of cattle (Naylor et al., 2005). The LEE4 operon encodes EspA, B, and D 
that form a filamentous channel through which Tir and other factors are translocated into 
host cells. Therefore, the T3S system is essential for terminal rectum colonization in 
cattle in EHEC. 
 
The assembly and regulation of the T3S system are very complex. It can be affected by 
many regulators and factors including pH, glucose, iron and temperature (Laaberki et al., 
2006). Ando et al. demonstrated that T3S apparatus  was matured  with the activation of 
the anaerobic respiratory system (Ando et al., 2007).   
 
Under my research, the hypothesis to be tested is that the tropism is driven, in part, by 
when the secretion system is expressed in the animal. One aspect of this will be the 
amount of oxygen available, either as a consequence of being at the very end of the 
gastrointestinal tract and/or due to proximity to epithelial cells. The T3S system and 
colonization was increased under microaerobic conditions in EHEC (Schuller & Phillips, 
2010). In this study, four mutants were constructed in established regulators of 
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respiratory-linked systems, including ZAP198 ∆arcA, ZAP198 Δfnr, ZAP198 ΔnarX and 
ZAP198 ΔnarP, all involved in controlling the switch between aerobic and anaerobic 
growth.  
 
These four mutants were successfully made using the λ Red recombinase technique 
(Murphy & Campellone, 2003) resulting in the replacement of the target regulatory genes 
with a CAM resistance cassette. This CAM resistance provides a simple selectable 
marker followed by PCR screening to confirm the allele replacement.  
 
E. coli responds to availability of oxygen and the presence of other electron acceptors via 
a large number of sensing/regulation systems such as the one-component Fnr protein, and 
the two-component Arc system (Guest JR, 1996; Gunsalus, 1992; Lin & Iuchi, 1991; 
Park & Gunsalus, 1995; Unden et al., 1995). The Arc system consists of two global 
regulators ArcA, the cytosolic response regulator, and ArcB, the transmembrane histidine 
kinase sensor. After switching from aerobic to micro-anaerobic growth conditions, ArcB 
is stimulated and remains in the activated state. ArcA is activated by ArcB through a His
→Asp→His→Asp phosphorelay (Georgellis et al., 1999). Interestingly, it has been 
recently shown that arcA is required for motility by interacting with FliA which controls 
motility-related genes (Kato et al., 2007). Motility was totally abolished in an arcA 
mutant E. coli BW25113 (Kato et al., 2007). However, FlhDC regulators and ArcB were 
not involved in this interaction. It has been shown that the H7 serotype flagella of EHEC 
O157 acts as an initial colonization factor on primary cells cultured from the bovine 
terminal rectum (Erdem et al., 2007; Mahajan et al., 2009). As T3S is co-ordinated with 
flagella expression via the GrlR–GrlA regulatory system (Iyoda et al., 2006), any effect 
of arcA on T3S could be through an impact on flagella expression. However, results 
showed that no obvious effect on T3S in the arcA mutant under both aerobic (dat not 
shown) and anaerobic conditions. It indicates that arcA in ZAP198 strain doesn’t affect 
the T3S system directly. However, Alexeeva et al have demonstrated that arcA functions 
as a redox regulator only under micro-aerobic growth conditions (Alexeeva et al., 2003). 
In addition, it was shown that arcA regulates the expression of genes related to oxygen 
regulation and the glycolysis pathway when incubated under micro-aerobic conditions 
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(Shalel-Levanon et al., 2005). In addition, it was recently reported that bacterial 
colonization of polarized human colon carcinoma cells was increased under micro-
aerobic conditions (Schuller & Phillips, 2010). Future work could address the effect of 
arcA deletion on T3S system by culturing the bacteria under micro-aerobic conditions or 
on tissue explants with controlled oxygen tensions.   
 
Fnr functions as a redox sensor containing a Fe-S cluster (Shalel-Levanon et al., 2005).  
It is regulated by the concentration of iron-sulfur cluster assembly proteins and the 
protease ClpXP which also degrades a LEE activator, GrlA (Tolla & Savageau, 2010). 
Fnr is only considered active during anaerobic growth conditions inducing the expression 
of genes that allow E. coli to grow anaerobically. It also represses genes expressed under 
aerobic condition. So the fnr mutant was cultured under anaerobic conditions in an 
anaerobic cabinet in order to examine the T3 secretion profile. A decrease in the level of 
T3S was found in the fnr mutant compared to the wild type ZAP198. This effect might be 
due to a higher ClpXP concentration in the mutant with increased degradation of the T3S-
activator GrlA.  Future work could address the mechanistic basis of this regulation.   
 
NarX and NarP belong to NarX-NarL and NarQ-NarP two-component regulatory systems 
respectively. NarX-NarL and NarQ-NarP two component regulatory systems are 
responsible to control transcriptional response to nitrate and nitrite (Stewart et al., 2003; 
Stewart, 1995).  The phosphorylation of the NarL and NarP regulators is determined by 
the NarX and NarQ sensors in response to signal nitrate, nitrite and ligands. A previous 
study demonstrated that a cross interaction may exist between these two systems (Stewart, 
1995). They are all related to the synthesis of anaerobic respiratory enzymes. The effect 
of narX and narP on T3S under anaerobic condition is tested in this study. The results 
showed that no significant differences were found in the narX and narP mutants with 
respect to T3S level in comparison to the wild type. It indicates that narX and narP are 







The formation of A/E lesions depends on T3SS (Jarvis et al., 1995), the outer membrane 
adhesive protein intimin (Jerse et al., 1990) and Tir, which is translocated into the host 
cell after attachment (Kenny et al., 1997). Therefore, consistent with the T3S level, a 
minor decrease was detected in binding to and A/E lesion formation on EBL cells in the 
four constructed mutants compared to the wild type. This result demonstrated that the 
T3S level did correlate to some extent with binding efficiency and A/E lesion formation 
in vitro.   
 
In conclusion, T3S profile, cell binding capacity and A/E lesions were investigated in the 
four constructed mutants. Minor reductions in binding efficiency were observed in all 
four mutants with significant differences in arcA, narP and narX mutants (P < 0.05). This 
result correlated with a decrease in A/E lesion formation. arcA and narX mutants showed 
significantly lower levels of A/E lesions compared with the wild type, with minor 
reductions in the fnr and narP mutants. However, the growth rates were all affected 
significantly (P <0.05) in these four mutants. The arcA, narP and narX mutants had 
reduced growth rates compared to the wild type. While the fnr mutant had a decreased 
doubling time under the conditions tested. The reduction in adherence and A/E lesions of 
arcA, narP and narX mutants might be due to the slow growth, and this issue really leads 
to stopping this line of research at a relatively early stage. Interestingly, the fnr regulatory 
system might be a significant controller of T3S. Recent work by Dr Jai Tree in our 
research group has examined post transcriptional control of LEE4 expression, in 
particular of the substrate switch protein SepL (Wang et al., 2008). sepl/LEE4 translation 
is dependent on Hfq which acts as a chaperone to bring mRNA and small RNAs together.  
From his work, FnrS is predicted to interact with the LEE4 transcript (Jair Tree, personal 
communication).   
 
Taken together, while it was evident that altering control of aerobic/anerobic respiration 
in EHEC O157 did have some impact on binding and A/E lesion formation capacity , the 
impact on T3S was minimal, with the possible exception of Fnr, under the conditions 
tested.  Given that the mutations also affected growth rates and will have other multiple 
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effects on other pathways, it was decided not to continue this work by testing the mutants 
in cattle, as this could not be justified. Consider trying to manipulate T3S regulation 
specifically might be more fruitful. My PhD work switched to construct an inducible 
T3SS to test the regulation of T3SS and examine the T3S effect on the colonization in 















































































The regulation of T3S is complex and controlled by many genes and effectors as 
described in the main Introduction. The aim of the work in this chapter was to try and 
override normal inputs into LEE1 promoter by replacing this promoter with one that is 
inducible.  This construct could then be used to examine the link between the tropism of 
O157 for the terminal rectum of cattle and the regulation of T3S. If successful, this 
construct could also be used to test whether heterogeneous expression of LEE4 and LEE5 
(Roe et al., 2003b) is completely independent of normal inputs at LEE1 and whether the 
expression level at LEE1 alters the proportion of bacteria expressing a functional T3SS.  
 
The approach was to replace the main LEE1 promoter with the inducible tetracycline (Tc) 
promoter. Bacteria resistance against widely used antibiotics has caused severe problems 
in contemporary medicine (Parkinson, 1993). Resistance against the broad-spectrum 
antibiotic Tc and its chemically-modified analogues is one of the best known examples of 
bacterial resistance. The inducible system using the Tet repressor (tetR) is broadly 
applied in molecular genetics (Saenger et al., 2000). When Tc and its analogues diffuse 
through the cytoplasmic membrane into bacteria, they chelate a divalent cation, 
preferentially Mg2+. The complex [MgTc]+ binds to the small (30S) prokaryotic 
ribosomal subunit, thereby inhibiting protein biosynthesis and preventing the growth of 
bacteria(Epe & Woolley, 1984). The main established resistance mechanism against the 
Tc-type antibiotics involves proteins that export Tc out of the bacterial cell(Eckert & 
Beck, 1989; Tovar K, 1988). Tc-resistance determinants encode active efflux pumps of 
the drug and are widely distributed in Gram negative bacteria and unique with respect to 
genetic organization and regulation of expression. Each determinant consists of tet 
activator gene (tetA) and tetR. The resistance protein TetA is a tetracycline/metal-proton 
antiporter located in the cytoplasmic membrane, while the regulatory protein TetR is a 
tetracycline (tc) inducible repressor of the system.  The expression of TetA is tightly 















The tetracycline repressor acts as the homodimer (TetR)2 in which two identical helix-
turn-helix (HTH) motifs bind in the absence of [MgTc]+. (TetR)2 has only a low affinity 
to nonspecific DNA sequences but binds tightly to two specific DNA operator sequences, 
tetO1 and tetO2 forming a [(TetR)2. tetO] complex. This complex composed by TetR 
(shown as green spheres) binds at tetO1 and tetO2 forming a homodimer to repress the 
expression of tetA. Tc (lt. blue triangle) distributes into the (bacterial) cell and forms a 
[MgTc]+ complex (pin triangles) with Mg2+. When [MgTc]+ binds to [(TetR)2  tetO] 
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homodimer, it leads to a conformational change  forming (TetR.[MgTc]+)2 complexes 
which release the tetO. Therefore, transcription of genes tetR and tetA are triggered 
(wavy lines represent mRNA). After translation, TetA protein is inserted into the 
cytoplasmatic membrane and translocates [MgTc]+ out of the cell to avoid the attacking 
to the ribosome. 
 
 Tet repressor blocks the transcription of the gene tetR (controlled by the operator tetO1), 
which encodes for TetR itself, and of the gene tetA (controlled by operator tetO1 and 
tetO2), which encodes for the resistance protein TetA. When Tc or its analogues diffuse 
into a resistant bacterial cell carrying the genes tetR and tetA, a chelate [MgTc]+ is 
formed with Mg2+. This chelate binds to the [(TetR)2. tetO] complex and leads to the 
structural changes in (TetR)2 which reduces its affinity to tetO. A complex 
(TetR.[MgTc]+)2 formed by (TetR)2 and two inducers [MgTc]+ releases tetO, then genes 
tetR and tetA can be expressed. The antiporter protein TetA is located in the cytoplasmic 
membrane and transfers [MgTc]+ to outside the cell, therefore preventing interaction of 
[MgTc]+ with the ribosomal 30S subunit. 
 
This well-defined switching between the two states relevant for regulation of gene 
expression is applied for molecular genetics to control the expression of other genes.  
According to the report by Lutz and Bujard (Lutz & Bujard, 1997), induction is mediated 
by a tetracycline-metal complex and requires only nanomolar concentrations of the drug.  
In the presence of anhydrotetracycline (aTc), tetR is induced and detaches from its 
cognate DNA sequence tetO. The regulation of gene expression over a 5000-fold range 
was achieved with promoter PLtetO1 (Tet operator, responsible for tetR expression) 
(Lutz & Bujard, 1997).  The aim of this study was to replace the LEE1 chromosomal 
promoter with the tetO2 operator (Tet promoter) by allelic exchange. tetR will also be 
introduced into the chromosome at lac. Thereby tetO2 expression level can be regulated 
by aTc via TetR. The construction process was depicted in Fig 4.2. Four steps (Fig. 4.2 
step1-4) were carried out to achieve the aTc inducible construction. This construction 
























Step 2 sacBkan cassette at lacY&Z was exchanged by constitutive tetR using allelic 






Step 3 LEE1 promoter was replaced by sacBkan cassette by allelic exchange, the 
resultant strain termed ZAP1327 
 






Fig. 4.2 Four steps used to construct an inducible LEE1 promoter, each step indicating 








4.2.1 Construction of an E. coli O157:H7 strain with tetR exchanged into the 
lac  
 
To obtain a strain containing tetR, two allelic exchange steps were used. The first 
exchange was to replace lacZY with the sacBkan cassette and the second one was to 
exchange the sacBkan cassette with tetR. This two step process takes advantage of 
counter-selectable SacB expression in the second step as detailed previously (Blomfield 
et al., 1991). 
 
4.2.1.1 Replacement of lacZY with the sacBkan cassette in ZAP198 (Step 1 Fig. 4.2) 
For the first exchange, a previously constructed plasmid, pAJR33 (Roe et al., 2003b), 
was used that contains the appropriate lac flanking regions. The process was performed 
as described in Materials and Methods. To identify the correct replacement, primer pair 
5-lacY and 3-lacZ (Table 5) were designed to test the presence or absence of  lacZY. 
Primer pair 5-lacI and 3-lacA (Table 5) was used to PCR across the whole lacZY region. 
PCR with primer pair 5-SacB and 3-SacB (Table 5) was carried out to determine whether 
the sacBkan cassette was present and primer pair 5-lacI and 3-SacB (Table 5) was used to 
test the conjunction of the sacBkan cassette and lacI. The gentic annealing sites of these 
primers was shown in Fig. 4.3. The PCR results showed the three colonies tested all 
acquired sacBkan cassette (Fig. 4.4) and had lost the lacZY genes (Fig. 4.4). To confirm 
the replacement, PCR from outside of lacZY genes using 5-lacI and 3-lacA (Table 5) 
indicated that the scaBkan cassette was inserted between lacI and lacA genes compared 
to a control, pAJR33 (Fig. 4.6). For further confirmation, PCR for conjunction of the 
cassette and lacA genes using primer pair 3-lacA and 3-SacB (Table 5) was carried out 
and demonstrated that the sacBkan cassette was integrated into the lac locus as 
















Fig. 4.3 A: Structure diagram of lacYZ locus and primers in ZAP198 


















3-sacB  5-sacB 




 1       2       3        4       5      M 
Fig. 4.5 PCR for screening the lacZY 
genes. 
Lane 1-3: colony 1-3; Lane 4: pAJR 33 
as templates for the PCR.  Lane 5: 
ZAP198;  Lane M: 1 kb ladder. PCR 
shows that all three colonies have 
potentially lost lacZY with ZAP198 as 
positive control. The expected region 
from ZAP198 is 4351bp. 
4kb 
Fig. 4.4 PCR for screening the 
sacBkan cassette: Lanes 1-3 are 
from colonies 1-3 respectively and 
Lane4 used pAJR 33 DNA as a 
template. Lane M: 100bp ladder 
PCR shows that colony 1-3 all got 
SacB with the size of 210bp.  

















































  M       1        2       3          4 
Fig. 4.7 PCR for screening the 
conjunction of lacI and sacBkan cassette 
Lane M - 1 kb ladder: Lane1-3 - colony 
1-3: 
Lane 4 - PCR amplified from pAJR33 as 
a positive control. 
Fig. 4.6 PCR for screening the outside 
lacZY genes using 5-lacI and 3-lacA 
Lane M - 1 kb ladder: Lane1-3 - colony 1-
3: 
Lane 4 - pAJR33 as a positive control.  
PCR substrate for pAJR33 is 4458bp. 
 





4.2.1.2 The exchange of the sacBkan cassette with PN25&tetR at lacZY (Step 2 Fig. 
4.2) 
To replace the sacBkan cassette at lac with tetR, a plasmid containing PN25&tetR with 
the same flanking regions as pAJR33 in PIB307 was constructed. The plasmid pAJR27 
created by Andrew J. Roe (Roe et al., 2003b) without thre sacBkan cassette was used and 
PN25&tetR was inserted into the BamH I site. PN25&tetR was amplified from 
commercial plasmids PZS4Int-laci/tetR in which a promoter (PN25) in front of tetR gives 
constitutive expression of tetR. The allelic exchange procedure was performed as 
described in Materials and Methods.  
 
4.2.1.2.1 The construction of a plasmid suitable for the exchange of the sacBkan 
cassette with PN25TetR at lac 
 
PN25&tetR was PCR amplified from PZS4Int-laci/tetR with a size of 764bp using primer 
pair 5-PN25-BamHI and 3-PN25-BamHI (Table 5, Fig. 4.8). Then the PCR product was 
cloned into the BamH I site in pAJR27, and verified by BamH I digestion (Fig. 4.9) and 
termed pXLS02. Fig. 4.8 shows that the size of plasmid from the clone is larger than 
pAJR27 and the expected band was obtained by BamH I digestion. pXLS02 was then 







































M      1          2          3 
Fig. 4.9 BamH I digestion of PN25&tetR 
in pAJR27. Lane1 - pAJR27: Lane2 - 
PN25&tetR in pAJR27: Lane3 - pXU02 
digested by BamH I: Lane M - 1 kb 
ladder.   A right size was obtained by 
BamH I digestion 
Fig. 4.8 PCR for PN25&tetR from 
PZS4Int-laci/tetR plasmid. Lane1-4 - 
PCR substrate from PZS4Int-
lacI/tetR:Lane5 - negative control: 
Lane M - 1kb ladder.  
Expected PCR product size is 764bp. 
500bp 















4.2.1.2.2 The exchange of sacBkan cassette with tetR 
 
To replace the sacBkan cassette with tetR in pXLS02, the plasmid was eletroporated into 
ZAP1212. The exchange was carried out as described in Materials and Methods. The 
resultant colonies were screened by PCR with primer pair 5-PN25-BamHI and 3-PN25-
BamHI (Table 5) for PN25&tetR, primer pair 5-lacI and 3-lacA (Table 5) for flanking the 
region. The loci of these primers on the genome was shown in Fig. 4.10. The PCR results 
indicated that one colony acquired PN25&tetR (Fig. 4.11) and this was confirmed by 
primer pair 5-lacI and 3-lacA (Fig. 4.12). The map for the correct exchange is shown in 








Fig. 4.10 Structure diagram of tetR and primers in ZAP1213 
 
 





































4.2.2 Testing aTc induction of GFP expression in ZAP1213 
 
1          2         M 1          2          M 
Fig. 4.11 PCR screening for 
PN25&tetR    
Lane 1: colony 1 
Lane2: pXLS01 as a positive control 
Lane M: 100bp ladder 
It shows one colony from the allelic 
exchange acquired PN25&tetR gene. 
Fig. 4.12 PCR screening for outside 
lacZY    
Lane 1: colony 1 
Lane2: pXLS01 as a positive control 






To investigate the aTc induction efficiency via TetR on the tet promoter, the promoter 
was cloned into pKC26 at XbaI site creating pXLS03. Then the pXLS03 was transformed 
into ZAP1213 containing TetR and aTc was applied for induction of tet promoter by 
acting on Tet repressor. Thereby the induction efficiency can be tested by measuring GFP 
levels (expressed by pKC26) which represents tet promoter expression level controlled 
by TetR. 
 
4.2.2.1 The construction of pXLS03   
 
In order to determine if the TetR repressor would function as anticipated on the tet 
promoter, a plasmid was constructed in which tet promoter was placed in front of egfp+. 
So this constructed plasmids can be induced with the presence of aTc. Firstly, the tet 
promoter was PCR amplified by annealing primer pair 5-Tet promoter-XbaI and 3-Tet 
promoter-XbaI (without a template) (Fig. 4.13). The sequence for the tet operator was as 
published (Lutz and Bujard, 1997). The cleaned PCR fragment was digested with XbaI 
and cloned into pKC26 in the XbaI restriction site.  The correct clone was verified by 















Fig. 4.14 Xba I digestion for tetO1 
cloning   
Lane 1: pKC26 as a negative control 
Lane 2: Colony obtained from 
cloning 












4.2.2.2 GFP measurement following aTc induction 
pXLS03, containing the tet promoter controlling gfp+, was transformed into ZAP1213 
(contains the Tet repressor - tetR) to determine whether aTc addition could induce GFP 
expression by removing TetR repression. Controls included pXLS03 in ZAP1213 without 
aTC as a negative control and pXLS03 in ZAP198 as a positive control as it does not 
have any TetR repression. The result showed that the GFP expression level in ZAP1213 
with pXLS03 without aTc was very low which indicated that tet promoter was tightly 
repressed by the Tet repressor in ZAP1213 compared to wild type ZAP198 (Fig. 4.15). 
When a concentration of 200 ngml-1 aTc was added to ZAP1213 with pXLS03, the GFP 
expression reached a similar level as the positive control group, i.e. pXLS03 in ZAP198 
(without TetR). It demonstrated that aTc can induce tet promoter expression to a very 
high expression level compared to the negative control and close to the positive control. 
To prove the induction was produced by inducing the tet promoter, a control plasmid 
pKC26 (blank plasmid without tet promoter insertion) was also transformed into 
ZAP1213 and GFP fluorescence level measured. Fig. 4.16 demonstrated that when a high 
induction level was induced by adding aTC in tet promoter group (pXLS03), the 








Fig. 4.13 PCR synthesis of tetO1 
Lane 1-2: tetO1 
Lane M: 25bp ladder 
It shows tetO1 was amplified 




































































Fig. 4.15 aTc induction for Tet repressor with tetO1 operator 
With a concentration of 200 ngml-1 aTc, pXLS03 GFP expression level in 































                            Fig. 4.16 aTc induction for Tet repressor with tetO1 operator 









4.2.3 Creation of strains with LEE1 promoter replaced by tet promoter in 
ZAP1213 
As described in Materials and Methods, two constructs were designed. The genetic 
organization of LEE1 promoter is shown in Fig. 4.17. The first construction keeps the 
original transcriptional start site and -10 region of the native LEE1 operon promoter, 
while the -35 regions are replaced by AT rich DNA sequence (tet promoter) synthesized 
artificially (Fig. 4.18). For the second construct, only the original transcriptional start site 
was kept with -35 and -10 regions replaced by a synthesized tet promoter (Fig. 4.19). To 
obtain a strain with tet promoter in front of LEE1 operon instead of the native LEE1 
promoter, two exchanges were carried out in each construct. The first exchange was to 
replace the native LEE1 promoter with sacBkan cassette to produce an intermediate strain 
for the exchange of tet promoter. Since the second construct deletes 25 bp more from the 
-35 region more than first construct, the intermediate strain from first construct can be 
used for the second exchange of the second construct. In the second exchange, the 
sacBkan cassette was replaced by the synthesized tet promoters in the two different 































Fig. 4.17 Genetic organization of LEE1 promoter 
-10 and -35 elements were shown in green with arrow; transcriptional start site was 















Fig. 4.18 Genetic organization of first construction 
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tet prmoter and -10 element were shown in brown and green with arrow respectively; 



























Fig. 4.19 Genetic organization of second construction 
tet promoter was shown in brown with arrow; transcriptional start site was labelled in 






















4.2.3.1 First exchange: The exchange of the LEE1 promoter with sacBkan cassette 
producing intermediate strains for both constructions (Step 3, Fig. 4.2) 
The aim of the first exchange is to obtain an intermediate strain for the exchange of LEE1 
promoter with tet promoter. As the second construction is only 25 bp more deletion than 
the first construction, the intermediate strain for first construction can also be used for 
second construction. Therefore only one strain was needed for the first exchange. Then in 
the second exchange, plasmids with different flanking region fragments were applied 
resulting in a different deletion of LEE1 promoter.   
 
4.2.3.1.1 The construction of plasmids suitable for the exchange of the LEE1 
promoter with sacBkan cassette 
 
In the first exchange, a plasmid containing LEE1 promoter flanking regions with the 
sacBkan cassette in pIB307 was produced for each construct. Briefly, two downstream 
flanking region fragments for each construct were PCR amplified from TUV93-0 using 
primer pairs 5-LEE1 down FR 1st BamHI & 3-LEE1 down FR XbaI and 5-LEE1 down 
FR 2nd BamHI & 3-LEE1 down FR XbaI (Fig. 4.20). These two flanking region 
fragments were digested by Xba I and BamH I  and then cloned into the same sites in 
PIB307. Fig. 4.21 showed insertions digested by Xba I and BamH I from PIB307. The 
clone was also sequenced (Data not shown). Then a downstream PCR fragment amplified 
from TUV93-0 using 5-LEE1 UP FR XmaI & 3-LEE1 UP FR BamHI was cloned into 
Xma I and BamH I sites into the two plasmids containing downstream flanking region for 
each construct (Fig.4.22). These two clones were digested with Xma I and BamH I to 
prove the insertions were the expected size (Fig.4.23) and then sequenced (data not 
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shown). The plasmid with both downstream and upstream flanking region insertions for 
first construct was termed pXLS04 and for second construct pXLS05. The sacBkan 
cassette was cloned into the BamH I site in pXLS04 producing pXLS06 and as only one 
intermediate strain was required for both proposed final constructs. Fig. 4.24 


































Fig.4.20 PCR for downstream flanking 
region fragments for first and second 
constructions 
Lane 1: first construction, 907bp  
Lane 2: second construction, 901bp 
Lane M: 1 kb ladder.  
 1        2        M 
1kb 
Fig. 4.21 Xba I and BamH I digestion 
for downstream cloning  
Lane 1: pIB 307 as a negative control 
Lane 2: First construction 
Lane 3: Second construction 
Lane M: 1 kb ladder 
The expected fragment was obtained by 
Xba I and BamH I digestion.  
1kb 

















































M         1        2 
Fig.4.22 PCR for upstream flanking 
region fragment for first and second 
constructions 
Lane 1: upstream flanking region 
PCR fragment for first construction, 
932bp 
Lane M: 1 kb ladder.  
 
Fig. 4.23 Xma I and BamH I digestion 
for upstream cloning  
Lane 1: First construction 
Lane 2: Second construction 
Lane M: 1 kb ladder 
A 932 bp fragment was detected 
following Xma I and BamH I digestion.  




 M        1        
Fig. 4.24 BamH I digestion for sacBkan cassette cloning  
Lane 1: First construction 
Lane M: 1 kb ladder 
A 3.9 kb sacBkan cassette was detected by BamH I digestion.  
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4.2.3.2 The exchange of the LEE1 promoter with sacBkan cassette  
 
The exchange method was used as described in Materials and Methods. Specifically, 
pXLS06 was electro-transformed into ZAP1213 and cultured at 30oC on LB-CAM plates 
separately. Ten transformants were then inoculated into pre-warmed LB-CAM at 42 oC 
and passaged repeatedly in LB-CAM broth at 42 oC to obtain co-integrates. The culture 
was further passaged at 30 oC  in LB-KAN broth in which the exchange of the LEE1 for 
the sacBkan cassette was carried out. The correct replacement strain was determined by 
KAN resistance and CAM sensitivity. Further confirmation was carried out by PCR with 
primer pairs 5-LEE1 test and 3-LEE1 test for inside of the LEE1 promoter; 5-SacB and 3-
SacB for inside of sacBkan cassette and 5-LEE1 UP FR XmaI and 3-SacB for a cross 
junction of the sacBkan cassette and that specific chromosomal region (Fig. 4.25).  The 
LEE1 promoter is absent in tested sample (Fig.4.26); the sacBkan cassette was present 








Fig. 4.25 A: Structure diagram of LEE1 promoter locus and primers in ZAP198 
             B: Structure diagram of sacBkan cassette and primers in ZAP1327 
 
 
 5-LEE1 test  3-LEE1 test  
 
downstream LEE1 promoter 
 5-LEE1 UP FR XmaI  
upstream 
 5-LEE1 UP FR XmaI  3-sacB

















































 M  1     2     3
Fig.4.27 PCR for sacBkan cassette 
Lane 1: positive control 
Lane 2: negative control 
Lane 3: Colony from exchange  
Lane M: 1KB ladder 
The expected size was 1.1 kb, the 
sacBkan cassette was present in the 
tested colony. 
Fig.4.26 PCR for testing inside LEE1 
promoter  
Lane 1:  Colony PCR from exchange 
Lane 2: ZAP198 as a positive control 
Lane M: 1 kb ladder 
The expected size was 336 bp, the 
LEE1 promoter was absent in the 
tested colony from the exchange. 
 1        2        M 
500b
1    2     3     M
1.5kb 
                       Fig.4.28 PCR for testing the junction of sacBkan cassette 
Lane 1: colony from exchange  
Lane 2: plasmids for exchange as a positive control 
Lane 3: negative control 
Lane M: 1kb ladder 
A right size was obtained compared to the positive control indicating sacBkan 
cassette was exchanged in the loci of LEE1 promoter. 
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4.2.3.3 The second exchange: the exchange of the sacBkan cassette with tet 
promoter (Step 4, Fig. 4.2) 
To exchange the the sacBkan cassette for the tet promoter, one plasmid for each construct 
was made based on pXLS04 and pXLS05. Then these two plasmids were used for 
exchange of the sacBkan cassette with the tet promoter in the intermediate strain. 
 
4.2.3.3.1 The construction of plasmids suitable for the exchange of the sacBkan 
cassette with tet promoter 
  
The tet promoters were PCR synthesized by using primer pairs 5-Tet promoter BamHI 1st 
3-Tet promoter BamHI 1st and 5-Tet promoter BamHI 2nd and 3-Tet promoter BamHI 2nd. 
The PCR fragments for the two constructs are shown in Fig.4.29. These two PCR 
fragments were digested by BamH I and cloned into pXLS04 and pXLS05 respectively. 
The insertions were confirmed by PCR using primers flanking the cloning site on PIB 5-
PIB test and 3-PIB test (Fig.4.30 and Fig.4.31). For the first construction, the sequencing 
result was 100% as expected from the design. The resultant plasmid for the first 
construction was termed pXLS07. However there was 1 bp missing in the second 
amplified tet promoter. Several further attempts were made to produce this construct but 
were unsuccessful.  Another approach included cloning the product in a DH5αZ1 strain 
containing Tet repressor to limit any expression from this promoter, but even in this case 
there were changes from the anticipated sequence, usually based around the sequences 







































  1         2         3 
75bp 
Fig.4.29 PCR for Tet promoter synthesis 
Lane 1: Tet promoter for the 1st 
construction, 56bp, lane 2: 25 bp ladder, 
lane 3: Tet promoter for the 2nd  
construction, 77bp 




1    2     3    
Fig.4.30 PCR for testing Tet promoter 
cloning for 1st construcion 
Lane 1: 100 bp ladder 
Lane 2: tested colony sample (315bp) 
Lane 3: negative control (259 bp) 
The positive sample contained a product 
of the expected size.  
300bp 
1    2    3   
Fig.4.31 PCR for testing Tet promoter cloning for 2nd construcion 
Lane 1: 100 bp ladder 
Lane 2: tested colony sample (319bp) 
Lane 3: negative control (253 bp) 





4.2.3.3.2 The exchange of the sacBkan for the tet  promoter 
 
To replace the sacBkan cassette with the tet promoter, pXLS07 was electroporated into 
ZAP1213 that contains the LEE1 promoter replaced by the sacBkan cassette. The 
exchange was carried out as described in Materials and Methods. The resultant colonies 
were screened by PCR with primer pair 5-SacB and 3-SacB (Table 5) for inside of the 
sacBkan cassette, primer pair 5-Tet promoter BamHI 1st and 3-Tet promoter BamHI 1st 
(Table 5) for tet promoter (Table 5), primer pair 5-Tet promoter BamHI 1st  and 3-LEE1 
down FR XbaI cross junction of tet promoter and chromosome (Fig. 4.32). The PCR 
results indicated that one colony had lost the sacBkan cassette (Fig. 4.33) and acquired 
PN25&tetR (Fig. 4.34). The results from a PCR across the junction of the tet promoter 
and the chromosome confirmed the exchange (Fig. 4.35). Another plasmid containing the 
tet promoter with LEE1 promoter flanking regions in pIB 307 for the second construction 






Fig. 4.32 Structure diagram of tet promoter and primers in ZAP1327 with LEE1 promoter 









BamHI 1st  
downstream tet promoter 
 5-LEE1 UP FR XmaI  
upstream 
3-Tet promoter  









































Fig. 4.35 PCR crossing junction of tet promoter and chromosome 
Lane 1: 1 kb ladder  
Lane 2: positive control 
Lane 3: sample from exchange 




1      2       3     4    
Fig.4.23 PCR for sacBkan cassette for 
exachange sacBkan cassette for tet promoter 
Lane 1: positive control 
Lane 2: 1 kb ladder 
Lane 3: negative control 
Lane 4: sample from exchange. The sacBkan 
cassette was absent in the tested strain. 
. 
1 kb 
 1     2    3    4    
Fig. 4.34 PCR for tet promoter 
Lane 1: sample from exchange 
Lane 2: positive control 
Lane 3: 25 bp ladder 
Lane 4: negative control 






1    2      3
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4.2.3.4 Testing induction of the tet promoter in ZAP1213 with the LEE1 promoter 
replaced by the two tet promoter constructs 
 
The resultant strains with the LEE1 promoter exchanged for the tet promoter controlled 
by the tet repressor was achieved as described above. To test the tet promoter induction, 
200ng/ml aTC was added to the MEM-HEPES cultures. The secreted proteins samples 
were prepared as described in Materials and Methods. Results from SDS-PAGE gel (Fig. 
4.36) and anti-EspD (Fig. 4.37) Western Blotting showed that there was no increase of 
T3S with aTC induction in the constructed strain for the first construct compared to the 
wild type. Similarly, the strain for the second construction also showed no increase with 




































































    1    2    3    4     5    
1 2 3 4
Lane 1: wide range Marker 
Lane 2: ZAP198  
Lane 3: ZAP198 with aTC 
Lane 4: sample strain 
Lane 5: sample strain with aTC 
No T3S protein was found with 
aTC induction in sample strain.  
Lane 1: ZAP198  
Lane 2: ZAP198 with aTC 
Lane 3: sample strain 
Lane 4: sample strain with aTC 
No EspD protein was detected by 






4.2.4 The control of T3S in ZAP1327 
I was very upset about the unsuccessful induction of T3S in the first construction, 
because it took me a lof of time in my PhD journey. With this disappointed mood, I 
didn’t keep this final strain (LEE1 promoter first construction). Otherwise, more work 
such as using RT-PCR to measure the transcriptional level of ler could be carried out in 
the future. But based on the results produced by my collegues described below, the final 
exchange might be repeated to get the strain of first construction as long as the 
constructed plasmids were stored. However, interesting result was found by other 
collegues in the intermediate strain I made as detailed below.   The control of T3S in 
ZAP1327 (ZAP198 with LEE1 promoter replaced by sacBkan cassette) described as 
above in Section 4.3.2 was investigated by three experiments including measuring LEE1 
promoter activity by pLEE1-GFP reporter (this measurement was carried out by Maryia 
Karpiyevich), determining the ler transcriptional expression levels by RT-PCR (this work 
was done by Jai Tree), examining the EspD secretion level by Western blotting (this 
work was done by Allen Flockhart). LEE1 promoter transcriptional activity was high 
compared to the negative control (pKC26) in ZAP1327 (Fig. 4.38). The T3S regulator, 
ECs1581 showed a higher ler expression. This was confirmed by the RT-PCR 
measurement of ler transcriptional expression in ZAP1327 with a low expression of ler 
detected in ZAP1004 (Ler deletion mutant) (Fig. 4.39). It was demonstrated that sacBkan 
cassette controlled ler transcription expressed in an equivalent level to the wild type 
(ZAP198).  However, no EspD was detected in ZAP1327 (Fig. 4.40). This sacBkan 
controlled Ler expression can be overridden by adding ler plasmids (with ler ORF 





































































































Fig. 4.39 RT-PCR measurement of ler expression levels in EHEC strains ZAP198, 























From genome analysis it is evident that EHEC strains contain a number of prophages and 
degenerated prophage regions that contribute to pathogenesis and host colonisation  
(Hayashi et al., 2001; Perna et al., 2001). EHEC are defined by the expression of Shiga 
toxins, encoded from integrated prophages, and the delivery of effector proteins via a 
type III secretion (T3S) system that is expressed from a degenerate prophage element, the 
locus of enterocyte effacement (LEE).  The T3SS is essential for forming intestinal 
attaching and effacing (A/E) lesions allowing colonization of intestinal epithelium in 
ruminant hosts and in humans. The LEE possesses five main operons (LEE1-5) (Elliott et 
al., 1998). LEE1-3 encodes components of the basal apparatus of the T3SS including 
EscC, J, R, S, T, U, V (Bustamante et al., 2001; Garmendia et al., 2005; Sperandio et al., 
2003), the CesAB chaperone and the EspH effector (EPEC EHEC LEE1). LEE4 encodes 
the translocon proteins plus SepL (Kresse et al., 2000) and EscF (Wilson et al., 2001); 
and LEE5 encodes an outer membrane adhesin called intimin, its translocated receptor 
Tir, and a chaperone known as CesT for intimin (Sanchez-SanMartin et al., 2001). 
 
There are multiple regulatory inputs that govern the expression of T3S involving 
environmental sensing and regulators that act on these signals by activating or repressing 
transcription (Laaberki et al., 2006). Most of the published regulation feeds into the 
promoter of the LEE1 operon and is passed through to the expression of the other LEE 
operons by the LEE-encoded regulator (Ler). The LEE1 regulatory region is controlled 
by many regulators, including IHF, Fis, H-NS, QseA, BipA, GadX, DksA, Hha, EtrA, 
EivF and  Pch together with Ler itself (Hansen & Kaper, 2009; Mellies et al., 2007) (Tree 
et al., 2009b) (Kendall et al., 2010). The nucleoid-associated protein H-NS, a global 
inhibitor of virulence-related genes in Gram negative bacteria, represses the expression of 
LEE1 which is particularly apparent at temperatures below 30°C. H-NS also negatively 
regulates LEE2 through LEE5 promoters in a temperature-independent way. However 
this effect is overcome by the related Ler protein (Bustamante et al., 2001; Sanchez-
SanMartin et al., 2001) (Umanski et al., 2002), and in turn has multiple inputs into the 
rest of LEE regulation. A second nucleoid-associated protein, integration host factor, IHF, 
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activates the expression of LEE1-3 and LEE5 by directly binding to the ler promoter and 
is essential for efficient expression of LEE (Friedberg et al., 1999). Another nucleoid-
associated protein (Fis), is also required for LEE1 expression. However this regulation by 
Fis was not transmitted to the rest of the downstream LEE operons (Goldberg et al., 
2001).  As the first gene of LEE PAI, Ler, is a regulator related to the H-NS family of 
nucleoid-associated proteins, which therefore activates the expression of LEE2, LEE3, 
LEE5 ((Elliott et al., 2000; Friedberg et al., 1999; Mellies et al., 1999; Sperandio et al., 
2000). In addition, GrlR and GrlA, encoded by a bi-cistronic operon grlRA located 
between LEE1 and LEE2, positively regulate the expression of LEE operons through Ler 
expression (Barba et al., 2005; Deng et al., 2004) (Jimenez et al., 2010).  Taken together 
it is apparent that many regulators and signals which affect T3S do so through LEE1 and 
in particular Ler expression.  
 
Previous work has demonstrated that T3S in EHEC O157:H7 can be controlled at LEE4 
in a post-transcriptional manner and that clear differences in this regulation occur 
between strains and may be important in the epidemiology (Naylor et al., 2005).  If 
expression can be controlled or fixed at LEE1 then this will allow assessment of how 
independent this LEE4 regulation is and may help define the regulatory mechanism, 
especially if LEE1 can be induced. Therefore, the aim of this study is to construct an 
inducible T3SS by controlling LEE1 promoter with a TetR-aTc system. In addition, it is 
proposed that the multiple regulatory inputs into the LEE may be an important factor in 
driving the rectal tropism in cattle. So quorum sensing in the large bowel (as high density 
of bacteria) plus sensing of specific ions, pH, oxygen tension and possibly particular 
carbohydrate sources, all may contribute flowing through LEE1 to switch on T3S, and 
then access to the rectal mucosa may be easiest on epithelium associated with lymphoid 
follicles so have M-like cells with less mucus coverage.  So, if T3S expression can be 
induced constantly or earlier in the gut, rectal tropism might be changed.  aTc could be 
used in an animal so possible with the construct being made here.   
 
 In Yersinia, the timing of T3S induction can be studied by altering the calcium 
concentration so that you can get a ‘synchronized’ culture allowing dissection of the 
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regulation (Torruellas et al., 2005).  For EHEC, there is no established single transition 
signal (perhaps not surprising given the points being made in 1 and 2 about multiple 
inputs), so again an inducible LEE1 construct would provide insights into the temporal 
regulation of T3S in EHEC.  
 
In most E. coli promoters, the key sequences required for activity are the -10 and -35 
hexamer elements, which are recognized by different domains of the RNA polymerase 
factors (McClure, 1985). The binding of transcription factors, DNA helicase, RNA 
polymerase, activators and repressors with this core promoter initiates transcription and 
in turn translation. Thus if this promoter is controlled ‘manually’, the expression of LEE 
can be controlled artificially. In this work, two constructs to replace the LEE1 promoter 
were designed in order to be able to induce LEE1 expression. The first construct keeps 
the original transcriptional start site and -10 region of LEE1 operon promoter, while the -
35 region will be replaced by AT rich DNA sequence (tet promoter) synthesized 
artificially (Fig. 4.18). For the second construct, only the original transcriptional start site 
will be kept with -35 and -10 regions replaced (Fig. 4.19).  
 
As shown in results, a strain containing the first construct strain was achieved. However, 
when induction with aTc was tested in this no T3S was detected by comparison with wild 
type levels. Relief of repressor activity was proven in this strain by demonstrating aTc 
induction of GFP from pXLS03 in ZAP1213 (Tet repressor exchanged at lac).  One 
explanation for the failure to induce detectable T3S levels may lie with expression levels. 
For GFP expression, the plasmid copy number will be 15-20 (Sambrook, 1989)So 
increased GFP measurement was detected indicating increased expression of tet promoter 
in .Potentially, the levels of mRNA produced from the LEE1 promoter were too low to 
give enough translated products leading to detectable T3S. A second possibility can be 
due to the unspecific binding or interaction of aTc with other chemicals or reagents other 
than Mg+ in O157 background. This unspecific reaction might block the release of TetR 
repression. Therefore, aTc induction can not be achieved as planned and in turn T3S was 




Another possibility might be the construction issue, i.e. the specific promoter sequence 
used. As described above, the original -10 region sequence was kept in the first construct. 
It indicated that the original repression by H-NS and other factors still existed and was 
passed to the promoter including -10 element. This promoter could control the expression 
of LEE and T3S causing undetectable level in the constructed strain even after inducing 
with aTc. A fourth reason why the first construction did not work might be the natural 
regulation of T3SS. Because a post transcriptional regulation after LEE1 promoter exists 
(Roe et al., 2003b), T3S expression level still can not be detected even with fully induced 
tet promoter.  
 
In the process of trying to obtain the second promoter region, mutations were always 
found in the inserted tet promoter which was cloned into pIB307 with both flanking 
regions of the original LEE1 promoter. It indicated that this tet promoter can’t be 
expressed, or maybe even cloned, in the vector with both LEE1 flanking regions which 
include the regulator Ler protein. One reason might be that the deleted -10 and -35 
hexamer elements led to the uninhibited expression of T3S causing toxic cell effect. In 
the absence of -10 and -35 elements, the expression of Ler, which is located down stream 
of tet promoter cloning site, might be very high. As an essential regulator, it can lead to 
enormous influence which might include toxic biological effect to the bacteria. In 
addition, tet promoter is a high activity promoter (Lutz & Bujard, 1997) with an increase 
of 5000 fold when the repression is released by aTc. Such a high expression of T3S 
proteins must be toxic to cells. Thus, in the process of cloning tet promoter into pIB307 
with both flanking region of LEE1 promoter, no successful vector was selected.   
 
Although the control of T3S in the obtained strain for the first construct did not induce 
detectable T3S levels and the construction of the strain with the designed 2nd construct 
could not be achieved, there is significant application for these and future application of 
the constructs.  
 
For example, lab colleague, Allen Flockhart (Mariya, Jai Tree as well) used the 
intermediate strain, ZAP1327 (LEE1 promoter replaced by sacBkan cassette), to identify 
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the mechanism of the phage regulator, ECs1581, effect on LEE and LEE1 promoter. 
From the results of three experiments as described in Section 4.5, it was demonstrated 
that comparatively high transcriptional level of LEE1 promoter (sacBkan) was found in 
ZAP1327. However, the secretion level of T3S proteins was not detectable in ZAP1327. 
This indicated that the translation level of T3S proteins keeps low even with an 
equivalent transcriptional LEE1 promoter expression level to the wild type. However, 
this control of sacBkan on T3S can be overriden by the present of Ler (plasmids of ler 
containing the ORF of ler). As the original -10 region and transcriptional start site were 
kept, the transcription of ler could not be induced any further, because a comparatively 
high transcriptional ler expression was found in ZAP1327 and  the LEE1 regulatory 
region it normally auto-induces is no longer there. It implied that additional factors or 
regulation is required at post transcription level of ler to switch on T3S. The resultant 
strain should be controlled by aTc as expected. Surprisingly, no detectable T3S protein 
was found with aTc induction in the first construction. However, it could still be the case 
that the tet promoter was being induced but that this did not result in T3S for reasons that 
are not currently understood. That is might be one of the reasons why no T3S proteins 
were detected in the first construction with aTc induction. 
 
In addition, ZAP1213 ( lacY and lacZ genes replaced by Tet repressor) can also be used 
for other inducible constructions. Future work can address to resolve the difficulties in 
cloning tet promoter in front of ler or find substitute promoter for tet promoter. For 
example, the λ Red recombineering technology can be used to exchange the LEE1 
promoter with tet promoter. Briefly, an antibiotic cassette plus tet promoter with a short 
flanking region of LEE1 promoter will be designed. An anticipated strain with LEE1 
promoter replaced by tet promoter with antibiotic cassette will be created. In this method, 
LEE1 promoter will be exchanged with tet promoter directly without any cloning needed. 















































Bacteria such as E. coli that colonise the mammalian gastrointestinal tract are exposed to 
a constant onslaught of bacterial viruses, known as bacteriophages (Kaper et al., 2004).  
Many bacteriophages inject their genetic material and use the bacterial host simply to 
produce more phage in a lytic cycle.  Other, temperate phages, can insert their genetic 
material into the bacterial genome (Hacker et al., 1997; Kaper et al., 2004; Lim et al., 
2010).  In this lysogenic state the phage genome is amplified along with the dividing 
bacteria (Friedman & Court, 2001). Lysogenic phages have evolved to initiate their 
replication and escape from the bacterial host by using the stress or SOS response of the 
bacterium (Waldor & Friedman, 2005). The integration of phage genomes and their 
subsequent degeneration is important in the evolution of many bacterial genera, for 
example Salmonella, Staphylococcus and Escherichia(Boyd & Brussow, 2002),(Brussow 
et al., 2004).  
 
Enterohaemorrhagic Escherichia coli (EHEC) are a subset of E. coli strains defined by 
the integration of lambdoid bacteriophages into their genomes that encode Shiga toxin 
(Stx) (Ogura et al., 2009) and the capacity of the strains to form characteristic attaching 
and effacing lesions on epithelial cells in the gastrointestinal tract as a result of type III 
secretion of effector proteins (Kenny et al., 1997; Kenny & Jepson, 2000; Nataro & 
Kaper, 1998). The different Stx types belong to a family of A1B5 exotoxins comprising of 
a single A subunit that is non-covalently associated with pentameric B subunits that are 
responsible for toxin binding to its receptor, the glycosphingolipid Gb3 
(globotriaosylceramide; CD77) (Lindberg et al., 1987; Lingwood, 1999; Sandvig, 2001). 
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The A subunit of Stx is an N-glycosidase which cleaves the N-glycosidic bond of a 
specific adenine residue of the 28S rRNA in the 60S ribosomal subunit. This inhibits 
protein synthesis by interfering with the elongation factor 1-dependent binding of 
aminoacyl-tRNA to the 60S ribosomal subunit (Law, 2000). Severe EHEC infections in 
humans are characterised by bloody diarrhoea and capillary damage in the kidneys and 
brain as a result of Stx activity with potential fatal consequences or long term morbidity 
(Kaper et al., 2004; Proulx F, 2001; Tarr et al., 2005).  
 
Humans though are an incidental host for the majority of EHEC strains and it is apparent 
that ruminants(Cherifi et al., 1994; Hancock et al., 1994), in particular cattle are the main 
reservoir for the principle EHEC serotypes associated with human infection, in particular 
EHEC O157:H7 and EHEC O26:H11 (Geue et al., 2009; Orskov et al., 1987). The 
success of the organism therefore needs to be considered in the context of the ruminant 
host in terms of selective factors that drive its evolution. In contrast to the situation in 
humans, there is little evidence for pathology associated with EHEC infection in mature, 
immuno-competent cattle or other reservoir hosts which typically carry EHEC 
asymptomatically (Chapman et al., 1993; Synge, 2000). This is related, in part, to 
differences in Gb3 receptor distribution in cattle versus humans and differences in how 
internalised toxin is trafficked in the cell (Hoey et al., 2002; Hoey et al., 2003) 
(Pruimboom-Brees et al., 2000). If phage insertion can confer an advantage to the 
bacterium then this will also increase the survival chances of the integrated phage DNA.  
Studies on Shiga toxin activity have provided some insight into possible benefits for 
EHEC in the ruminant host, even though a subset of the bacteria must lyse to release the 
toxin.  Advantages for colonisation include the redistribution of nucleolin to the epithelial 
cell surface where it aids bacterial attachment via interaction with the bacterial outer 
membrane protein intimin (Robinson et al., 2006).  Stx has also been shown to have 
immuno-modulatory functions, including the suppression of inflammatory responses and 





Epidemiological studies have shown that particular strain types emerge that are more 
likely to be associated with human disease.  In the USA, Clade 8 is associated with more 
serious human disease (Manning et al., 2008) and in Europe particular phage types are 
more commonly associated with human infections (Pearce et al., 2009). In a previous 
study, Chase-Topping et al (Chase-Topping et al., 2007b) investigated fecal pat samples 
from 481 farms throughout Scotland for the presence of E. coli O157:H7.  Three main 
phage types were identified, 21/28 (46%), 32 (19%), and 8 (12%). Previous research had 
shown that cattle colonized at the terminal rectum can shed bacteria at higher levels than 
transient colonization, leading to the concept of ‘super-shedders’.  Low or high-level 
shedding was defined by whether the E. coli O157 counts were below or above 103 CFU 
g-1 feces respectively. PT 21/28 strains were more likely to be associated with high 
shedding and PT 32 with low-level shedding samples.  PT 21/28 strains are the 
predominant type associated with human infection in the UK (Chase-Topping et al., 
2008). The initial aim of this study was to identify genetic differences between PT 21/28 
and PT32 strains.  The research indicated that Stx bacteriophage carriage was different 
between the two as was the regulation of T3 secretion.  This led us to determine the 
impact of Stx phage lysogeny on T3S regulation in EHEC with the conclusion that the 
bacteriophage usurps control of this essential colonization factor and propose that this 
modulation further limits immune stimulation and recognition in the host animal.  
 
 
5.2 Results  
5.2.1 Comparative genomic hybridization of PT 21/28 and PT 32 strains  
In order to investigate genomic differences between the two phage types, twelve strains 
(six of each type) were analyzed by comparative genomic hybridization (CGH) as 
detailed in Materials and Methods. The strains were chosen to include the variation in 
type III secretion (T3S) profiles apparent by colloidal blue staining of culture 
supernatants and strains originating from faecal pats with both high and low bacterial 
counts. Full details of the strains are provided in Tables 5.1.   While multiple differences 
in gene content were identified between the phage types, the most consistent difference 
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was in hybridization to the Stx2 bacteriophage immunity region, with 1/6 PT32 strains 
showing hybridization to this region and 6/6 PT21/28 strains (Table 5.1). The array 
design is based on the E. coli O157:H7 Sakai sequence (Table 5.1), which contains both 






























Fig. 5.1 Analysis of CGH data for Stx2 phage for PT 21/28 and PT 32 (Jai Tree) 
Upper panel: The copy number of each gene increased in the order of blue, grey, yellow 
and red. Blue indicates absence of gene. Gray means lower copy number than Sakai. 
Yellow indicates similar copy as Sakai. Red means higher copy number than Sakai. 
Bottom panel: PT 32 was indicated in red with PT/28 in yellow. The numbers shown in 








5.2.2 Identification of Stx2 and Stx2c phage 
Previous characterization of the strains had already determined that they all contained at 
least one type of Stx2 phage (IPRAVE study), so to investigate whether Stx2 vs Stx2c 
prophages could account for the hybridization differences, genomic DNA preparations 
from strains (n=62) were analyzed for these prophages by PCR (Materials and Methods).  
While the majority of all the strains analyzed contained the Stx2c prophage (87%), the 
main difference was in the distribution of the Stx2 prophage.  With respect to strains 
isolated from cattle, PT 21/28 strains were more likely to contain Stx2 compared to PT 32 
strains (P<0.01) (Table 5.1).  However, PT 32 strains from humans were more likely 
(p=0.01) to contain Stx2 than the PT 32 bovine isolates (75% versus 25%), while the 
majority of 21/28 strains from either source contained Stx2 (Table 5.1).  This indicates 
that PT32 strains associated with human disease appear more likely to be lysogenized 
with Stx2 phage and PT21/28 strains, which are the main human disease associated phage 




































Bovine 21/28 <50 no 7692 - + + 
Bovine 21/28 <50 no 11923 - + + 
Bovine 21/28 <50 no 12692 - + + 
Bovine 21/28 <50 no 15000 - + + 
Bovine 21/28 <50 no 3078 - + + 
Bovine 21/28 300000 yes 5000 - + + 
Bovine 21/28 686400 yes 6154 - + + 
Bovine 21/28 150000 yes 10769 - + + 
Bovine 21/28 384000 yes 12692 - + + 
Bovine 21/28 269200 yes 12692 - + + 
Bovine 21/28 77600 yes 24615 - + + 
Bovine 21/28 16100 yes NT - + + 
Bovine 21/28 59300 yes 5385 - + + 
Bovine 21/28 11500 yes NT - + + 
Bovine 21/28 42400 yes 10385 - + + 
Bovine 21/28 150000 yes NT - + - 
Bovine 21/28 46000 yes NT - + + 
Bovine 21/28 21000 yes NT - + + 
Bovine 32 36150000 yes 28461 - + + 
Bovine 32 NK unknown 20000 - - + 
Bovine 32 <50 no 20385 - - + 
Bovine 32 <50 no 18846 - - + 
Bovine 32 <50 no 16923 - - + 
Bovine 32 <50 no 16923 - + - 
Bovine 32 900 no NT - - + 
Bovine 32 <50 no 14231 - - + 
Bovine 32 <50 no 12692 - - + 
Bovine 32 <50 no 21538 - - + 
Bovine 32 <50 no NT - - + 
Bovine 32 <50 no 19230 - - + 




Bovine 32 119600 yes 28845 - + + 
Bovine 32 <50 no 13078 - - + 
Bovine 32 <50 no NT - - + 
Bovine 32 <50 no NT - + + 
Bovine 32 <50 no 13846 - - + 
Bovine 32 <50 no 11923 - - + 
Bovine 32 <50 no 13846 - - + 
Human 21/28 -  13461 - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + - 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + - 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
Human 21/28 -  NT - + + 
        
Human 32 -  36155 - + - 
Human 32 -  20385 + - + 
Human 32 -  NT - - + 
Human 32 -  NT - + + 
Human 32 -  NT - + - 
Human 32 -  NT - + + 
Human 32 -  NT - + + 
Human 32 -  NT - + - 
Human 32 -  NT - + + 
Human 32 -  NT - - + 
Human 32 -  NT - + + 
 32   NT - + - 
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5.2.3 T3S levels in PT 21/28 and PT 32 strains 
5.2.3.1 EspD and EscJ levels in PT 21/28 and PT32 strains 
The secretion profiles of thirty strains of each phage type were analyzed, including 
Western blotting for the translocon protein EspD (a subset of strains is shown in Fig 5.2).  
From these initial profiles it was evident that more PT32 strains were secreting higher 
levels of EspD.  The strains also produced variable levels of EscJ, with higher levels of 
the T3S apparatus protein EscJ correlating with higher levels of EspD secretion (Fig 5.2). 
Anti-RecA blotting was used as control for lysis. A same level of RecA from whole cell 
preparation indicated a similar level of lysis.  
 
 
Fig. 5.2 Western blot analysis of a subset of PT21/28 and PT32 strains. 
EspD was detected from bacterial supernatants and EscJ and RecA from whole cell 
samples prepared as described in Materials and Methods. 
 
5.2.3.2 LEE1 promoter expression levels in PT 21/28 and PT32 strains 
In order to quantify any differences in the expression of the T3S system in the two phage 
types, a subset of the strains (n=31) were transformed with a LEE1::egfp reporter 
construct (Roe et al., 2003b). Fluorescence levels were then measured for the different 
strains during standard growth curves. For statistical analyses, fluorescence values were 
determined from multiple experiments for OD600= 1.0 (Table 5.1).  PT32 strains had a 
significantly higher median level of expression compared to the PT21/28 strains (Fig 5.3).    
As an alternative analysis, strains exhibiting expression levels over the mean of 13,000 
fluorescence units were grouped separately from those with lower values. On this basis, 
PT32 strains were more likely to express the LEE1 fusion at higher levels than the 
PT21/28 strains (p<0.01), consistent with the secretion profiles and Western blotting data. 
αEspD





There was no correlation between T3S expression and single point shedding levels of the 
strain obtained from the faecal pat at the time of sampling (Table 5.1).   
 
Based on the observation that PT 21/28 was more likely to contain two types of Stx2 
phage (Stx2 and Stx2C) and generally demonstrated lower levels of T3S, we compared 
LEE1 expression levels with Stx2 and Stx2c carriage.  Strains containing both Stx2 and 
Stx2c phages were significantly more likely (p=0.016) to have lower LEE1 expression 
levels than strains containing just one Stx2 phage (Fig 5.4).  All bar one of these strains 
did not contain a Stx1 phage. 
 
 
















































Fig. 5.3 Relative fluorescence levels from a
LEE1-GFP reporter construct transformed
into 20 PT21/28 and 20 PT32 strains with
levels measured at OD600=1 (produced with
collaboration with David Gally).  The
median level of fluorescence from the PT32
strains is significantly higher than for the
PT21/28 (p<0.001), the variability in
expression levels correlates with the
Western blotting data in part Fig 5.4. 
Fig. 5.4 LEE1-GFP expression levels 
compared between strains containing either 
one or both Stx2 or Stx2c prophages
(produced with collaboration with David 
Gally).  Strains containing both Stx2 phages 
have a significantly reduced median level of 
LEE1 expression determined at OD600=1 
















5.2.4 Comparison of T3S expression in the presence and absence of Stx 
phages  
5.2.4.1 Comparison of EDL933 and TUV93-0 
In order to investigate whether the expression of the T3S system is repressed by the 
presence of Stx prophages, secretion profiles and LEE1 expression levels in pairs of 
EHEC strains, with and without integrated Stx2 prophages, were analyzed.  The 
sequenced isolate EDL933 was compared with a published Stx1 and Stx2 phage-cured 
derivative TUV93-0 (Fig 5.5).  Higher levels of EspD secretion were detected in bacterial 
supernatants of TUV93-0 compared with EDL933 (Fig 5.5).  This correlated with higher 
levels of the apparatus protein, EscJ, in the whole cell fractions compared with RecA as a 
control (Fig 5.5).  Again, to quantify this difference, the LEE1 promoter fusion was 
introduced into both strains. The expression in TUV93-0 was higher than EDL933 
throughout the growth curve with a significance difference for values determined at 
OD600 = 0.9 (Fig 5.6-7).  As both the EDL933 and TUV93-0 strains used have been 
cultured in a number of different laboratories and EDL933 was also subject to genetic 
manipulation during which phage excision occurred (Campellone et al., 2007), there may 
be other genetic changes, in addition to the absence of the Stx phages, that may account 
for the increased level of T3S in TUV93-0.  To investigate this, two approaches were 
taken.  In the first, a Stx2 phage marked with a kanamycin resistance cassette from a 
derivative E. coli O157 Sakai strain (Sakai stx-, Table 2.1) was conjugated into TUV93-0 
(This work is carried out by Sean McAteer) and EspD secretion level, EscJ expression 
and LEE1-GFP expression determined (Fig 5.5-6). This conjugation partially restored 
repression of T3S but not to the level demonstrated for EDL933.  It is appreciated that 
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this conjugation may introduce additional non-phage DNA from the Sakai strain and also 
acts on a background that may already contain other genetic changes.  As a second 
approach, another series of strains were generated from EDL933 in which the Stx2 phage 
and then the Stx1 phage were deleted by allelic exchange to generate another Stx phage 
negative derivative of EDL933.  This strain also exhibited increased levels of T3S and 
LEE1 expression by comparison with the isogenic EDL933 parent, but at lower levels 
than shown for TUV93-0 (Fig. 5.5-8).  Taken together, it is evident that the presence of 
Stx prophages in the EHEC O157 chromosome can limit T3S by repressing LEE1 
expression.  However, other uncharacterized changes between our laboratory stocks of 
EDL933 and TUV93-0 also contribute to T3S differences between these strains.  
 
To examine if Stx phage excision has an effect on T3S in another EHEC serotype, two 
pairs of published E. coli O26:H11 strains were obtained from Dr Helge Karch (Table 
2.1).  Both pairs are considered isogenic apart from the presence and absence of Stx2 
prophages (Mellmann et al., 2008), the phages were lost during culture of the bacteria.  
For one pair, T3S increased significantly in the absence of Stx phage (Fig 5.5), while for 
the other no T3S was detectable for either strain under the conditions tested (data not 
shown).  For the pair with detectable T3S, the LEE1-GFP reporter was transformed into 
both strains and levels of expression measured throughout the growth curve.  Again the 
presence of the Stx2 phage correlated with significant repression of LEE1 expression in 
agreement with the Western blotting profile for EspD secretion and EscJ apparatus 
































TUV control GFP reporter
TUV LEE1-GFP
TUV Stx2 phage conversion LEE1-GFP
EDL LEE1-GFP
EDL(Stx2 deleted) LEE1-GFP





































































EspD was detected from bacterial supernatants and EscJ and RecA from whole cell 
samples prepared as described in Materials and Methods.     EDL is the sequenced 
EDL933 strain and this was originally compared with a published Stx1/2 derived strain 
TUV93-0 (lane 4), which shows higher secretion levels and EscJ expression.  Both Stx1 
and Stx1/2 were deleted from EDL933 (lanes 2 and 3 respectively) leading to increased 
T3S. A marked Stx2 phage was conjugated into TUV93-0 (lane 5) resulting in a 
reduction in T3S and Esc expression.  The final two lanes contain samples from a 
published isogenic pair of EHEC O26 strains from which one has lost the Stx2 phage 



















Fig. 5.6  LEE1-GFP measurement of the same strain sets as in Fig 5.5 (produced with 
collaboration with David Gally) 
 To quantify differences in T3S expression, the same strain sets as in Fig 5.5, were
transformed with a LEE1-GFP construct and fluorescence measured throughout the






















EcO26 (Stx2+) control plasmid
EcO26 (Stx2+) LEE1-GFP



















                                                  
Fig. 5.8 LEE1-GFP expression of E. coli O26 pair of strains 
The E. coli O26 pair of strains blotted in Fig 5.5 (Table 2.1) were transformed with the 
LEE1-GFP expression construct or a control plasmid and population fluorescence levels 
measured through the growth curve (produced with collaboration with David Gally).  
Taken together the data demonstrates that lysogeny with a Stx phage represses T3S 
expression.  
Fig 5.7 A minimum of three values were determined from the expression curves for
OD600=0.9 and plotted in Fig 5.7.  p<0.001 for the TUV strains and p=0.001 for the EDL













5.2.4.2 Plasmid constructs to create deletion mutants 
To obtain the Shiga toxin phage and CII deletion strains, a series of plasmids were 
constructed as described in Materials and Methods. pXLS11, pXLS12, pXLS13, pXLS15 
and pXLS16 were used to obtain Stx phage deletion strains. Briefly, flanking regions of 
z1449 (cIIstx2), Stx1, Stx2 were PCR amplified from EDL933, cloned into pIB307 and 
confirmed by restriction with the appropriate enzyme; the plasmids were termed pXLS11 
(Fig. 5.9-10) , pXLS12 (Fig. 5.12-13), and pXLS15 (Fig. 5.15-16) respectively. Then a 
sacBkan cassette was cloned into both pXLS11 and pXLS12 at the BamH I site 









































Fig. 5.9 pIB307 with the z1449
digestion with BamH I and Hind
III. Lane1-2: positive sample, lane
3-4: negative sample, lane 5:
negative control lane 6: 1 kb ladder
750bp
  1       2      3      4     5    6
  1         2        3       4        5 
500bp
Fig. 5.10 pXLS11 digested by BamH I
and Sal I to check for cloning the
downstream flanking region of z1449.
Lane1: negative control, lane 2-4:
positive sample lane 5: 1 kb ladder 
Fig. 5.11 pXLS13 digested by BamH
I to demonstrate the insertion of the
sacBkan cassette. Lane1: 1 kb




  1     2 
Fig. 5.12 pIB307 with stx1 upstream
flanking region inserted; digested
with BamH I and Hind III. Lane1: 1
kb ladder, lane 2: negative control,
lane 3: positive sample 




























      1             2             3              4 
Fig. 5.15 pIB with the stx2 upstream 
flanking region inserted; digested with
BamH I and Hind III. Lane1-3: positive 
samples, lane 4: 1 kb ladder 
 
    1      2
500 bp 
Fig. 5.16 pXLS15 digested by
BamH I and Sal I to show the
insertion of the stx2 downstream
flanking region. Lane1: 1 kb ladder
lane 2: positive sample 
500 bp 
       1           2           3 
Fig. 5.13 pXLS12 digested by BamH I
and Sal I to cut out the downstream
flanking region of stx1. Lane1: 1 kb




    1             2          3 
Fig. 5.14 pXLS16 digested by
BamH I to detect sacBkan cassette.
Lane1: 1 kb ladder, lane 2-3:
positive sample  
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5.2.4.3 Construction of Stx phage deletion strains in EDL933 
To obtain a stx2 clean deletion mutant, an intermediate strain with z1449 (cIIstx2) replaced 
by the sacBkan cassette was constructed. As detailed in Materials and Methods, plasmid 
pXLS13 (Table 2.2) was used for this construction. A flow of constructed strains and 
plasmids used to create these strains were shown in Fig. 5.17. The replacement of z1449 
with sacBkan cassette was confirmed by PCR with primer pairs z1449 5’ and z1449 3’ for 
the inside of z1449 (Fig. 5.23), z1449 external 5’ and z1449 external 3’ for outside of 
z1449 (Fig. 5.24), sacB 5’ and sacB 3’ for sacBkan cassette (Fig. 5.25). These primers 
positions on the genome were demonstrated in Fig. 5.18 and Fig. 5.19. PCR results 
indicated that z1449 was replaced by sacBkan properly (Fig. 5.23-25). The resultant 
strain was termed as ZAP1321. ZAP1321 was then transformed with plasmids pXLS15 
and allelic exchange carried out to generate strains with Stx2 phage clean deletions.  The 
required clones were identified by sensitivity to both kanamycin and chloramphenicol 
and confirmed by PCR using primer pairs: wrbA and intW plus z1503 and z1504 for the 
junction sites of Stx2 (Fig. 5.26-27); stx2 F and stx2 R for a region inside the Stx2 phage 
(Fig. 5.28). PCR primers for Stx2 phage were shown in Fig. 5.20. The clean stx2 deletion 
strain was termed ZAP1322 (Table 2.1).  In order to construct a strain deleted for both 
Stx1 and Stx2 phages, ZAP1322 was used to create a strain with stx1 replaced with the 
sacBkan cassette using pXLS16 (Table 2.2). The required strain was selected on the basis 
of KAN resistance and CAM sensitivity; further confirmation was carried out by PCR 
with primer pairs yehU and z3305 for the left end of the Stx1 phage (Fig. 5.29), intV and 
yehV for right end of the Stx1 phage (Fig. 5.29), stx1 5’ and stx1 3’ for inside of Stx1 
phage (Fig. 5.30), yehU and yehV for outside of Stx1 phage (Fig. 5.31), sacB 5’ and sacB 
3’ for sacBkan cassette (Fig. 5.32) (Table 2.3). These PCR primers positions on the 
genome were depicted in Fig. 5.21 and Fig. 5.22.   The resultant strain was designated 






Fig. 5.17 Schematic diagram of strains construction 





Fig. 5.18 Structure diagram of z1449 locus and primers in EDL933 















Fig. 5.19 Structure diagram of z1449 locus and primers in ZAP1321 






Fig. 5.20 Structure diagram of Stx2 phage locus and primers in EDL933 







Fig. 5.21 Structure diagram of Stx1 phage locus and primers in EDL933 






Fig. 5.22 Structure diagram of Stx1 phage locus and primers in ZAP1326 


























Fig. 5.25 PCR of sacBkan cassette for
exchange of z1449 for sacBkan
cassette 
Lane 1: positive sample, lane 2:
positive control, lane 3: 1 kb ladder,
lane 4: negative control.  
It was showed sacBkan cassette was
present in the tested sample (lane 1). 
1   2    3   4 
500b bp
500 bp 
1       2       3     4 
Fig. 5.23 Internal PCR of z1449 
Lane 1: 1 kb ladder, lane 2: negative control,
lane 3: positive control (EDL933), lane 4:
tested sample. PCR indicated z1449 was lost
in the tested sample. 
Fig. 5.24 External PCR of z1449 
Lane 1: tested sample, lane 2:
negative control, lane 3: positive
control (pXLS13) lane 4: 1 kb
ladder. It was demonstrated that
sacBkan cassette replaced z1449 in
the right chromosome site. 
    1            2        3        4
4 kb 
 1        2        3        4 
500 bp 
Fig. 5.26 PCR of junction of Stx2 using
primer pair wrbA and intW 
Lane 1: positive control (EDL933), lane
2: tested sample 1, lane 3: tested sample
2, lane 4: 100 bp ladder. PCR indicated






























1        2       3     4 
Fig. 5.27 PCR of junction of Stx2
using primer pair z1503 and z1504 
Lane 1: 100 bp ladder, lane 2:
positive control (EDL933) , lane 3:
tested sample 1, lane 4: tested
sample 2. PCR showed that sample
2 might have lost Stx2 phage. Thus
sample 2 was taken for next steps. 
Fig. 5.29 PCR of left end and right end of 
Stx1 phage  
Lane: 1 kb ladder, lane 2-4: PCR of left end 
of Stx1, lane 2: positive control (EDL933), 
lane 3: negative control, lane 4: tested 
sample; lane 5-7: PCR of right end of Stx1, 
lane 5: negative control, lane 6: positive 
control (EDL933), lane 7: tested sample. 
PCR results showed that Stx1 was lost in 
tested sample. 
500 bp 
 1    2   3    4   5   6    7 
5 kb 
 1              2          3 
Fig. 5.30 PCR of outside of Stx1 
Lane 1: tested sample, lane 2:
positive control, lane 3: 1 kb
ladder. PCR indicated that sacBkan
cassette was replaced in Stx1
phage loci on the chromosome. 
1            2            3 
200 bp
Fig. 5.28 PCR of inside of Stx2 using
primer pair stx2F and stx2R 
Lane 1: 100 bp ladder, lane 2: tested
sample, lane 3: positive control
(EDL933). PCR result showed that





























1   2    3  4
Fig. 5.32 PCR of sacBkan cassette 
Lane 1: negative control, lane 2:
positive control, lane 3: tested sample.
It indicated that tested sample obtained
sacBkan cassette.  
 
Fig. 5.31 PCR of inside of Stx1 with
primers stx1 5’ and stx1 3’ 
Lane 1: negative control, lane 2:
positive control (ELD933), lane 3:
tested sample, lane 4: 1 kb ladder.
PCR result showed that Stx1 subunit
A was absent in tested sample. 
250 bp 
     1       2       3         4 
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5.2.5 Repression of LEE1 promoter activity in E. coli K12 transduced with a 
Stx2 bacteriophage 
In order to determine whether the repression of T3S expression by Stx prophages could 
also be detected in a distinct genetic background; the marked Stx2 phage induced from E. 
coli O157:H7 Sakai was used to transduce E. coli K12 MG1655.  This transduction was 
achieved and the establishment of a lysogen in E. coli K-12 confirmed by selectable 
markers and PCR assays (this strain was constructed by Sean McAteer).  The recipient 
strain was Lac negative and Nalidixic acid resistant making it easy to distinguish from the 
original Sakai strain and the final strain was also shown to contain stx2 genes and not 
intimin (data not shown). This E. coli K-12 Stx2 lysogen and the parental MG1655 strain 
were then transformed with the LEE1::egfp promoter fusion plasmid and fluorescence 
levels measured throughout the growth curve (Fig. 5.33A).  While there was some 
detectable expression from the LEE1 promoter there was no significant difference in 
LEE1 expression levels between the strains (Fig. 5.33A).  However, neither of these 
strains contains the LEE-encoded regulator (Ler) which is known to relieve H-NS 
repression of the LEE1 and other LEE promoters to activate T3S expression. To examine 
Ler induction of LEE1 in the two backgrounds, ler was cloned into the inducible 
pWSK29 vector and this was transformed into the same pair of K-12 strains containing 
the reporter for LEE1.  Induction of Ler was carried out using IPTG and fluorescence 
levels measured throughout the growth curve.  As anticipated Ler induction significantly 
increased expression from the LEE1 promoter fusion in the E. coli K-12 strain (Fig. 
5.33A).  However, this ler-dependent activation did not occur to the same extent in the E. 
coli K-12 derivative containing the Stx2 lysogen (Fig. 5.33A).  This result implied that 
Stx2-based repression of T3S involved inhibition of Ler activation of the LEE1 promoter.  
To confirm that Ler was induced by IPTG induction to a similar level in the two 
backgrounds, ler was cloned into pWSK29 with a carboxy-terminal six histidine tag to 
allow levels to be determined by Western blotting.  This construct was also able to induce 
LEE expression in E. coli MG1655 but not to the same extent as the strain transduced 
with the Stx2 phage (Fig. 5.34).  Whole cell protein samples were blotted for detection of 
6xHis-Ler and the isogenic Stx2+ and Stx2- K-12 strains containing the LEE1-GFP 
reporter (Fig 5.35, lanes 6 & 8)  contained equivalent levels of the tagged Ler protein 
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when compared to RecA levels as a control.  This implied that although Ler was induced 
and present its capacity to act on the LEE1 promoter was limited by the presence of the 




































K12 GFP vector, pWSKler




































































Fig. 5.33 LEE1-GFP measurement of K12 and K12 Stx2+ (produced with collaboration with 
David Gally) 
(A) A marked Stx2 phage was transduced into E. coli K-12 MG1655 as described in Materials
and Methods.  Expression of the LEE1-GFP reporter, or from a control GFP plasmid (GFP
vector) were then compared in the Stx+ and Stx- K-12 strains with and without induction of the
LEE-encoded regulator (pWSKler) or control plasmid (pWSK29) with 1mM IPTG.  This
experiment was repeated four times and fluorescence values determined at OD600=0.9 used in






































K12 GFP vector pWSKler*
K12 LEE1-GFP pWSKler*






















































Fig. 5.34 LEE1-GFP measurement of K12 and K12 Stx2+ with plasmids ler(produced 
with collaboration with David Gally) 
The experiments were repeated with a 6xHis-tagged Ler construct (pWSKler*) to
determine if Ler was present in equivalent levels in both K-12 strains (Fig 5.35). Again
Ler induction led to significantly reduced levels (p=0.002) of population fluorescence
in the K-12 Stx2 lysogen (red and black squares in (A) when compared at OD600=0.9 in












Fig. 5.35 6xHis-tagged Ler levels were compared with RecA in the different strains
by Western blotting from whole cell samples taken at OD600=0.9.  Both strains
containing the LEE1-GFP fusion and the induced pWSKler contained equivalent
levels of the induced 6xHis-tagged Ler protein, lanes 6 & 8.    
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5.2.6 The lysogeny regulator CII can repress type III secretion 
One explanation for the failure of Ler to induce LEE1 expression in the presence of the 
Stx2 lysogen is that a regulator or regulators expressed from the Stx2 lysogen repress Ler 
activity on the LEE1 promoter.  Several of the key lysis/lysogeny regulators 
characterized for phage lambda were cloned from the EDL933 Stx2 phage into the 
arabinose inducible vector pBAD18.  These clones were sequenced and confirmed as 
identical to the published Stx2 (BP933-W) genes (NCBI).  The clones were 
electroporated into the Stx phage negative E. coli O157:H7 strain TUV93-0 and the T3S 
profiles determined from supernatants following arabinose induction (Fig 5.36).  Only the 
clone of cII showed any evidence of T3S repression.  However, it is established that CII 
induction can be toxic for cells and we observed reduced growth rates when expressing 
cII.  It is also apparent that in this case even though EspD levels are reduced, EscJ 
expression is not, indicating a different regulatory pathway. Of note though was that the 
same reduced growth rate was measured when cII was induced in EPEC O127 E2348/69, 
but in this case there was no repression of T3S (data not shown), indicating a regulatory 
difference in this Stx phage negative background. To determine the relevance of cII to 
repression of T3S at physiological levels, the cII gene was deleted from both the Stx2 
phage and from the Stx1 phage in E. coli O157 EDL933. Western blotting for T3S 
proteins as well as fluorescence levels from the LEE1-GFP reporter transformed into the 
strain demonstrated significantly increased LEE1 expression and T3S in the absence of 
cII (Fig. 36-37).  The induction and deletion experiments with cII confirm a role in T3S 







































Fig. 5.36 Western blot detection of EspD from bacterial supernatants and EscJ & RecA 
from whole cell samples. 
The defined bacteriophage lysis/lysogeny regulators were cloned into the pBAD vector
and induced in E. coli TUV93-0 which does not contain any Stx prophages.  
Fig. 5.37 Western blto analysis of the same proteins from E. coli EDL933 and
an isogenic strain from which both the Stx1 phage cII gene and the Stx2 cII
gene had been deleted by allelic exchange as described in Materials and




























































































Fig. 5.38 LEE1-GFP measurement of EDL933, TUV93-0 and TUV Stx1&2cII deletion
(produced with collaboration with David Gally) 
 (A) Population fluorescence from the LEE1-GFP reporter, or control plasmid, were
examined in EDL933 and the double cII deletion.  Deletion of both cII genes led to a













5.2.6.1 Constructs for allelic exchange  
In order to construct plasmids that would facilitate chromosomal exchange, flanking 
regions of the z1449 (cIIstx2) (described above) and z3357 (cIIstx1) genes were PCR 
amplified and cloned into the temperature-sensitive plasmid pIB307 (Table 2.2). These 
products were cleaned with a Invitrogen PCR purification kit, digested with BamH I and 
Hind III or Sac I, or Sal I , re-cleaned, and then ligated with digested pIB307 (Table 2.2) 
to obtain pXLS10 (Fig. 5.39- Fig. 5.40) and pXLS11 (Fig. 5.9-10) containing flanking 
regions of z3357 and z1449 genes respectively. To produce plasmids for exchange, a 
sacBkan cassette was cloned into the BamH I sites of pXLS11 and pXLS10 creating 
pXLS13 (Fig. 5.11) and pXLS14 (Fig. 5.41) that would allow the chromosomal 
replacement of z1449 and z3357 genes respectively with a selectable marker and a 




































Fig. 5.40 pXLS10 digested by BamH I
and Sal I  
Lane 1: 1 kb ladder, lane 2: tested
sample. z3357 upstream fragment was
detected from pXLS10 by BamH I and
Sal I digstion. 
500 bp 
 1              2 
Fig. 5.39 z3357 downstream flanking
region inserted into pIB307 digested by
BamH I and Hind III  
Lane 1: tested sample, lane 2: 1 kb ladder.
z3357 downstream fragment was detected
by BamH I and Hind III digestion.
500 bp 



















5.2.6.2 Strain construction 
The method of Emmerson et al. was used for allelic exchange (Emmerson et al., 2006).   
Plasmid pXLS13 (Table 2.2) was transformed into ZAP1321 (described above) to obtain 
z1449 (cIIstx2) clean deletion. Briefly, pXLS13 was electroporated into ZAP1321 (Table 
2.1) and cultured at 30°C on LB-C plates. Ten transformants were then inoculated into 
pre-warmed LB-C at 42°C and passaged repeatedly in LB-C broth at 42°C to obtain co-
integrates. The culture was further passaged in at 30°C in LB broth to select for the 
complete exchange. The kanamycin sensitive and chloramphenicol sensitive strain was 
confirmed by PCR with primer pairs z1449 external 5’ and z1449 external 3’ for outside 
of z1449 (Fig. 5.44), sacB 5’ and sacB 3’ for sacBkan cassette (Primer Table) (Fig. 5.45). 
PCR primer locations on the genome were shown in Fig. 5.18. The resultant strain was 
termed as ZAP1323. ZAP1323 was then transformed with plasmids pXLS14 and allelic 
exchange carried out to generate ZAP1324 with z3357 (cIIstx1) replaced with sacBkan 
cassette. This allelic exchange was carried out as above except that the cultures at 30°C 
contain kanamycin antibiotic selection.  The required clones were identified by 
6 kb 
4 kb 
 1              2
Fig. 5.41 PXLS14 digested by BamH I 




kanamycin resistance and chloramphenicol sensitivity and confirmed by PCR using 
primer pairs: z3357 external 5’ and z3357 external 3’ for outside of z3357 (Fig. 5.46), 
sacB 5’ and sacB 3’ for sacBkan (Fig. 5.47), and cassette z3357 3’ for inside of z3357 (Fig. 




Fig. 5.42 Structure diagram of z3357 locus and primers in EDL933 

















Fig. 5.43 Structure diagram of z3357 (replaced by sacB/kan cassette) locus and primers in 





















Fig. 5.44 External PCR of z1449 in
ZAP1323 
Lane 1: 100 bp ladder, lane 2: tested
sample 1, lane 3: tested sample 2,
lane 4: negative control. It indicated
that tested samples lost sacBkan
cassette and z1449.  
1       2         3        4 
100 bp 1 kb 
   1          2        3
Fig 5.45 PCR of sacBkan cassette in ZAP1323
 Lane 1: positive control, lane 2: 1 kb ladder,
lane 3: tested sample. It indicated that tested











































    1       2          3      4        5        6       7 
4 kb 
Fig. 5.46 Internal PCR of z3357 in
ZAP1324 
Lane 1,2,4,5: tested samples, lane 3:
negative control, lane 6: positive control,
lane 7: 1 kb ladder. It indicated z3357 was
replaced by sacBkan cassette.  
1 kb 
 1     2      3     4
Fig. 5.47 PCR of sacBkan cassette in
ZAP1324 
Lane 1: tested sample, lane 2: positive
control, lane 3: negative control, lane 4:
1kb ladder. PCR result showed that
sacBkan cassette was present in tested
sample  
1       2      3       4 
250 bp 
Fig. 5.48 Internal PCR of z3357 in ZAP1324 
Lane 1: positive control, lane 2 negative control, lane 3: 1 kb ladder, lane 4:
tested sample. 


















EHEC strains are characterised by the integration of lambdoid-like phages into their 
chromosome that encode Shiga toxins (Ogura et al., 2009; Perna et al., 2001).  EHEC 
O157 strains can be lysogenized by different types of Stx phage, but those associated 
with Stx2 and Stx2c are considered the most important in terms of human virulence 
(Garcia-Aljaro et al., 2005; Muniesa et al., 2004). Some strains carry multiple Stx phages 
indicating some differences in phage exclusion regulation beyond that characterised for 
classical lambda (Dobrindt et al., 2010).  A key question is what evolutionary advantage 
can Stx phage lysogeny have for the EHEC strain, and do these underpin the 
epidemiology of EHEC O157 strains?  A large epidemiological study of farms in 
Scotland demonstrated that PT21/28 strains were more likely to be associated with higher 
level faecal counts compared with PT32 strains.  In addition, PT21/28 strains over that 
period were the most prevalent phage type associated with human infection (Chase-
Topping et al., 2008; Chase-Topping et al., 2007b).  The initial aim of this study was to 
compare PT21/28 and PT32 strains in terms of genomic differences to determine how 
these inform the epidemiology. 
 
Comparative genomic hybridisation (CGH) analysis of 12 strains indicated that one of the 
main differences between the phage types was with Stx phage carriage.  Based on the 
CGH, PCR was used to determine the presence of Stx2 and Stx2c in 60 strains.  PT21/28 
strains generally carried both Stx2 and Stx2c bacteriophages, irrespective of whether the 
strains were sourced from cattle or humans.  By contrast, nearly all the bovine PT32 
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strains analysed carried only the Stx2c phage.  The situation for the limited number of 
human PT32 strains was more complex, but these were significantly more likely to 
contain a Stx2 phage in comparison to the bovine strains.  This data indicates that strains 
carrying both Stx2 and Stx2c phages are more likely to be associated with human 
infection.  This result is in line with recently published research on Clade 8 strains in the 
USA that are considered to be more virulent. Clade 8 strains were significantly more 
likely to carry both the stx2 and stx2c genes in comparison to the other clades containing 
stx2c (Manning et al., 2008).  All clade 8 strains tested had stx2, and 57.6% had stx2c.  
Whether this association for both relates to differences in toxicity of the strains or other 
phenotypes associated with the strains is not known, although more recent work has 
indicated that levels of Stx2 production alone are likely to be important, irrespective of 
lineage, in terms of association with human clinical disease (Zhang et al. 2009).  
 
As type III secretion (T3S) is essential for cattle colonisation and variation in its 
regulation may associate with differences in shedding level from cattle (Pearce et al., 
2009), we investigated T3S levels between PT32 and PT21/28 by Western blotting 
bacterial supernatants for the secreted translocon protein EspD and whole cell fractions 
for the T3S apparatus protein EscJ.  LEE1 expression was also measured by determining 
fluorescence levels from a previously published LEE1-GFP reporter (Roe et al., 2003a). 
Levels of T3S varied markedly between strains in agreement with our previous work on 
T3S profiles of EHEC O157 strains (Roe et al., 2004).  T3S levels were low in the 
majority of PT21/28 strains compared with the PT32 strains.  Extensive research has 
defined multiple regulatory inputs for T3S and it is likely that the variation observed will 
be due to a complex combination of alleles.  For example, use of a LEE1 reporter readout 
in different lineages of EHEC O157 strains has yielded a complex and widely distributed 
pattern of expression with no clear association with particular integrated O-islands or S-
loops (Yang et al., 2009).  However, the finding in the present study that strains with both 
Stx2 and Stx2c phages had on average lower levels of LEE1 expression than strains with 
a single Stx2 bacteriophage prompted us to test strain pairs with and without Stx 
bacteriophages.  Analysis of these strains demonstrated that Stx phage insertion into the 
chromosome leads to repression on T3S (Fig. 5.5-8), this was also apparent in a pair of 
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O26 strains, including one from which the Stx2 phage had been naturally cured 
Bielaszewska ref at end.  As stated there are likely to be multiple variable inputs into T3S 
expression and this was confirmed by analysis of the potentially isogenic EDL933 and 
TUV93-0 strains.  While Stx bacteriophage insertion and deletion repressed and activated 
T3S respectively, other differences between the strains also account for the marked 
difference in T3S levels between these strains.  Further research using information on the 
sequences of multiple strains in comparison with T3S profile should help clarify the main 
alleles responsible for this variation.    
 
To confirm and study the Stx2 bacteriophage repression in another background, the 
sequenced E. coli K12 MG1655 strain was lysogenised with a marked Stx2 phage from 
the sequenced E. coli O157:H7 Sakai strain (Table 3).  Without the presence of the LEE-
encoded regulator (Ler) there was no difference in the expression levels from the LEE1-
GFP reporter transformed into these two strains, indicating that there was no inherent 
difference in these backgrounds affecting the basal level of GFP detected.  However, 
upon induction of Ler, expression of LEE1 was always significantly lower in the K-12 
strain containing the Stx2 lysogen.  To rule out that the lower level of expression may be 
due to reduced Ler expression, the experiments were repeated using a 6xHis-Ler 
construct with nearly identical results (Fig. 5.37-38).  This set of experiments 
demonstrates that the capacity of Ler to induce LEE1 expression is reduced in the 
presence of the Stx2 lysogen.  Attempts were made to examine T3S in the K-12 
backgrounds by transforming in a full length LEE clone (McDaniel & Kaper, 1997), but 
this clone failed to express any detectable T3-related proteins in either background (data 
not shown).   Our results are in line with recently published work examining the impact 
of Stx phage insertion on gene expression in E. coli K-12 by micro-array (Su et al. 2010). 
Of 166 genes found to be differentially expressed, 62 were down-regulated and 104 of 
these were up-regulated, including motility and acid-resistance associated genes. GadE is 
known to be involved in repression of T3S so increased gadE expression following Stx 
phage lysogeny may well account for some of the reduced expression (Kailasan Vanaja et 
al., 2009; Tatsuno et al., 2003). In addition, there is established reciprocal cross-talk 
between motility and T3S governed by GrlA/R and so a decrease in T3S may lead to an 
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increase in motility, although this cannot be the molecular basis for the increase in 
motility in E. coli K-12 (Su et al. 2010).  
 
Previous work has established that the LEE2/3 operons, but not LEE1 are subject to 
repression by LexA in EPEC with activation following SOS induction (Mellies et al., 
2007).  The repression of Ler activiy on LEE1 may be the result of established lambda 
lysogeny regulators and/or regulators encoded elsewhere in the bacteriophages.   To test 
established lambda phage regulators, cI, cII, cro, anti-terminators N and Q were cloned 
and induced in TUV93-0.  CI was a potential regulator as this is the main phage encoded-
protein known to be expressed constitutively during lysogeny (Oppenheim et al., 2005) 
but its induction had no impact on T3S.  CII was the only induced regulator that had an 
effect, but in this case the growth rate of the cells was also reduced and there was not the 
concomitant reduction in EscJ levels as seen for lysogeny with the whole phage.  De-
regulated CII expression is established to have affects on growth rates through the cell 
cycle (Kedzierska et al., 2003) and so the T3S changes may have been due to indirect 
effects.  For example, ClpX activity is increased in stressed bacteria and this is known act 
predominately on LEE4/5 and so would affect T3S levels of the LEE4-encoded EspD but 
not EscJ expressed from LEE3 (Iyoda & Watanabe, 2005).  To test the potential 
importance of cII, both copies were deleted from the Stx1 and Stx2 phages in EDL933.  
For this mutant T3S was increased indicating a role of cII in the control of T3S regulation.  
This result is however incongruous with the established regulation and function of CII, 
which is thought to only be expressed to establish the lambda lysogen (Oppenheim et al., 
2005). While this appears to be the case for bacteriophage Lambda there may well be 
differences in the regulation between classic lambda and Stx lambdoid bacteriophages. In 
addition, we cannot rule out that other Stx phage-based regulators may also contribute to 
repression of T3S following lysogeny and investigating this will be the basis of future 
work in this area.  
 
A key question is why is this repression of T3S associated with Stx phage lysogeny?  In 
the host, the bacterium will be subject to multiple stresses that will lead to a subset of the 
bacterial signalling and relocating nucleolin to the epithelial cell surface where it binds to 
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the EHEC adhesin, intimin, expressed from LEE5 (Robinson et al., 2006) population 
undergoing lysis (Liu et al., 2010). Shiga toxins released from the lytic subset of the 
bacterial population have been shown to provide a colonisation advantage both by 
reducing inflammatory).  This function of Stx directly links Stx phage regulation/lysis 
control and LEE-promoted adherence.  The findings of the present study have 
demonstrated that Stx2 bacteriophage integration represses T3S.  We propose that Stx 
phages repress LEE1 expression to effectively take control of this critical colonisation 
factor.  The Stx bacteriophage, through this regulation, ensures that bacterial colonisation 
and persistence become dependent on the bacteriophage.  It is interesting that EHEC 
strains, by comparison with the sequenced EPEC strain O127:H6 strain have a greater 
number of T3S effector proteins expressed from a variety of cryptic prophages (Ogura et 
al., 2009; Tobe et al., 2006).  More than 60 effectors from Sakai O157:H7 genomes were 
identified in which 39 proteins were proved to be experimentally functional (Toru Tobe, 
2006, PNAS). The majority of these functional genes are located on the prophages of 
Sakai O157:H7 strain. These effectors can be classified into many proteins family such as 
NleG, NleA, NleH, NleB, NleC, LRR, EspF, PerC family etc. Seven homologue genes of 
PerC are encoded within OIs in EHEC including PchA-E, PchX and PchY. The effect of 
these effector proteins are mediated via PchA/B regulators that act by increasing 
expression from LEE1 (Abe et al., 2008). It is considered that prophages can contribute 
to the change of phenotype or fitness of host bacteria. Consequently, these resulted 
bacteria are more competitive in host and environment, and even more pathogenic to 
animals and human.  We propose that Stx phages provide a selective advantage in EHEC 
strains for colonisation and persistence in cattle not just through the effects of Shiga toxin 
but also through repressing T3S expression favoring the selection of multiple prophage 
units encoding effector proteins with regulators that overcome this repression (Fig 5.49-
51). As a consequence, it is the network of prophage-based repressors and activators 
controlling T3S that is important for EHEC strains (Tree et al., 2009b). 
 
It is established that EHEC strains vary markedly in their capacity to produce Stx toxins 
(Zhang et al., 2009), a phenotype that is intricately associated with Stx phage carriage 
and levels of lysis induction.  The lysis/lysogeny decision will be affected by the 
 
 184
genotype of the strain, number of Stx phages and possible cross-talk between phage 
regulators.  The heterogeneous nature of lysis induction means that for the subset of cells 
that do not lyse, then the remaining subset may have induced T3S ready to benefit from 
Stx priming of the epithelium.  In this way, the Stx phage and effector prophage 
repertoire of an EHEC strain are intimately associated with excretion level from the 




Additional work could be carried out on the confirmation of Stx phage and cII regulation 
on T3SS. Using single copy of ler with GFP, the plasmids multiple copy number effect 
on the measurement of expression in bacteria can be excluded. Other work also could 
focus on the cII transcription level in different strains such as Stx+/- strains to confirm cII 
effect of T3SS. 
 
Some future work will examine the mechanism of the Stx phage regulation of T3SS. 
Firstly, cII, as a potential regulator on T3S, will be investigated in the binding with LEE1 
promoter and ler. Briefly, cII protein will be purified. Then the electrophoretic mobility 
shift assay will be used to test the binding between CII and LEE1 promoter region and ler. 
If interaction is indentified, then specific mutations will be designed to figure out the 
exact binding site on LEE1 promoter region and or ler. If no binding is detected, future 
work will address on the question which genes are responsible for the regulation of T3SS 
on Stx2 phage. Deletions of the candidate genes on conjugated Stx2 phage in K12 can be 
constructed. The expression of LEE1 promoter indicating the level of T3S can be 
measured by GFP reading. If any gene is identified, further work including protein-



































Fig. 5.49 Schematic diagram showing that the integrated Shiga toxin prophage represses 




  Under the conditions shown there is no expression of the PchA/B regulators associated 











Fig. 5.50 Schematic diagram showing that the repressive control of the Stx prophage is 
overridden by the activity of activators such as Ler, and PchA/B that are induced 
following sensing of niche specific signals in the animal host (This graph was produced 
by Eliza Wolfson). While a number of environmental signals are known to control T3S at 





















Fig.5.51 A model for EHEC interaction with the epithelium (produced by Eliza Wolfson). 
SOS stress responses result in prophage induction and Stx release in a subset of the 
population.  Potentially certain stresses associated with the interaction with epithelial 
cells may induce this response.  The released toxin induces the expression and 
redistribution of receptors to the epithelial cell surface.  T3S is repressed but can be 
induced by Pch activators (Tree et al., 2009a; Yang et al., 2009) present on cryptic 
lambdoid prophages that ensure co-ordination of effector protein expression with 
production of the T3S system (Fig. 5. 49-50).  The induction of T3S includes intimin 
expression on the outer membrane of the bacteria allowing binding to Stx-induced 
receptors, including nucleolin (Kenny et al., 1997).  This leads to intimate attachment and 
lesion formation.  Secreted effector proteins can repress inflammation as can Stx.  It is 
proposed that the degree and nature of this modulation will be different between strain 
types impacting on bacterial replication and therefore the extent of excretion from the 







































E. coli O157:H7 is a devastating pathogen causing serious diseases including bloody 
diarrhea, HC, HUS and even death. The latest biggest outbreak occurred in Germany 
leading to over 800 HUS cases (including over 30 fatalities) reported in Germany  with 
over 36 HUS cases (at least 1 fatality) and 66 EHEC cases (none fatal) from other 
European countries. HUS develops from released Stx binding to Gb3 expressing 
endothelial cells in the kidney and the subsequent host responses to repair the killed cells. 
Stx phages are key prophages acquired into the chromosome during the evolution of E. 
coli O157:H7 (Filee et al., 2003; Perna et al., 2001). Cattle are considered as the main 
reservoir of E. coli O157:H7 (Perna et al., 2001). T3S is essential to the colonization of E. 
coli O157:H7 in the terminal rectum (Naylor et al., 2005). Bacteria utilize the T3SS to 
export effectors into host cell and the open conduit may even allow the import of 
essential nutrients. These secreted effectors affect host cell signal transduction pathways 
and drive the formation of A/E lesions. However, the tropism of E. coli O157:H7 for the 
terminal rectum in cattle is not understood.  One hypothesis proposed in this study is that 
variant oxygen levels in different parts of the gastrointestinal tract may influence the 
maturation of T3SS. This is supported by a report demonstrating that the maturation of 
T3SS was enhanced by the activation of anaerobic system (Ando et al., 2007). T3SS 
responds to many regulators and factors such as pH value, glucose, iron and temperature 
(Laaberki et al., 2006). Previous work has demonstrated marked variation in the levels of 
T3S among EHEC O157 strains.  The aim of this research was to further investigate the 
regulation of T3S towards two objectives: (1) to understand the localization of EHEC 
O157 at the terminal rectum of cattle; (2) to understand the strain variation in T3S and 
whether this might be related to differences in strain epidemiology. 
 
In relation to rectal and mucosal colonization, I investigated the importance of four 
aerobic/anaerobic regulators (ArcA, Fnr, NarX and NarP) on T3SS. Four deletion 
mutants were constructed by λ recombination technology in the E. coli O157:H7 Walla 3 
(ZAP198) background. Adherence efficiency, A/E lesions formation, growth rate and 
T3S level, were examined in these four mutants as well as the wild type (ZAP198). All 
the four mutants showed some reduction in adherence level, while arcA, narX and narP 
mutants showed a significant decrease (P < 0.05). A/E lesions are formed by the T3SS 
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following colonization and attachment to intestinal mucosa. Consistent with the binding 
data, A/E lesions in the four regulatory mutants were also decreased compared with the 
wild type strain, especially for the arcA and narX mutants (P < 0.01). However, the 
results from growth basic growth rate determinations indicated that the arcA, narX and 
narP mutants were affected. In contrast, the fnr mutant grew faster than the wild type. 
These results indicated that the adherence and A/E lesions reduction in arcA, narX and 
narP mutants might due to growth issues with these strains. Slower growth can cause less 
adherence and A/E lesion formation in the same time period. Interestingly, the fnr mutant 
showed decreased adherence and A/E lesion level with a shorter generation time 
compared to the wild type. This may indicate that Fnr can enhance attachment and A/E 
lesion formation by up-regulating the T3SS directly or indirectly. Recent work by Dr Jai 
Tree in our group has demonstrated that FnrS (Fnr sRNA) is predicted to interact with the 
LEE4 transcript (Jai Tree, personal communication). Further work may address Fnr 
regulation of T3S, but my PhD research switched to an alternative approach involving the 
construction of an inducible LEE1 promoter to allow induction of T3S by addition of the 
chemical inducer.  
 
The aim of this second section of work was to override normal signal inputs into the  
promoter by replacing this promoter with tet promoter which can be induced with aTc.  
This construct could then be used to examine the link between the tropism of O157 for 
the terminal rectum of cattle and the regulation of T3S, as aTc could be administered to 
animals or a constitutive promoter used in its place. If successful, this construct could 
also be used to test whether heterogeneous of LEE4 and LEE5 (Roe et al., 2003b) is 
completely independent of normal inputs at LEE1 and whether the expression level at 
LEE1 alters the proportion of bacteria expressing a functional T3SS. Two constructs 
were designed. The first construction kept the original transcriptional start site and -10 
region of the native LEE1 operon promoter, while the -35 regions are replaced by AT 
rich DNA sequence (tet promoter) synthesized artificially (Fig. 4.16). For the second 
construct, only the original transcriptional start site was kept with -35 and -10 regions 
replaced by a synthesized tet promoter (Fig. 4.17). The first construction was successfully 
obtained by allelic exchange with LEE1 promoter -35 region replaced by the tet promoter. 
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The resultant strain should be controlled by aTc as expected. Surprisingly, no detectable 
T3S protein was found with aTc induction in this strain. However, it could still be the 
case that the tet promoter was being induced but that this did not result in T3S for reasons 
that are not currently understood. Based on subsequent work using my ZAP1327 strain 
(ZAP198 with the LEE1 promoter replaced by sacBkan cassette), Allen Flockhart, Jai 
Tree and Mariya demonstrated that a comparatively high level of transcription of LEE1 is 
occurring from this cassette into the LEE1 operon, but that despite this there is no T3S   
detected by Western blotting. Interestingly, the introduction of a plasmid containing ler 
and its promoter region lead to T3S being detectable from ZAP1327.  Given that ler 
should not be able to induce LEE1 any further in this strain (as the LEE1 regulatory 
region it normally auto-induces is no longer there) then this T3S must be the result of the 
introduced additional ler acting on LEE2-5 and/or a controlling factor present upstream 
of ler, such as an sRNA, that is also required for T3S. It does though indicate that even 
with successful aTc induction from my construct it is unlikely that I would have induced 
T3S.  Future work will examine by RT-PCR whether the aTc induction is producing 
increased levels of the LEE1 transcript.  In attempting to obtain the second construction 
strain, I had difficulties in cloning tet promoter in front of ler. I tried many times in 
cloning the tet promoter into pIB307 with both LEE1 promoter flanking regions 
including ler. But mutations were always detected in the cloned tet promoter.  This might 
be due to a high expression levels from the tet promoter in the cloning vector leading to 
an extremely high expression of Ler which could be lethal to the bacteria and therefore 
selected against. So only defective tet promoter regions could be selected in the process 
of cloning. Although the constructed strain (first construction) can not be used for the 
designed purposes, the intermediate strains, such as ZAP1213 (ZAP198 with lazY&Z 
replaced by tetR) and ZAP1327 (ZAP1213 with LEE1 promoter replaced by sacBkan 
cassette), can be used for other related work and other constructions using the inducible 
TetR system. My PhD work moved on to investigate variable T3S levels in different 
strains.  
 
An IPRAVE (Wellcome Trust funded) study reported that PT21/28 strains were more 
likely to be associated with higher level faecal counts compared with PT32 strains in  
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cattle.  In addition, PT21/28 strains over that period were the most prevalent phage type 
associated with human infection (Chase-Topping et al., 2008; Chase-Topping et al., 
2007b).  The initial aim was to compare PT21/28 and PT32 strains in terms of genomic 
differences and phenotypes including T3SS to determine how these inform the 
epidemiology. 
 
CGH analysis of 12 strains indicated that one of the main differences between the PT 
21/28 and 32 strains was with Stx phage carriage.  Based on the CGH, PCR was used to 
determine the presence of Stx2 and Stx2c in 60 strains. Results indicated that PT21/28 
strains generally carried both Stx2 and Stx2c bacteriophages, irrespective of whether the 
strains were sourced from cattle or humans.  By co 
ntrast, nearly all the bovine PT32 strains analyzed carried only the Stx2c phage.  The 
situation for the limited number of human PT32 strains was more complex, but these 
were significantly more likely to contain a Stx2 phage in comparison to the bovine strains.  
This data indicates that strains carrying both Stx2 and Stx2c phages are more likely to be 
associated with human infection.  This result is in line with recently published research 
on Clade 8 strains in the USA that are considered to be more virulent. Clade 8 strains 
were significantly more likely to carry both the stx2 and stx2c genes in comparison to the 
other clades containing stx2c (Manning et al., 2008).  All clade 8 strains tested had stx2, 
and 57.6% had stx2c.  Whether this association for both relates to differences in toxicity 
of the strains or other phenotypes associated with the strains is not known, although more 
recent work has indicated that levels of Stx2 production alone are likely to be important, 
irrespective of lineage, in terms of association with human clinical disease (Zhang et al. 
2009).  
 
To identify the T3S levels in these two phage types, we investigated for the secreted 
translocon protein EspD and T3S apparatus protein EscJ by Western blotting.  LEE1 
expression was also measured by determining fluorescence levels from a previously 
published LEE1-GFP reporter (Roe et al., 2003a). T3S levels were low in the majority of 
PT21/28 strains compared with the PT32 strains. The results also demonstrated that both 
Stx2 and Stx2c phages had on average lower levels of LEE1 expression than strains with 
 
 193
a single Stx2 bacteriophage.  Analysis of strain pairs demonstrated that Stx phage 
insertion into the chromosome leads to repression on T3S (Fig. 5.5-8), this was also 
apparent in a pair of O26 strains, including one from which the Stx2 phage had been 
naturally cured Bielaszewska ref at end.  While Stx bacteriophage insertion and deletion 
repressed and activated T3S respectively, other differences between the strains also 
account for the marked difference in T3S levels between these strains.  Further research 
using information on the sequences of multiple strains in comparison with T3S profile 
should help clarify the main alleles responsible for this variation.    
 
To confirm and study the Stx2 bacteriophage repression in another background, the 
sequenced E. coli K12 MG1655 strain was lysogenised with a marked Stx2 phage from 
the sequenced E. coli O157:H7 Sakai strain (Table 3, this work is done by Sean McAteer) 
and LEE1 transcription levels were measured this constructed strain and MG1655. It was 
revealed that expression of LEE1 was significantly repressed in the K-12 strain 
containing the Stx2 lysogen. GadE is known to be involved in repression of T3S so 
increased gadE expression following Stx phage lysogeny may well account for some of 
the reduced expression (Kailasan Vanaja et al., 2009; Tatsuno et al., 2003). The 
repression of Ler activiy on LEE1 may be the result of established lambda lysogeny 
regulators and/or regulators encoded elsewhere in the bacteriophages.  To test established 
lambda phage regulators, cI, cII, cro, anti-terminators N and Q were cloned and induced 
in TUV93-0. CII was the only induced regulator that had an effect on T3S, but in this 
case the growth rate of the cells was also reduced and there was not the concomitant 
reduction in EscJ levels as seen for lysogeny with the whole phage. To test the potential 
importance of cII, both copies were deleted from the Stx1 and Stx2 phages in EDL933.  
For this mutant T3S was increased indicating a role of cII in the control of T3S regulation.  
This result is however incongruous with the established regulation and function of CII, 
which is thought to only be expressed to establish the lambda lysogen (Oppenheim et al., 
2005). While this appears to be the case for bacteriophage Lambda there may well be 
differences in the regulation between classic lambda and Stx lambdoid bacteriophages. In 
addition, I cannot rule out that other Stx phage-based regulators may also contribute to 
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repression of T3S following lysogeny and investigating this will be the basis of future 
work in this area.  
 
Some future work will examine whether increased persistence or excretion of strains 
in/from cattle is associated with integration of multiple Stx phages and increased Stx 
toxin levels, with the obvious negative ramifications for human EHEC infections. Briefly, 
paired strains including Stx positive and negative such as 1238 (Stx2+) and 1239 (Stx2-), 
EDL933 and TUV93-0 will be used to infect cattle. The shedding levels will be measured 
in the following weeks. In the end, the colonization persistence and tropism in the cattle 
will be examined. At the same time, the A/E lesions and toxin production levels of these 
tested strains will be measured in the lab.  
 
Additional future work can address further the regulatory mechanisms working between 
the Stx phage and the T3SS. To investigate the mechanism of CII regulation on T3S, the 
interaction of CII with the ler/LEE1 promoter could be examined. Briefly, expressed CII 
proteins would be used to examine with the interaction with ler DNA including the 
promoter of ler by electrophoretic mobility shift assay. Further work would be carried out 
to investigate the the specific site on ler to which CII binds. If no interacion is found 
between CII and ler, future work could address other regions to which it may bind such 
as grlA/R and the gadE promoters.  Other phage based controlling factors could be 
screened for by deleting Stx phage regions from the K12 Stx2 phage lysogen and the 
effect on T3S induction measured with a LEE1-GFP reporter.  
 
Overall the key finding of my work is that the Stx bacteriophage ‘takes control’ of the 
key EHEC colonisation system, potentially allowing selection of other prophage elements 
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